ID,title,status,study_type,arm_group_type,intervention_type,interventional_type_model,phase,fda_regulated_drug,fda_regulated_device
IRST174.22,What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?,Recruiting,Interventional,"No Intervention, Experimental, Experimental",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
GCO 17-2188,Increasing African Immigrant Womens Participation in Breast Cancer Screening,Recruiting,Interventional,Other,Behavioral,Single Group Assignment,Not Applicable,No,No
233756,The HIFUB Study (HIFU in Breast Cancer),Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
D16196,A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
RO1912-30902,RCT Comparing 2 Radiotherapy HypoFractionation Schedules In Breast Cancer Patients,Unknown status,Interventional,"Other, Experimental",Radiation,Parallel Assignment,Not Applicable,No,No
UMCC 2021.087,Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
LNs Staging of Breast cancer,Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.,Unknown status,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
SA18i0002,The Effect of a Patient Decision Aids for Breast Cancer Screening,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
494936,Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening,Recruiting,Interventional,Experimental,Genetic,Single Group Assignment,Not Applicable,No,No
042210,Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
(818)109A-57,Mobile Application Support for Women With Breast Cancer Undergoing Chemotherapy,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
21 SEIN 01,Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.,Completed,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
18-181,Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
catheter guided chemo-infusion,Catheter Guided Chemo-infusion in Breast Cancer,Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2020/132,Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS),Completed,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,Not Applicable,No,No
17-689,Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening,"Active, not recruiting",Interventional,Experimental,"Device, Device",Single Group Assignment,Not Applicable,No,Yes
831804,[18F] F-GLN by PET/CT in Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
154/2019,Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery,Suspended,Interventional,"Experimental, Other",Other,Parallel Assignment,Not Applicable,No,No
Amr Ahmed,"The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism",Not yet recruiting,Interventional,"Experimental, Experimental",Combination Product,Parallel Assignment,Early Phase 1,Yes,No
2022-11-076-002,Comparison of Ultrasound and Breast MRI for Breast Cancer Detection,Not yet recruiting,Interventional,"Experimental, Experimental",Diagnostic Test,Crossover Assignment,Not Applicable,No,No
Health Literacy of Breast Ca,The Effect of Breast Cancer Screening Training,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
ZY(2018-2020)-CCCX-2005-04,Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
22IC7498,Behavioural Science Messages in Breast Cancer Screening,Completed,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
18 SEIN 11,"Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.",Recruiting,Interventional,Experimental,Other,Single Group Assignment,Phase 2,No,No
17-447,Imaging With [11C]Martinostat in Breast Cancer,Withdrawn,Interventional,Experimental,"Drug, Device",Single Group Assignment,Phase 1,Yes,No
22-509,Breast Cancer Survivor Educational Intervention,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ID-BCRPS-02-20220913,The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
17-01549,Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,Yes
202101073,Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
"estPerMed 1, Breast",Personalised Risk-based Breast Cancer Prevention and Screening,Unknown status,Interventional,"Active Comparator, Active Comparator, No Intervention",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
68824072019,Risk Reduction Program for Women Having High Risk of Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
20220303swj0211,The Psychology Intervention on Disease Acceptance and Quality of Life in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
RC20_0532,Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
KMUHIRB-E(I)-20200041,"Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self-Efficacy, and Resilience Among Newly Diagnosed Breast Cancer Patients Undergoing Treatment",Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
4452,Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,Not Applicable,No,No
SK-421-BRCA,A Digital Solution for Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
autotaxin1,Autotaxin: a Potential Biomarker for Breast Cancer.,Completed,Interventional,"Active Comparator, Sham Comparator",Biological,Parallel Assignment,Not Applicable,No,No
DS8201-A-U302,"DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
CCR 5113,PIONEER Study of Lifestyle Intervention to Reduced Breast Cancer Risk,"Active, not recruiting",Interventional,"No Intervention, No Intervention, Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
ICO-N-2017-02,Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse,Terminated,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
medicin,Autotaxin (ATX) as a Marker for Breast Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other, Other",Parallel Assignment,Not Applicable,No,No
METCZ20200211,Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2020-A00058-31,Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening,Recruiting,Interventional,"Other, Other, Other",Other,Parallel Assignment,Not Applicable,No,No
351-19,mULM to Support Breast Cancer Diagnosis and Therapy,Recruiting,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
PekingUPH10B004,Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
CD3-MUC1 in breast cancer,Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer,Withdrawn,Interventional,"Experimental, Active Comparator, No Intervention","Biological, Procedure",Parallel Assignment,Phase 2,No,No
LCCC 1829,Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
2022-080,"Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
20218,A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
LA LEAST,Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2015-004027-31,HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer,Recruiting,Interventional,"Other, Other",Radiation,Parallel Assignment,Not Applicable,No,No
BREACE,Exercise in Older Women With Breast Cancer During Systemic Therapy,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
495077,18F-FDG PET/CT Imaging for Breast Cancer,Recruiting,Interventional,"Other, Other",Other,Parallel Assignment,Not Applicable,No,No
CCR4684,"Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours",Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
211753,BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
1705018188,Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer,Terminated,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,Yes
22-136,"A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer",Recruiting,Interventional,Experimental,"Diagnostic Test, Radiation, Procedure",Single Group Assignment,Phase 1,No,No
RECO_CT29B,Investigation of Urinary Biomarkers for the Detection of Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
D8531C00002,A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy,Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SOLTI-1910,Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.,Recruiting,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,Phase 2,No,No
Targeted axillary dissection,Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy,Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Phase 4,No,No
2021-0215,BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
17-398,Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
IC 2018-01,Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer,Completed,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,Not Applicable,No,No
IC 2020 08,Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer.,Completed,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,Not Applicable,No,No
PI17/00834,Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening,Completed,Interventional,,Other,Single Group Assignment,Not Applicable,No,No
PekingUMCH-FAPI-BC-1,Characterizing Breast Cancer With 68Ga-FAPI PET/CT,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
PekingUMCH-FAPI-BC-2,Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
180034,ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
IRB17-0721,Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
BCL IDE,Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
REO 027,A Window-of-opportunity Study of Pelareorep in Early Breast Cancer,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,Early Phase 1,No,No
V3-MOMMO-01,Open Label Immunotherapy Trial for Breast Cancer,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,No,No
077-2019,Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Locally-Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
Juçara Phd Thesis,Emotional Evaluation and Reconstructed Breast Satisfaction,Unknown status,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
18 SEIN 08,The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.,Terminated,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
2021-012,Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE),Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
CASE12119,Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Genetic, Genetic, Other, Other, Device",Parallel Assignment,Not Applicable,No,Yes
18-124,ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
EFC16133,"Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity",Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
s66248,Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
964635,The Benefit of Surgery in Stage IV of Breast Cancer,Unknown status,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
SCCC-11118; STU-2018-0015,Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
2019402,Supportive Effects of Craniosacral Therapy for Female Patients With Breast Cancer and Their Partners,Not yet recruiting,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
RADIO-SLEEP,Sleep Disorders Prior to and During a Course of Radiotherapy for Breast Cancer,Not yet recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
19-001,Individualizing Surveillance Mammography for Older Breast Cancer Survivors,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
UCaenNormandie,A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile),Enrolling by invitation,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
17-552,Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,Yes
CCR5348,Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer,Not yet recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
STUDY00011606,Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Other, Other, Other, Other",Factorial Assignment,Not Applicable,No,No
03/21,A Prospective Single-center Cohort Study Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients,Not yet recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
AHQU-2021007,Genetic Predictors of Response to Acupuncture for Cancer-related Fatigue Among Breast Cancer Patients After Chemotherapy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
D8530C00003,"A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
2019-05-157,Genetic Characteristics of Metastatic Breast Cancer Patients,Recruiting,Interventional,Other,Diagnostic Test,Sequential Assignment,Not Applicable,No,No
200056,"BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)",Terminated,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Biological, Biological",Sequential Assignment,Phase 1,Yes,No
182-20-CA,18F-fluoroestradiol (FES) PET/CT for Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,Phase 2,Yes,No
Shengjing-LCG008,Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy,Not yet recruiting,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,Phase 3,No,No
NeoRadUKD,NeoRad Breast Cancer Study,Not yet recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
STUDY19060359,Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
UEM0002,Synergic Effects of Physical Activity and Probiotic on Gut Immune System and Quality of Life of Breast Cancer Survivors.,Withdrawn,Interventional,"Experimental, Experimental, Placebo Comparator","Other, Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
004181,Together After Cancer,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
21 SEIN 09,"Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.",Recruiting,Interventional,Other,"Other, Other",Single Group Assignment,Not Applicable,No,No
CINEICC-3-IAT,Mind Programme for Women With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Bakircay University,Training With Mobile Application in Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
21149002,The Effect of Virtual Reality on Anxiety and Fatigue in Women With Breast Cancer Receiving Adjuvant Chemotherapy,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
AAAU1629,FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments,Not yet recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
BC-NEO-IIT-SHR1316-SHR6390-RT,Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,Not Applicable,No,No
IRB202100182 -N,All-extremity Exercise During Breast Cancer Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2019-KY-001-003,PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer,Completed,Interventional,Experimental,Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
AbantIBU,Early Detection of Lymphedema With Bio-Electrical Impedance Analysis in Patients After Breast Cancer Surgery,Withdrawn,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
121K686,Online Group Therapy for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
NADOPTIC,Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
Pro00020917,Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Breast Cancer,"Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy Treatment",Not yet recruiting,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
BSU,The Effect of Metformin on Breast Cancer Patients,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
URomLS Prot.0930/2021Rif. 6528,To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study),Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
SOLTI-1716,Pembrolizumab + Paclitaxel in Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2-negative (HER2-) Non-luminal (by PAM50) Advanced Breast Cancer After Cyclin-dependent Kinase 4/6 (CDK4/6) Inhibitors Progression,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
LCCC 1749,Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging,Recruiting,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,Not Applicable,No,No
GIMI-IRB-20005,Multi-4SCAR-T Therapy Targeting Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
202302017,Cryoablation vs Lumpectomy in T1 Breast Cancers,Not yet recruiting,Interventional,"Experimental, Active Comparator, Other, Experimental","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
2015-4-6-003,Prevention of Sequelae Pain After Breast Cancer Surgery by Self-massages and Self Stretching. Impact of Learning Workshops.,Recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
FIRST,FreezIng bReaST Cancer in Brazil: a Before-after Study,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
147/19,Breast Cancer: Feasibility of an Educational Intervention,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
STUDY00001641,Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
PetrovRIO,Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB),Recruiting,Interventional,"Experimental, Experimental",Procedure,Single Group Assignment,Not Applicable,No,No
wanghaibo,Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer,Not yet recruiting,Interventional,Experimental,Biological,Single Group Assignment,Early Phase 1,No,No
852-20,"Breast Cancer, Reasoning, and Activity Intervention",Withdrawn,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
2020[84],HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Early Phase 1,No,No
IBCSG 59-19,Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
33293720.9.0000.5505,Tele-rehabilitation in Women With Breast Cancer During COVID-19 Pandemic.,"Active, not recruiting",Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
199080,Prospective Trial of Digital Breast Tomosynthesis (DBT) in Breast Cancer Screening.,Recruiting,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
SLN SPECT,Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT,Unknown status,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,Not Applicable,No,No
SOLTI-1907,Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SDS-HER-01-2018,Safety and Efficacy Assessment of Diagnostic Microprobe (inPROBE) in Women at High Risk of Breast Cancer,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
APHP211502,Breast Cancer Prevention and Screening Membership,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
SCHBCC-N024,Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
CELC-G-301,Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1),Recruiting,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
DBCG Proton trial,The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,Not Applicable,No,Yes
OOTR-N016/KBCRN-B-003/HT-PAB,"Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer",Completed,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
710/2021,The Effect of Arm Exercises on Arm Oedema After Breast Cancer Surgery,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
KL166-IIS-001,HER2-positive Breast Cancer Project Initiated by Investigators,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
N19ASC,Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy,Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
SNBvsPET/MRI 2,Axillary Staging in Early Breast Cancer: SNB vs PET/MRI,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
dingxwyh01,Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Not Applicable,No,No
SNUH_FMI,Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer,Unknown status,Interventional,Other,Genetic,Single Group Assignment,Not Applicable,No,No
2022/0035986,Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
RF-2013-02358165,Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial),Unknown status,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
18-516,GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
19-147,Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer,Completed,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,Phase 1,Yes,No
dingxwyh02,The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Not Applicable,No,No
19 SEIN 14,E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
AURORA,New Techniques to evAlUate Response to neOadjuvant Treatments in bReast cAncer (AURORA),Unknown status,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
BR02/03/21,Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer,Recruiting,Interventional,Experimental,Device,Sequential Assignment,Phase 1,No,No
2018-9529,TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer,Recruiting,Interventional,"Other, Other","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
REaCT-HER TIME,Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
SOLTI-1911,Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
IC 2018-08,Breast Cancer Risk After Diagnostic Gene Sequencing,Completed,Interventional,Experimental,"Genetic, Genetic, Behavioral",Single Group Assignment,Not Applicable,No,No
AHQU-2021006,Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
V2011201,Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
HCB-ONC001 (ML41519),Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy,Recruiting,Interventional,"Experimental, No Intervention",Biological,Single Group Assignment,Phase 2,No,No
IRB-300002157,RAD 1802: Pilot Trial of Dose Adapted Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI),Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,Yes
Shengjing-LCG009,Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
OTT-19-06,"A Phase II Window of Opportunity Trial of PRMT5 Inhibitor, GSK3326595, in Early Stage Breast Cancer",Completed,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
FAST feasibility in CU,Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
BC001,Moving on After Breast Cancer Plus- for Breast Cancer Survivors,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
UT BCS ECS Study,Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors,Withdrawn,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
19-509,Genetic Testing for All Breast Cancer Patients (GET FACTS),"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
19-277,Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients,"Active, not recruiting",Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
UW 20-064,Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
20-1039,Couples QOL in Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
UC-0105/1701,SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer,Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
18-1025,Coping Together After Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
09.2019.984,Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema,Unknown status,Interventional,Experimental,Combination Product,Single Group Assignment,Not Applicable,No,No
O4M-B001,Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients,Unknown status,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
TaiHao TVGH2020-07-006AC#1,Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes,"Active, not recruiting",Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
STGKS001,Artificial Intelligence in Large-scale Breast Cancer Screening,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
19-086,"AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
CNER 202107/05,eHealth Intervention for Medication Adherence in Breast Cancer Survivors,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
Optimune Trial,Evaluating a Novel Web-based Intervention for Breast Cancer Survivors,Terminated,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
1808019498,Converting HR+ Breast Cancer Into an Individualized Vaccine,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Radiation, Drug, Biological",Parallel Assignment,Phase 2,Yes,No
HYGEE,Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.,"Active, not recruiting",Interventional,"No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,No
STU-2018-0370,Infrared Imaging for Breast Cancer Modeling,Completed,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
Prix Ruban Rose/2021/FF-01,Personalized Follow-up After Breast Cancer Surgery Via Electronic Patient Reported Outcomes,Completed,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
Pyrotinib neoadjuvant,Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,Phase 2,No,No
FUSCC-OMIT,A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT),Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
SMC 2021-02-102,"Selective Omission of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm studyTrial",Enrolling by invitation,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
BSMMU/2019/8874,Effect of Vitamin C and E in Breast Cancer Patients Undergoing Chemotherapy,Unknown status,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,Not Applicable,No,No
99mTc-ADAPT6 vs 99mTc-DARPinG3,Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Not Applicable,No,No
Telemonitoring BCS,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors",Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
CCTG MA.39,Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Radiation, Other",Parallel Assignment,Phase 3,No,Yes
19/317-2101,Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
2021-1116,Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,No,No
SPT-2021-002,Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 4,No,No
s66248-aim2,Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity,Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
BGB-290-201,Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China,Completed,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
10038,Autologous huMNC2-CAR44 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,Phase 1,Yes,No
Pro00085352,Examining Bioactivity of PVSRIPO in Invasive Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Early Phase 1,Yes,No
EORTC 1745-ETF-BCG,Adjuvant Palbociclib in Elderly Patients With Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
4523,Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
17-455,The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,Phase 2,Yes,No
01AB21- PIK3CA,Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
ICO-N-2017-12,Clinico-biological Data Collection Study of Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Procedure, Biological, Behavioral",Parallel Assignment,Not Applicable,No,No
Optimune Trial Add-on,Evaluating a Novel Web-based Intervention for Breast Cancer Survivors,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
2018396H,TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,Phase 2,No,No
PROICM 2020-05 SKY,Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.,Recruiting,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
GEICAM/2019-01,Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
MA-BC-Ⅱ-040,Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2019-1183,A Phase I Dose Escalation Study of Single Fraction Ablative Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 1,No,Yes
IJB-NERABRAIN-ODN-007,Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
19-066,Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,Yes
EH18-203,The MEDITATE-BC Study: Mindfulness-Enhanced Decision Intervention To Aid Treatment Election - Breast Cancer,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
A211801,Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,Phase 3,Yes,No
CAAE: 39277420.8.0000.5313,Adaptations to Breast Cancer and Exercise Using Telehealth (ABRACE: Telehealth),Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
D361DC00001,Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292),Recruiting,Interventional,"Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
PekingUMCH-NM25,99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
5354-CL-1201,A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 2,Yes,No
2019-228,Prophylactic Irradiation to the Contralateral Breast for BCAs Patients,Recruiting,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,Not Applicable,No,No
800646,Intervening on Womens Health for Rural Young Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Sequential Assignment,Not Applicable,No,No
NP 1521/19,Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,Not Applicable,No,No
DARE,"DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
[2019]52,HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
NOV2016PhD818,Living Better With Advanced Breast Cancer: Feasibility Evaluation of an Online Supportive Intervention.,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
GEICAM/2017-01_IBCSG 62-20_BIG,Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET),Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
PekingUMCH-FES-BC-1,Characterizing Breast Cancer With 18F-FES PET/CT,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
GCO 17-00563,Integrated Intervention for Breast Cancer Survivors With Diabetes,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
EudraCT 2020-005200-19,Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC),Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
D9673C00007,A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,Yes,No
J21125,Cardiometabolic Screening Program,Recruiting,Interventional,Other,"Other, Other, Behavioral, Behavioral, Other, Other, Behavioral, Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
UBRS20139,Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
TQB3616-III-03,Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
20 SEIN 13,Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
20190283,SABER Study for Selected Early Stage Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Sequential Assignment,Not Applicable,No,Yes
NCC3075,Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,No,No
19900601,Effect of Lymphedema Prevention Program Based on Theory of Knowledge-attitude-practice on Postoperative Breast Cancer Patients,Completed,Interventional,"Experimental, No Intervention",Behavioral,Factorial Assignment,Not Applicable,No,No
DBCG RT Recon,Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
PROICM 2019-11 PRA,A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other, Radiation",Parallel Assignment,Phase 3,No,No
SPHIC-TR-BCa2022-01,A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 1,No,No
SRMBCNabP2022,Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,No,No
C3441020,Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
FDRT-BC009,FSRT in Breast Cancer Patients With Brain Metastases,Unknown status,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
18-223,Olaparib + Sapacitabine in BRCA Mutant Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
MCC-20897,DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer,Recruiting,Interventional,Experimental,"Biological, Biological",Sequential Assignment,Phase 1,Yes,No
IIT2018-01-McArthur-IPI,Peri-Operative Ipilimumab+Nivolumab and Cryoablation in Women With Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Procedure, Procedure",Single Group Assignment,Phase 2,Yes,No
BCHRD201,AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer,Unknown status,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
BrIMA,Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
ChanghaiHTB,Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure, Drug",Sequential Assignment,Not Applicable,No,No
2018-00838; ch20Weber2,Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS),Recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
WSG-AM09,A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1),Completed,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
UC-0107/1903,Patients Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer,Recruiting,Interventional,"Other, Other, No Intervention","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
AHQU-2021005,Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
BC-2019,The Influence of Treatment Position (Prone vs. Supine) on Whole Breast Target,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
19-188,"Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
SP00049673,Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
17-512,Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
SCBCS025,"Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in China",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
19-239,Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
LC2019L06,Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy,Recruiting,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,Phase 2,No,No
HNCH-BC003,Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients,Withdrawn,Interventional,"Experimental, Active Comparator","Combination Product, Other",Parallel Assignment,Phase 2,No,No
02AB21-TucErBit,"A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
IRB-48150,68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer,Suspended,Interventional,Experimental,"Drug, Procedure, Procedure, Device",Single Group Assignment,"Phase 1, Phase 2",Yes,Yes
IUSCC-0613,An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug",Sequential Assignment,Phase 1,Yes,No
16-145,Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy,Recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
State University of São Paulo,Aerobic Training in Treatment for Breast Cancer,Completed,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
21-440,Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
YM107109E,Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
GEICAM/2020-08,Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
2023-09,Feasibility of Carbon-Dye Marking of Axillary Lymph Nodes Before Neoadjuvant Chemotherapy in Patients With Breast Cancer,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
ARV-471-BC-201,A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Procedure",Parallel Assignment,Phase 2,Yes,No
18-333,A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy,"Active, not recruiting",Interventional,Experimental,"Device, Device",Single Group Assignment,Not Applicable,No,Yes
MA-BC-II-024,Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
GNC-035-103,"A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
DS8201-A-U301,DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02],"Active, not recruiting",Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
M18DMB,ModraDoc006/r in Patients With Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ZNJC201935,Nomogram to Predict Breast Cancer Related Lymphedema,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
SCHBCC0N026,A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCC,Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
MUKDEN-09,"Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
RGT-419B_01-101,"First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
21-003046,"Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer",Recruiting,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,Phase 2,Yes,No
SSGJ-302H-mBC-IIT-01,Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC,Recruiting,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,Phase 4,No,No
KY2019-070,Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
D8530C00001,Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
BT006,Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
1R01CA236860-01A1,Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors,Recruiting,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
310-17-SZMC,Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
CINDERELLA,Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.,Not yet recruiting,Interventional,"Experimental, Other",Device,Parallel Assignment,Not Applicable,No,No
2017-01282 (BASEC),Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer,Terminated,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
RP-20-013,Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 4,Yes,No
CCR5214,"Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression",Not yet recruiting,Interventional,"Experimental, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
MCC-21757,Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Phase 2,No,Yes
K2022-025-01,A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
0720222005,The Postoperative Radiotherapy in N1 Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
D967UC00001,"Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)",Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
PLEASURABLE,"Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
21822,"COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
CTNZ-2017-01,Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy,Completed,Interventional,"Other, Other","Drug, Drug",Crossover Assignment,Phase 2,No,No
20-649,"Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,Phase 2,Yes,No
Qassim QDs-VELD,Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer,Unknown status,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 1,No,No
HR-BLTN-III-EBC,A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
14-833-02,Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study,Completed,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
17-519,Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis,"Active, not recruiting",Interventional,Experimental,"Drug, Procedure",Single Group Assignment,Phase 2,Yes,No
Radiotherapy in Breast Cancer,Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients,Completed,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,Phase 3,No,No
STML-ELA-0222,Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
H-41818,Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
CLUE-BCL,Evaluation of the Treatment Response in Breast Cancer Related Lymphedema,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
nihan25,Women on Breast Cancer Health Belıefs and Screenıng Behavıors,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2020-0927,Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
2020FES,16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer,Unknown status,Interventional,Experimental,Radiation,Single Group Assignment,"Phase 1, Phase 2",No,No
SCLND0919,Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer Patients With Ipsilateral Supraclavicular Lymph Node Metastasis,Unknown status,Interventional,"Experimental, Active Comparator","Procedure, Radiation",Parallel Assignment,Not Applicable,No,No
PUMA-NER-6203,A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib,Completed,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
KBCSG-24,Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NAC (OPTIMIST),Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
AHQU-2021001,Effect of Oxygen Inhalation on Fatigue After Chemotherapy of Breast Cancer in High Altitude Area,Recruiting,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
Fenofibrate in Breast Cancer,Fenofibrate Role in Breast Cancer Patients,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
AHQU-2021003,Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2018LS148,BAriaTric Surgery After Breast Cancer Treatment (BATS),Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,Not Applicable,No,No
PekingUMCH-BCa093,68Ga PET/CT Imaging in Breast Cancer Patients,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,"Phase 1, Phase 2",No,No
ADA,"An Integrative Intervention Based on Physical Activity, Nutrition and Supportive Care (the ADA Program) to Improve the Quality of Life of Breast Cancer Survivors",Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
514-0213/21-5000,Insulin Sensitivity After Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Not Applicable,No,No
CentroHLOBreastUnit,HOrmone Therapy Immediately After Histological Diagnosis of Breast Cancer,Unknown status,Interventional,"Experimental, No Intervention, Other, Other",Drug,Parallel Assignment,Phase 4,No,No
CCR4965,Evaluating a Digital Tool for Supporting Breast Cancer Patients,"Active, not recruiting",Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
GCO 21-0699,"Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
DBCG RT Natural Trial,Partial Breast Versus no Irradiation for Women With Early Breast Cancer,Recruiting,Interventional,"Active Comparator, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
IPNCb-01,Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CSPC-KAL-BC-12,Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
003-2017,Stereotactic Body Radiation Therapy for Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Sequential Assignment,Not Applicable,No,No
Breast cancer treatment,The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer,Not yet recruiting,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
18-561,NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Vitamin D and breast cancer,Vitamin D and Calcium Supplementation in Breast Cancer,Not yet recruiting,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,"Phase 2, Phase 3",No,No
SYSEC-KY-KS-2021-182,Quantitative Assessment of Diffusion Spectrum Imaging in Breast Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
CASE6119,Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,Early Phase 1,Yes,No
KX-ORAX-CN-007,A PK Study of Oraxol in Breast Cancer Patients,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
NCC2018M-042,Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ),Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
55791222.0.0000.5313,Water and Land-based Aerobic Training in Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
UF-BRE-002,Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients,Withdrawn,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
GIM21 - LiqERBcept,Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial),Completed,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
BREAST-SK-001,"Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.",Unknown status,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
LR19/011/50551,Increasing Knowledge of Alcohol as a Risk Factor for Breast Cancer Among Women Attending Breast Screening Services,Completed,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
STU00201961A,A Research Study for Latina Women Undergoing Breast Cancer Treatment,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
18-641,"Young, Empowered & Strong (YES): The Young Womens Breast Cancer Study 2- Focus on Intervention Pilot",Completed,Interventional,"Experimental, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
CLEE011O12301C,A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,Phase 3,Yes,No
HIRSLANDEN 01 SAKK 23/18,Intelligent Vacuum Assisted Biopsy Immediately Before Surgery as an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer,Recruiting,Interventional,Experimental,Procedure,Sequential Assignment,Not Applicable,No,No
CCH-IRB-190414-P,Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective Study,Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,Not Applicable,No,Yes
348455,Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer,"Active, not recruiting",Interventional,Other,Behavioral,Single Group Assignment,Not Applicable,No,No
SOLTI-2101,Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
Zz123456.,The Effect of the Mobile Application-based Support Program on the Outcomes of Breast Cancer Patients in the Pandemic,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
GBG102 - SASCIA,Sacituzumab Govitecan in Primary HER2-negative Breast Cancer,Recruiting,Interventional,"Experimental, Other","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
FWA00015574/6-01-2019/korany,Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment,Completed,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,Phase 2,No,No
UI-ROD-OCTU02,MicroRNA Profiles in Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
PN-301-21,"Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
ROCK,Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
SOLTI-1805,"A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Early Phase 1,No,No
KY20202075-F-2,Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
06805118.2.1001.5404,Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
AN.MCME.CR.12,Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
MedOPP293,Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
iOM-110383,A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
IRST174.25,Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
EUROPA,ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,Phase 3,No,No
HM022BC3C01,A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
UF-BRE-007,Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer Patients,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
SOLTI-2103,NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
SOLTI-1503,Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Biological, Drug",Single Group Assignment,Early Phase 1,No,No
LQ009,Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
BGB-900-2001-IIT,"A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)",Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 2,No,No
CLEE011H2301,Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ONAWA (SOLTI-1802),Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
1,Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction,Recruiting,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
STUDY00010776,REJOIN Trial for Older Breast Cancer Survivors,Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
CASE13119,Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Biological, Other",Parallel Assignment,Not Applicable,No,No
ZX-2021-FES-ESTROTIMP-4,Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
2017-0499,"Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer",Completed,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 1,Yes,No
IIT-UM2018001,Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
UPCC 17120,Telehealth Weight Loss Program for Breast Cancer Survivors,"Active, not recruiting",Interventional,Experimental,"Behavioral, Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
Shengjing_002,Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
IRB-57723,Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
3764,Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis,Unknown status,Interventional,Experimental,Radiation,Single Group Assignment,Early Phase 1,No,No
D8530C00006,"A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
115858,SIGNAL During a COVID-19 Pandemic,Withdrawn,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
CCH-IRB-190414-R,Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy for Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,Not Applicable,No,Yes
UCCS20110,Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer,"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Phase 1,No,No
2019-004559-35,Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial),Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,Phase 2,No,No
KARMA Kontrast,KARMA Kontrast - a Controlled Trial Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer,Unknown status,Interventional,Other,Combination Product,Single Group Assignment,Not Applicable,No,No
ACE-Breast-03,"ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
FMBSUREC/10102021/Rabie,Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,"Phase 2, Phase 3",No,No
2020-535,Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
EF141,Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
STUDY00001225,The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Phase 2,No,No
CCR5119,KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
3475-756,"Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)","Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug, Radiation, Procedure",Parallel Assignment,Phase 3,Yes,No
2022-0055,A Study for the Neoadjuvant Treatment of Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 4,No,No
WEFITTER,Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib,Recruiting,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
ARO-2015-1,Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,Not Applicable,No,No
HNCH-MBC11,Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SOLTI-1507,Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,No,No
DKFZ-2019-008,Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE),Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
20170328,Low-dose Apatinib Combined With Neoadjuvant Chemotherapy in the Treatment of Early Triple Negative Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SHPD005,Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 2,No,No
20-124,YES Study - Newly Diagnosed/Metastatic Intervention,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
LaPemERLA,Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
Pro00020138,Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
18-394,DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
2019SABE028,The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Other",Parallel Assignment,Not Applicable,No,No
IIBSP-PRO-2021-10,Prehabilitation for Breast Cancer Surgery,Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
SYSUCC-015,Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
REO 026-1,Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
2019.429,Effectiveness of Character Strengths-based Intervention Among Breast Cancer Patients,Completed,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
CP7-005,A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
2021/193780(REK),Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
123123,Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
JTU-6H-20211011001,Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CIMS-4FMFES-2021-3966,4FMFES-PET Imaging of ER+ Advanced Breast Cancers,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Phase 2,No,No
SOLTI-1718,Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HLX11-BC301,A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
Zoledronic Acid In Breast Ca,Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 3,Yes,No
Tacrolimus_2020,Tacrolimus as Treatment of Breast Cancer-Related Lymphedema,Completed,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
KSRAD001,Using AI to Select Women for Supplemental MRI in Breast Cancer Screening,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
Stage 2 compression therapy,Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
CASE5120,Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
PROICM 2020-07 VIS,Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work,Recruiting,Interventional,Other,"Other, Other",Single Group Assignment,Not Applicable,No,No
CL1-81694-003,S 81694 Plus Paclitaxel in Metastatic Breast Cancer,Completed,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
Shengjing-LCG005,Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
2020.KB.SAG.069,The Effect of Mobile Lymphedema Self-Care Support Program on Self-Care in Women With Breast Cancer-related Lymphedema,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
INNOVBC,A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer,Unknown status,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,"Phase 2, Phase 3",No,No
R20-003,Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
MedOPP319,CB-103 Plus NSAI In Luminal Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
WO39391,A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
20-157,Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD),Recruiting,Interventional,"Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,Yes
2021.693,mHealth Usage Among Nigeria Women Diagnosed With Breast Cancer Receiving Chemotherapy,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
GENEXAN,GENe EXpression After Regional or General ANesthesia in Patients Undergoing Breast Cancer Surgery,Unknown status,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
HSC20160245H,Improving Adherence to EHT Among Breast Cancer Patients,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
GRO-06-001,ABUS for Early-stage Breast Cancer,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
REC-H-PHBSU-21010,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
YOUNGBC-22,"Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
16D.674,Prospective Breast Cancer Biospecimen Collection,Unknown status,Interventional,Other,"Procedure, Other, Other",Single Group Assignment,Not Applicable,No,No
SMC- 5725-18,The Breast Cancer Personalized Nutrition Study,Recruiting,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
2000025837,Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
2020/33,Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
DS8201-A-U305,A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05),Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2018.016,Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
HE071-CSP-021,A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
PREDIX II HER2,Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer,Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
ATADEK 2022-17/27,The Effect of Wearable Vibration Therapy on Shoulder Functionality in Individuals Receiving Adjuvant Radiotherapy After Breast Cancer Surgery,Recruiting,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,Not Applicable,No,No
CHIR-01-sentinel,Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
R.20.05.834,Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
MCC-20902,Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
D3615C00001,Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SMC-2019-05-021 (2),Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled Trial,Completed,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
17/209,The Tomosynthesis Trial in Bergen - Part 2,"Active, not recruiting",Interventional,Other,Radiation,Single Group Assignment,Not Applicable,No,No
1563/2018,Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery,Unknown status,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
18-603,"Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors",Completed,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2021-0170,Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
PUMCH-SBSBC,Survival Benefits of Statins in Breast Cancer Patients,Recruiting,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,Phase 3,No,No
B27IB3856,UCLA Breast Cancer Survivor Health Promotion Research Study,Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2018.08.ST,Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
YYS-20200305,Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer,Completed,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
CAN04CLIN005,Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
ORIN1001-001,ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",Yes,No
Breast Cancer-RISS,Ultrasound Guided Rhomboid Intercostal and Subserratus Plane Block in Breast Cancer Surgeries,Completed,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,Phase 4,No,No
STML-ELA-0322,"ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
HNCH-BC010,A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
22SCH740,STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER),Not yet recruiting,Interventional,Other,Drug,Single Group Assignment,Phase 2,Yes,No
eMOUVOIR-1901,Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
20G.605,Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,Early Phase 1,Yes,No
19-002792,Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
UT BCS Sleep Study,Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors,Withdrawn,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
919PP17,Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin,Completed,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,Phase 2,No,No
H-50349,Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
B002-101,B002 in Patients With HER2-positive Breast Cancer,Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
"2016-051-000001, 2563",Investigating Barriers for Decision Making in a Danish Breast Cancer Screening Context,Recruiting,Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
MCC-21378,Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological",Sequential Assignment,Phase 1,Yes,No
010006,Integrin α6-targeted SPECT Imaging of Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
2021-0358,A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC),Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
LACUDY,Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient,Not yet recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Not Applicable,No,No
CSPC-DMS-BC-17,Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
UC-0105/1815,"Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
NCC3340,A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
YOMA,Effects of Yoga on the Quality of Life of Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2022-7735,Life After Breast Cancer - Impact of a Life Coach,Not yet recruiting,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
IRB00130428,The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Diagnostic Test, Diagnostic Test",Parallel Assignment,Phase 2,Yes,Yes
HR BLTN 014,Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
GS-US-595-6184,Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physicians Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy,Recruiting,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug",Parallel Assignment,Phase 3,Yes,No
C4891023,TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B),Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,Phase 2,Yes,No
SYSU-2022-02,"Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GO40987,"A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer",Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Procedure",Parallel Assignment,Phase 1,Yes,No
HR-BLTN-008,"Pyrotinib in Combination With Letrozole in Patients With HER2-Positive, ER-Positive Metastatic Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HNCH-MBC08-BM02,Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
SNF4,Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
MA-BC-II-006,Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC),Recruiting,Interventional,Experimental,"Biological, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
17/013,Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,Phase 2,No,No
SNF3,PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2020 - 176,Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
HR-TNBC-HN100,SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
2018-68-1461,Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
STU00206180,A Web-Based Tool to Improve Breast Cancer Survivorship,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2019-09-09,Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
UBRS20013,Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
HR-BLTN-014,Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SPI-POZ-101,A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
EC/TMC/108/17,Hypo-Fractionated Radiotherapy in Breast Cancer,Unknown status,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
SGRT-BC,Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,"Phase 2, Phase 3",No,No
CMUH108-REC3-090,A Study to Evaluate the Safety and Clinical Outcome of Using FR-Mask in Breast Cancer Patients With Radiation-irritated Skin After Radiotherapy,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
RC48-C012,A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
261\\2021,Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic Therapy,Not yet recruiting,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
ERIBRAIN-IPC 2017-014,Eribulin in Brain Metastases From HER2-negative Breast Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CYH33-G103,"Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer",Unknown status,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,No,No
OTT 18-02,Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT),Completed,Interventional,"Active Comparator, Active Comparator",Combination Product,Parallel Assignment,Phase 4,No,No
SYSA1901-002,Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
YBCSG-21-03,Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
EBaran,The Effect of Complex Decongestive Physiotherapy on Sensory Parameters in Breast Cancer Related Lymphedema.,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2019-0088,Proton Accelerated Partial Breast Irradiation,Withdrawn,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
R20-030,Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 1,Yes,No
NL77000.029.21,Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
MUKDEN 07,A Study of SHR-A1811 Combined With Pyrotinib Maleate as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
OstacoliMIND&BC,Mindful-life: Mindfulness Based Intervention vs Cognitive Behavioral Therapy in Patients With Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
NCC3286,A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway,Recruiting,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 2,No,No
HR-BLTN-010,A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer,Unknown status,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
CMUH106-REC3-137,Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors,Completed,Interventional,"Experimental, Experimental, Experimental",Drug,Crossover Assignment,Not Applicable,No,No
2010134480,Prospective Comparison of Breast MRI vs Contrast Mammography Prior to Surgery in Breast Cancer Patients,Unknown status,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,Yes
DS8201-A-U303,Trastuzumab Deruxtecan (DS-8201a) Versus Investigators Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04],"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
H18-02581,"Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers",Not yet recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
SMX 22-002,Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
18-371,"Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial","Active, not recruiting",Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,Yes
K171005J,"Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility",Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
X-XJTU1AFLSY-93,"Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2019/2452,Impact of a Breast cAncer Survivorship Interprofessional Community Care Model,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
J1836,"Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer","Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
20-104,"Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)",Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
SCHBCC-N030,Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS),Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 2,No,No
D967JC00001,A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
LMengmeng,An Online Psychosocial Intervention for Fear of Cancer Recurrence in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NCC1888,Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
XZP-3287-3002,A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
R21-072,Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI),Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
HCI131027,Functional Precision Oncology for Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
SCHBCC-N025,A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS),"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ERC/2020/10/11 (26/10/2020),Improving Access to Breast Cancer Screening and Treatment in Nigeria: The Triple Mobile Assessment and Patient Navigation Model,Recruiting,Interventional,"No Intervention, Experimental","Device, Other, Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,Yes
19-055,A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients,Recruiting,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 1,Yes,No
20F.259,Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation,Recruiting,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,"Phase 2, Phase 3",Yes,No
2019/1318,Exercise in Breast Cancer Survivors,Completed,Interventional,"Experimental, No Intervention, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
BC-P29,Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
Smart,An Innovative Smartphone Application for Adverse Event Management During Breast Cancer Adjuvant Chemotherapy,Not yet recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
RS-NAT01,Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy,Unknown status,Interventional,"Active Comparator, No Intervention, Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
2021/32,The Effect of Self-compassion on Breast Cancer,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
SMX 20-001,Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
BOMB,Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Other",Parallel Assignment,Not Applicable,No,No
XuzhouMedSch3,Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
MC220301,Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,Phase 2,Yes,No
FUSCC-TNBC-BLIS,Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
TeMP 2021,The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial.,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
D931CC00001,Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Combination Product",Parallel Assignment,Phase 2,Yes,No
WuhanU,Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
Stage 1 Compression Therapy,Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
4298,mHealth for Breast Cancer Survivors With Insomnia,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
018-745,LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,Yes,No
20-371,Niraparib + Dostarlimab In BRCA Mutated Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
HBMUFH-101,A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
2019-KY-051,Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
GCX-BCT-06,Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy,Recruiting,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,Not Applicable,No,No
213355,Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
2022-0056,A Study for the Adjuvant Treatment of Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 4,No,No
20192755,Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer,Completed,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,Phase 2,No,No
K3_K1_2,An Intervention for Female Breast CANcer: Acceptance and Commitment Therapy (I-CAN-ACT) for Depression and Physical Pain,Recruiting,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
MEDOPP437,PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
D9670C00001,"Study of Trastuzumab Deruxtecan (T-DXd) vs Investigators Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ACR A4707,Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts,Not yet recruiting,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
OTT 20-11 (IT-02),INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
PREBCA,Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor Therapy,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
OBU-SC-BB-BC-II-010,"Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
20-09022641,Combined Immunotherapies in Metastatic ER+ Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,Phase 2,Yes,Yes
SaglikBilimleriU_DU,Investigation of the Effect of Education on Symptom Management on Symptom Management in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
mTPVB SPPB Ver 2,Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery,Not yet recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
SYSKY-2023-129-01,Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
UW20035,Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
ID-TMS-02-20201012,CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population,"Active, not recruiting",Interventional,"Experimental, No Intervention",Drug,Single Group Assignment,Not Applicable,No,No
ACE-Breast-07,ARX788 in Breast Cancer With Low Expression of HER2,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CABC012,Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
2019-053,Intervention to Promote Breast Cancer Screening Among American Indian Women,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
SNB vs PET/MRI 1,Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
AITIC,Artificial Intelligence in Breast Cancer Screening Programs in Córdoba (AITIC),Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
NIHR 128311,Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
Pro00104868,Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
STUDY00000023,TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
2022/0132,The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors,Not yet recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
GMI-1359-210,A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
SHERO,"Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer",Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
MA-BC-II-023,Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
0494-22-RMB,A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
ICO-A-2018-10,Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
REG-074-2020,Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer,Recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
Woman health,Whole Body Vibration Training and Breast Cancer Risk Factors,Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
CSIIT-C39,Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
99mTc-ZHER2,Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.,Enrolling by invitation,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
HCC 22-003,Preoperative Irradiation for Stage I Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,Yes
CSIIT-C03,Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
IBCSG 55-17,To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH),"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
WO42633,A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2022-05093-02,The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.,Recruiting,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,Not Applicable,No,No
NRG-BR007,"De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)",Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Drug",Parallel Assignment,Phase 3,No,No
CLP0008,Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,Phase 2,Yes,Yes
18-040,Topical Calcipotriene Treatment for Breast Cancer Immunoprevention,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 1,Yes,No
UPCC 01121,Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Molecular imaging of HER2,Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3,Completed,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
OP-1250-002,A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
GEICAM/2018-06,"Trial to Evaluate Diarrhoea Discontinuations at 3 Cycles in Patients With Early-stage HER2+, HR+ Breast Cancer Treated With Neratinib Plus Loperamide Versus Neratinib Dose Escalation Plus Loperamide Administered as Needed Versus Neratinib Plus Loperamide Plus Colesevelam (DIANER)",Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
26272819.3.0000.0068,Breast Cancer and Intrauterine Contraception,Recruiting,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
SA20I0060,Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
1094/2020,Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy,Withdrawn,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
WO42133,"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)",Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 2,Yes,No
110-163-F,A Study Evaluating Near-infrared Zone II Imaging in Sentinel Lymph Node Mapping in Breast Cancer Patients,Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
MUKDEN 06,A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
KN035-TH-HER2,KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer,Unknown status,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,Phase 2,No,No
COSMOPOLITAN,Intraoperative Electron Radiotherapy for Low-risk Early Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
21-VIN-0166/SAN-0647,"A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With BRCA Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer",Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,Phase 1,Yes,No
ISB 1302-103,Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological",Parallel Assignment,"Phase 1, Phase 2",Yes,No
0063-17,A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
M16-735,A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC),Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
19-524,Effects of Exercise in Patients With Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
HR-BLTN-002,A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physicians Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer,Unknown status,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
CTO-IUSCC-0684,Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Tele-Relax,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
NCC1865,A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
A5481126,Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy,Completed,Interventional,"Other, Other",Device,Single Group Assignment,Not Applicable,No,No
KCSG BR18-16,Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
LY01005/CT-CHN-303,Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
IFG-08-2019,Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON),Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 4,No,No
XZP-3287-3001,A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
GEP,Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC),Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
2019/2632,An Innovative Care-improvement Smartphone-based Perioperative Solution for Women Undergoing Breast Cancer Surgery,Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
UMMCHTNBC,Telemonitoring Hypertension and Breast Cancer,Not yet recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
BTCRC-BRE18-337,"Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
J18138,Automated Method for Breast Cancer Detection,Terminated,Interventional,Other,"Procedure, Device",Single Group Assignment,Not Applicable,No,Yes
19-09020752,CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer,Withdrawn,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,Phase 2,Yes,Yes
RC31/21/0368,Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
20-503,Feasibility of Fasting & Exercise in Pts With HR+ MBC,"Active, not recruiting",Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
PGG-BCA2121 / MK-3475-C99,Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA),"Active, not recruiting",Interventional,Experimental,"Biological, Biological",Single Group Assignment,Phase 2,Yes,No
ACTRN1261000928213,A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
Pro2020002182,Breast Cancer and Resistance Exercise Program,Recruiting,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
160178,"Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
MRG002-004,A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
BC-Pyrotinib-NVB,Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
SYSUCC-016,GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer,Recruiting,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,Phase 3,No,No
19-396,Liquid Biopsies and Imaging in Breast Cancer,Unknown status,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
Shengjing-LJY07,Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
HMPL-012-SPRING-R103,Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
CA209-7FL,"Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer","Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Biological, Drug, Other, Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 3,Yes,No
NCC2021291,A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN),Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
20-2338,Effects of Pinkwashed Alcohol Ads in an Online RCT,Completed,Interventional,"Other, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
22-5307,Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CEP0431/2018 arm 2,LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2),Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,Not Applicable,No,No
MA-BC-II-035,Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer,Enrolling by invitation,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
F2017000 (UAB 17112),Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
22040,Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Behavioral",Single Group Assignment,Phase 2,Yes,No
CTMS 17-0037,Imipramine on ER+ve and Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
D0816R00025,Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
MedOPP238,POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
BTCRC-BRE19-409,"Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
2020-0342,Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
25IB-0023,Exercise Study for Breast Cancer Survivors,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
919PP18,Role of Adding Metformin to Neoadjuvant Chemotherapy in Patients With Breast Cancer (METNEO),Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
18-002,A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy,"Active, not recruiting",Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 1,Yes,No
ZYYY-BC-001,Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CAAE: 82691818.0.0000.5154,Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.,Unknown status,Interventional,"Other, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
PMD-026-1-001,Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
18432,Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other, Other, Other, Behavioral",Parallel Assignment,Not Applicable,No,No
2020-KY-140,Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
21-159,ATEMPT 2.0: Adjuvant T-DM1 vs TH,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2020-KY-125,Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
CAAE 42627521600005274,Surgical Pre-habilitation in Breast Cancer.,Recruiting,Interventional,"Experimental, Experimental, No Intervention, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
20201101.2,"Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SYSUCC-008,Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SURVIVE,Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Parallel Assignment,Not Applicable,No,No
4352,Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions,Unknown status,Interventional,"Experimental, Experimental, Sham Comparator","Other, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
SPHIC-TR-BCa2022-02,A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
KCSG BR22-20,"Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer",Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
CRE2018013,Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical Mastectomy,Completed,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
IRB_00137018,A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors,Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
2022-0353,Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Phase 1,No,No
MCC-19765,Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases,"Active, not recruiting",Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 1,Yes,No
LCCC 1931,LCCC1931:Post-treatment Intervention in Women With Breast Cancer (70y/o+),"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
4-2018-0264,Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16),Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2018/TMC/133/IRB/31,One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
BRE 354,A Study of U3-1402 in Subjects With Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 2,Yes,No
IR-1.1,Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SYSUCC-017,Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
IB 2015-01,High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
20-5215.0,An Impact Assessment of a Culturally Tailored Online Psychosocial Program for Chinese Immigrant Women With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
MEN1611-01,MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
SGNTUC-028,A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SYSUCC-020,"Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
BC-RWS,Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
C4891001,A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
CCR4884,PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
2016-0537,Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug, Biological, Biological",Parallel Assignment,"Phase 1, Phase 2",Yes,No
69HCL21_1085,Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,Not Applicable,No,No
SGNTUC-025,A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
AIRC IG-23118,Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer,Recruiting,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,"Phase 1, Phase 2",No,No
3-2021-0026,"Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
STU-2022-0385,Real-time Intraoperative Breast Cancer Visualization for Margin Assessment,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Device, Procedure",Sequential Assignment,"Phase 1, Phase 2",Yes,Yes
BC-P26,Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
KOTK/2022/12550,Patient-centered Breast Cancer Teleprehabilitation,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
SCHBCC-N029,Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
PUMCH-MIRC213,99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Early Phase 1,No,No
TMS01190510,Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels,Completed,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
1752/20,Local Therapy for ER/PR-positive Oligometastatic Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental","Radiation, Procedure, Other",Parallel Assignment,Phase 2,No,No
IMAP-CM,Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material,Completed,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
SRB_201808_163,Controlled Ovarian Stimulation in Newly Diagnosed Breast Cancer PatiEnts (fAMHOPE),Recruiting,Interventional,"Active Comparator, Experimental, No Intervention","Drug, Other",Parallel Assignment,Phase 4,No,No
SMC 2020-11-051,Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
2016-A01344-47,Adapted Physical Activity for Breast Cancer HER2 Positive Patient,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
1807187-2,Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE),Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
Lilly-I3Y-US-I026,Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
D8532C00001,A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
RG1121129,"Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial",Completed,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
21-123,Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
UC-BCG-2103,Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
Ketogenic Diet,Effects of Ketogenic Diet in Overweight and Obese Women With Breast Cancer,Not yet recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
20-172,Taking AIM at Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
CMUH108-REC1-113,Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
ALT-P7,"Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients",Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
2019-7-Non-NSU Health,Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts,Completed,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,Yes
I236,CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
GCO 17-1585,Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer,Terminated,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
PRO00028602,Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
D0816C00018,To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,Yes,No
HUB-PSI-CAMAD,Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression,Terminated,Interventional,"Experimental, Experimental","Drug, Behavioral",Parallel Assignment,Phase 2,No,No
REP0121,To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer,Withdrawn,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
SBMASTER,The MASTER Study (MAmmary Cancer STatin ER Positive Study),Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
AMCI-001,PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Fukui-2019-1,Exercise Post-Diagnosis of Breast Cancer,Recruiting,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
PRO00028925,"Fulvestrant+Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer",Recruiting,Interventional,"Other, Experimental","Other, Other",Parallel Assignment,Phase 2,Yes,No
K160913J,Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Genetic, Biological, Other",Single Group Assignment,Not Applicable,No,No
N-20180090,Analgesic Effect of Resistance Training for Breast Cancer Survivors,Completed,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
FDRT-BC016,Neoadjuvant Radiation in Locally Advanced Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
RF-2016-02363686,Tomosynthesis as Primary Test for Breast Cancer Screening,Recruiting,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
A231901CD,Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Other, Other, Procedure, Other, Other, Other, Other, Other, Other",Factorial Assignment,Not Applicable,No,No
UPCC 10117,"Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer (GLACIER)",Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
22/409-3611,Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
BC-CIH-H-RWS,H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
4-2020-1453,"Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing (MUTATION2)",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
IRB15-1005,Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer,Withdrawn,Interventional,"Experimental, Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
LCCC1820,Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
GC101-21K177,Study on TIL for the Treatment of Advanced Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Early Phase 1,No,No
2019.046,Lifestyles and Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2020-004696-41,Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy,Recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental, No Intervention, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
V3002401,Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2021-0768,A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,Phase 2,No,No
FDRT-BC008,Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
TILS001 trial,Treatment of Advanced or Metastatic Triple-negative Breast Cancer With Adoptive Therapy of PD1+ TILS,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
SYSEC-KY-KS-2022-056,Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer,Not yet recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
S1709-101-888,Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
ARV-471-mBC-102,"ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
BR01/02/21,"Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
MA-BC-II-020,Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
NL68820.091.19,Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance,Recruiting,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
6010121027,Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
FS-1502-III1-01,FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,Phase 3,No,No
2020-0708,"Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study",Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
20-347,"A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer",Recruiting,Interventional,Experimental,"Combination Product, Drug",Single Group Assignment,Phase 2,Yes,No
NCC2493,Radiotherapy for Extracranial Oligometastatic Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,Phase 3,No,No
ICO 13-001,Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer,"Active, not recruiting",Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Early Phase 1,No,No
2018-A01128-47,EMDR Psychotherapy for Anxious-depressive Symptoms in Breast Cancer Patient,Recruiting,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
SCBCG-006,A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
LRP/PegGCSF/2016/004,Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
GRACE,GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
21-600,Early Intervention,Not yet recruiting,Interventional,Experimental,"Device, Device",Single Group Assignment,Not Applicable,No,Yes
114,The Effect of Reiki on Symptom Control and Quality of Life in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
IIT2018-17-McArthur-TCDRT,"Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer",Withdrawn,Interventional,"Active Comparator, Experimental","Drug, Radiation, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
20 KHCC 91,SBRT for Breast Cancer Oligometastases,Recruiting,Interventional,Other,Radiation,Single Group Assignment,Not Applicable,No,No
SYSUCC-019,"Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
IIT-CRM2020001,Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2020-154,Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema,Recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,No
CTO-IUSCC-0715,Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
SP0048722,Optimizing Quality of Life in Women Living With Metastatic Breast Cancer,Completed,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
38341220.8.0000.0072,"Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery",Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Radiation, Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
Neo-ACT,Physical Exercise During Preoperative Chemotherapy for Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
CH-BC-059,A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）,Enrolling by invitation,Interventional,"Experimental, Active Comparator","Drug, Other, Genetic, Drug",Parallel Assignment,Phase 3,Yes,No
07102022_SR,Consciousness-based Ayurveda Lifestyle Program for Improving Quality of Life in Survivors of Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
GO42784,"A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physicians Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
New theory(Tamoxifen&retinoic),"Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.",Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Sham Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
145314,Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients,Not yet recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,"Phase 1, Phase 2",Yes,No
20-505,A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,Phase 2,Yes,No
RadiaAce001,The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
Neo-program 2021.02.23,Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
ARV-471-mBC-101,A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
275078,Digitally Distributed Yoga for Women Treated for Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
IIT-2017-NeoPACT,Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
2021000247,"Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer.",Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",Yes,No
REaCT-70,Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Phase 4,No,No
BTCRC-BRE16-042,"Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
TVD-101-002B,Study of TTI-101 in Combination for Participants With Metastatic Hormone Receptor (HR)-Positive and Human Epidermal Receptor 2 (HER2)-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
20-0140-A,MonaLisa Laser Intervention for Post-Menopausal Breast Cancer Patients: A SHE CAN Study,Withdrawn,Interventional,"Experimental, Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
CA209-929,"Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients",Terminated,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Single Group Assignment,Phase 2,Yes,No
Glnz87?,The Effect of Guided Imagery Based on the Health Promotion Model on the Quality of Life in Breast Cancer Patients,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
GIM24-PALBO-BP,Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
18-115,Physiotherapy Program for Breast Cancer Women Following Surgery: A Pilot Clinical Trial,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
IBISCO Trial,Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
NBC Che001,Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
IC 2021-08,Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of Treatment,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
AI Yoga Study on Facebook - 1,Effect of Sukshma Vyayama Yoga on Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
6222/22.03.2017,Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
EUBREAST-01,Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
1216-4-011,Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients,Completed,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
UPCC 15121,Breast Cancer Outreach Among Primary Care Patients,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
OMERIC-1904,Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer,Recruiting,Interventional,,Procedure,Single Group Assignment,Not Applicable,No,No
18-217,Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
ACE-Breast-06,ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CHLOBREASTASP,"Breast Cancer Active Surveillance, Alternative Option, Aspirin Included",Not yet recruiting,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
CTO-IUSCCC-0781,Exercise in Metastatic Breast Cancer: EMBody,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Phase 2,No,No
TT420X2101,Safety of TT-00420 Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
201808046,Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma,"Active, not recruiting",Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,Not Applicable,No,Yes
Versión 4- 20/09/2020,Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors,Completed,Interventional,Other,Drug,Single Group Assignment,Phase 4,No,No
HS-10352-102,A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 1,No,No
CSPC-KAL-BC-16,Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer,Unknown status,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
REaCT-Wellness,A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Phase 4,No,No
NEXT-BRCA,Implementing Exercise Into Clinical Practice in Breast Cancer Care,"Active, not recruiting",Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
MedOPP167,Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients,Terminated,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 2,No,No
LPM-008,The LightPath® and 68Ga-RM2 in Breast Cancer Study,Not yet recruiting,Interventional,"Other, Experimental, Experimental","Combination Product, Drug",Sequential Assignment,Phase 3,No,No
DATOS-20220624-ASJF-Efecto car,Cardioprotective Effect of Acute Exercise in Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
NSABP FB-13,Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,Phase 2,Yes,No
202207198RINB,Can ILR Reduce the Risk of Arm Lymphedema?,"Active, not recruiting",Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
FZPL-Ⅲ-303,A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physicians Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SYSUCC 019,Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
BCSPilot01,A Combined Exercise Training Program for Women Living With Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2014CB543202-03,Acupuncture for Breast Cancer Related Lymphedema,Unknown status,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
578-21-FB,Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
107CS-6,Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer,Unknown status,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
BRE 381,Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
2022-009,Thero2-01S22 in HER2-positive Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
KCT 005,"A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery",Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
G1T28-212,"Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer",Completed,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological",Single Group Assignment,Phase 2,Yes,No
SCHBCC-NO28,Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
ID-RCB 2022-A01488-35,Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI,Not yet recruiting,Interventional,"No Intervention, Experimental",Device,Crossover Assignment,Not Applicable,No,No
PI-2021-3,Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
2021-KY-124-001,Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner Quadrant,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
MA-BC-Ⅱ-021,Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Procedure, Drug, Procedure",Parallel Assignment,Phase 2,No,No
DFP22-0020,Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
CCM 1505,Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer,Recruiting,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
PER.CIN.BN.95.III,Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
21-5021,Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN),Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
C4891006,TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A),Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2021-0840,Acupuncture for Psychoneurological Symptoms Among Breast Cancer Survivors,"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
OV-121,Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
042110,CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage,"Active, not recruiting",Interventional,"Active Comparator, Other","Drug, Other",Single Group Assignment,Early Phase 1,Yes,No
BC-09638,GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 4,No,No
2018-0601,Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women,Recruiting,Interventional,"Placebo Comparator, Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
D967JC00002,A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
UKM14_0016,Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
RJBC-HFRNI,Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
m-VCAP1,Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
19-133,An Online Research Study: BrainHealth in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Placebo Comparator",Behavioral,Crossover Assignment,Not Applicable,No,No
CLEE011A2206,"Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.","Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
CASE3118,Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer,"Active, not recruiting",Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
2020(55),Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
WO40324,"A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer","Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,Phase 3,Yes,No
ML39208,A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment,Completed,Interventional,Experimental,"Device, Drug",Single Group Assignment,Phase 2,No,No
18/028,"Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,No,No
A231701CD,Increasing Patients Engagement in Breast Cancer Surgery Decision-Making,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Other, Other",Crossover Assignment,Not Applicable,No,No
FDRT-BC017,Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
AC699-001,Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
2020-495,Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
CTRIAL-IE 17-13,Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer,Terminated,Interventional,Other,"Drug, Drug",Single Group Assignment,Phase 1,No,No
00005038,Family History and Breast Cancer Education Trial,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
H-43432,Sitravatinib in Metastatic Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
HCRN BRE18-334,"Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Other",Parallel Assignment,Phase 2,Yes,No
ACT16105,Phase 2 Study of Amcenestrant (SAR439859) Versus Physicians Choice in Locally Advanced or Metastatic ER-positive Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
OSU-22013,Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
I-3364822,Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Experimental","Other, Other, Procedure, Other",Parallel Assignment,Not Applicable,No,No
ICO-N-2019-04,[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
20140299,Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases,Completed,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,Phase 1,Yes,No
CS003-BC,Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,Phase 2,No,No
2020-005722-28,Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MD-127-2019,Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study),Unknown status,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
2020-07-064-002,Improvement of Range of Motion in Frozen Shoulder in Breast Cancer Survivors,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
UC-BCG-2204,Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,No,No
PYHOPE-BC-104,Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
TMZ-TNBC,Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC),Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
STUDY-20-01174,Increasing Breast Cancer Screening in Chinese Immigrants,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
SIM-1907-02-SERD-101,"Phase I Study to Evaluate SCR-6852 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,No,No
20-151,Refining Local-Regional Therapy for IBC,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
RJBC-SHF RNI,Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
HREBA.CC-21-0429,Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy,Recruiting,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
UW17107,ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer,Terminated,Interventional,"Experimental, Experimental","Drug, Dietary Supplement",Parallel Assignment,Phase 2,Yes,No
NL63209 041 18,MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer,Withdrawn,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
2020-AHL-001,"Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer",Not yet recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 1,Yes,No
202201100,A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors,Recruiting,Interventional,Experimental,"Other, Procedure",Single Group Assignment,Not Applicable,No,No
SAMuhammad,Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt,Unknown status,Interventional,"Active Comparator, Active Comparator",Drug,Single Group Assignment,"Phase 2, Phase 3",No,No
2019-A02195-52,Immunomonitoring of Breast Cancer Patients During Systemic Treatment,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
ShantouCH02,Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
PekingUPH10B003,Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
CTMS# 19-0028,Effects of Creatine Supplementation in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,Not Applicable,No,No
NEO-01,OA for Breast Cancer NAC Response,Completed,Interventional,Experimental,Device,Sequential Assignment,Not Applicable,No,Yes
NL58040.091.16,Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance,Terminated,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
LQ006,Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
MCC-19-15740,Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters),Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
K180603J,Advanced MR Techniques for Breast Cancer Detection,Withdrawn,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
ABLE02,A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
MCC-21-BRE-54,"Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
HUM00140468,Acupressure for Pain and Opioid Use Among Breast Cancer Patients,Terminated,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CLEE011A3201C,Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Combination Product, Combination Product, Combination Product, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2/108/7,What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?,Unknown status,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,Not Applicable,No,No
EOC202A1101,Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer,Completed,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 1,No,No
18-2562.cc,Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
19-586,Prolonged Nightly Fasting in Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2014CB543202-02,Warm Acupuncture for Breast Cancer Related Lymphedema,Completed,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
IB 2017-05,Brief Intervention for Tobacco and Alcohol Risk Reduction for Couple During Breast Cancer Treatment.,Unknown status,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,Phase 3,No,No
On4Rehab Pilot Trial,Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based,Completed,Interventional,"Active Comparator, Experimental",Other,Parallel Assignment,Not Applicable,No,No
IIT-0005,Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting,Unknown status,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Drug",Parallel Assignment,Phase 2,No,No
PROTECT,Prospective Surveillance for Breast Cancer-Related Lymphedema,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
NCC2129,Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
001,Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SYSU-CSCO-2020,Pyrotinib in Breast Cancer Patients With Poor Response to the Neoadjuvant Treatment of Trastuzumab and Pertuzumab,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
IRB18-0970,A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer,Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
2019-09-023,Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial,Not yet recruiting,Interventional,"Placebo Comparator, Experimental",Procedure,Single Group Assignment,Not Applicable,No,No
Shengjing-LCG004,Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
MedOPP168,"Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer",Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
I239,CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
IRB00158622,Auricular Point Acupressure to Self-Manage Chronic Pain or Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors: Effectiveness and Scientific Underpinnings,Completed,Interventional,"Active Comparator, Sham Comparator, Other","Other, Other, Other",Factorial Assignment,Not Applicable,No,No
RFTMBCPW,Fulvestrant in Metastatic Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 4,No,No
s63338,The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot Study,Completed,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
2017-0071,"Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
20200628GD,Neoadjuvant Tucidinostat and Exemestane in Early Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
ANLO-BC,Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
SHR-A1811-III-306,SHR-A1811 Versus Investigators Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
REO 028,A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study,"Active, not recruiting",Interventional,"Active Comparator, Experimental, Experimental","Drug, Biological, Drug",Parallel Assignment,Phase 2,Yes,No
LQ007,Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
2019-KY-049,Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
D9268C00001,"A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigators Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ET17-203 DISCO,Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer,Completed,Interventional,"Experimental, Experimental, Experimental, No Intervention","Device, Behavioral",Factorial Assignment,Not Applicable,No,No
EC/2017/0200,Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
200277,Focused Ultrasound and Gemcitabine in Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,Phase 1,Yes,Yes
CFT / sp123,A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2021-1201,3D Printed Breast Models in the Surgical Management of Breast Cancer,Not yet recruiting,Interventional,"Experimental, No Intervention",Diagnostic Test,Single Group Assignment,Phase 2,No,No
FDRT-BC012,Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,"Phase 1, Phase 2",No,No
99mTc- RM26,Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26,Enrolling by invitation,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,Phase 1,No,No
2103254164,Pioglitazone Therapy Targeting Fatigue in Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator, No Intervention","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
MA-BC-II-026,Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
OBU-BC-II-079,Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
BCD-178-2,Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
SHR6390-Ib/II-201,A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
AAAT4412,Breast Elasticity Imaging During Neoadjuvant Chemotherapy,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
N19MIM,Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial,"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 2,No,No
CA209-7A8,A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer,Completed,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
CFT/sp123,"A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer",Withdrawn,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
EVER-132-002,Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC),"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
KY20192081-F-1,Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
AC682-001,A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
ATOS-Z-201,(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
UC-0140/1711 - UCBG3-06,Study on Androgen Receptor and Triple Negative Breast Cancer,Completed,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,Phase 2,No,No
2018-05-0155,Improving Brain Function After Breast Cancer Study,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
SBU-PCWRT-BREAST,Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Early Phase 1,No,Yes
2021.240,Effectiveness of Mobile Messenger-initiated Reminder on Biannual Mammography Adherence in Breast Cancer Screening,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
HNCH-BC008,Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
PLATO study,PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate,Recruiting,Interventional,Experimental,"Drug, Drug, Genetic",Single Group Assignment,Phase 2,No,No
RSRB00066846,"A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer",Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
KC19EESI0325,Real-time Interactive Digital Healthcare System in Post Operation Patients With Breast Cancer; Pilot Study,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
16-007764,Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission Mammography,Withdrawn,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,Yes
114421,Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care,Completed,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
18-621,Tucatinib + Abemaciclib + Herceptin for HER2+ MBC,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
IRB-59141,Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
STOP-BC Trial,Sulindac and Breast Density in Women at Risk of Developing Breast Cancer,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
SYSU005,Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ZN-c5-002,A Study of ZN-c5 in Participants With Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
Fudan University,NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy,Unknown status,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,Phase 3,No,No
18-8214-BO,Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,Not Applicable,No,No
1711-048-898,Unnecessary Mastectomy Due to False Size Prediction by Preoperative Imaging Studies in Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
HR-BLTN-001,Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2021-A03091-40,Evaluation of the Interest of a Postural and Functional Analysis for the Follow-up of the Adapted Motor Activity of Patients Treated for Breast Cancer,Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
P.T.REC/012/002968,RESISTANCE VERSUS AEROBIC EXERCISES ON Breast Cancer Patients,Unknown status,Interventional,"Active Comparator, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
IIT-2021-ASSET,Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
4-2020-1131,Talazoparib Maintenance Therapy in Triple-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
145358,"A Phase I/II Multicenter, Open-Label Study of Lu-177-αvβ3-IAC, for the Treatment of Angiogenic Breast Cancer Patients.",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
UMCC 2018.016,The ConnectedCancerCare Pilot Study (CCC),Completed,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
TP.102.17.22.PAR,Pilot Clinical Evaluation of a Microwave Imaging System for Breast Cancer Detection,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
EFC15935,Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
BC-NEO-IIT-SHR6390,SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GDWCH-001,Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
SMC-2018-10-062,Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
SMX 18001,Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
NRG-BR008,Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,Phase 3,No,No
TEBICA002,Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells,Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
CWCD118B12201,Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
CALORIE,Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
S2010,"Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study",Recruiting,Interventional,"Experimental, Active Comparator","Other, Procedure, Procedure, Behavioral, Other, Other",Parallel Assignment,Not Applicable,No,No
2019-A01592-55,Transcutaneous Breast Cancer Diagnosis by Canine Odorology,Suspended,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
ABY-025-MI301,A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
202202045MIPA,Olaparib Maintenance Therapy in Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
22-07025006,Diabetes Care for Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2019/044,Evaluation of the Effect of Mediterranean Diet on Breast Cancer Patients,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
B2017-11,Neoadjuvant Goserelin for Triple Negative Breast Cancer,Unknown status,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
Pro00088926,Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Tmab-TK006-102b,Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
Ahead-BC-20170323,Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 2,No,No
21090645,Omega-3 and Vitamin D Supplementation in Breast Cancer Women,Recruiting,Interventional,"Experimental, Experimental, Experimental, No Intervention","Dietary Supplement, Dietary Supplement, Combination Product",Parallel Assignment,Early Phase 1,No,No
18-0234,The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
P20CA217199-9492018,A Community Dance Intervention Engaging Breast Cancer Survivors in a Middle-income Country,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
Pro00107216,The Effect of Intermittent Fasting on Body Composition in Women With Breast Cancer,Withdrawn,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
HREBA.CC 19-0363,Rise Up After Breast Cancer,Completed,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
AHQU-2021004,Acupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
H20-03123,Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.,Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
SYS-C-201801-5010,Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
15-017,Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer,Unknown status,Interventional,Experimental,"Other, Other",Single Group Assignment,Not Applicable,No,No
ZN-c5-003,A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
M14ABC,"A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients",Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
18-004803,Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes,Terminated,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
34615/4/21,The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer,Completed,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
CLAG525B2101,"A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer",Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
MINERVA,Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
LACOG 0419,Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
CHB18.04,Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer,Completed,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
CSIIT-C21,A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
BOOG 2018-01,Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
AMC2020-17,Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy Intervention,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
KY20222062-C-1,"Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
20201540,Prospective Evaluation of Targeted Axillary Dissection (TAD),Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
RCVDBCIIR005,Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
STUDY00003282,Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
IRB-2022-348,Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery,Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
LCCC 1639,"Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC",Terminated,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
SCHBCC-N034,Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D),Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 2,No,No
2022-0431,A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC),Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
CBYL719C1201,Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
SYSA1802-CSP-006,A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC),Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
KY2019-023,Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MEDOPP447,Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast Cancer,Withdrawn,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
GE-226-004,Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Diagnostic Test, Diagnostic Test",Sequential Assignment,Phase 1,Yes,No
2021P002871,Optimizing Functional Recovery of Breast Cancer Survivors,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
CABC - Kreftfor project - SEB,Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions,Recruiting,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
201708076,Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Other, Procedure, Behavioral, Procedure, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
TWT-203,"CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CO41101,A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.,Completed,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
EA1183,"Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study",Recruiting,Interventional,Experimental,"Procedure, Other, Procedure",Single Group Assignment,Phase 2,No,No
WO42312,"A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physicians Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
NHP,Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
JU 2020/1732-51,Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NCCH1607,"PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
NL69081.041.19,The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY Trial,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
AAAS2359,Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
HSEARS20210816002,The Effects of a Nurse-led mHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
D926XC00001,A Study of Dato-DXd With or Without Durvalumab Versus Investigators Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03),Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
HRS-8080-I-101,A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults,Enrolling by invitation,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
ONA-XR-103,Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
2022-0315,Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 1,Yes,No
KCSG BR19-13,High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
STU00216520,Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Phase 3,No,No
20805,BATs in Patients With Breast Cancer and Leptomeningeal Metastases,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
ICO-2020-25,Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HRS-1358-I-101,A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer,Enrolling by invitation,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
IRFMN-BRC-7103,Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
BL-M02D1-101,A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
RJBC1901,Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer,Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 2,No,No
PELICAN-IPC 2015-016,Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
852000,FES BPET-DBT in Newly Diagnosed Breast Cancer,Not yet recruiting,Interventional,Experimental,"Device, Drug",Single Group Assignment,Early Phase 1,Yes,Yes
YO41137,"A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer","Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,Phase 3,Yes,No
BC2,A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
CO40016,"A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer",Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ADIGYN,Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
NICSO-GINSENG,American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients,Unknown status,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
ATADEK-2018 / 9,KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
UW22095,Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
HREBA.CC-18-0657,Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer,Enrolling by invitation,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NSABP FB-12,Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,Phase 2,Yes,Yes
4469,PIK3CA in HER2+ BC and pCR Trial,"Active, not recruiting",Interventional,Experimental,Genetic,Single Group Assignment,Not Applicable,No,No
STUDY00018504,"Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Drug, Drug, Biological, Drug, Other, Drug",Parallel Assignment,Phase 2,Yes,No
YOUNGBC-19,Chidamide in Combination With Abemaciclib and Fulvestrant in Breast Cancer Patients Previously Treated With Palbociclib,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
CCR5316,A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
STUDY00000675,Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Drug, Drug, Procedure",Single Group Assignment,Phase 1,Yes,No
FILBLAU1022,Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy,Not yet recruiting,Interventional,"Active Comparator, Experimental","Biological, Biological",Parallel Assignment,Phase 3,No,No
CBYL719C2303,"Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-postitive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Crossover Assignment,Phase 3,No,No
BC-IIT-SHR6390-FMTN,A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
LV,"Breast Cancer, Omics, and Precision Medicine",Not yet recruiting,Interventional,"Experimental, No Intervention",Biological,Factorial Assignment,Phase 2,No,No
CAPRICE-IPC 2020-053,A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
HMPL-012-SPRING-R101,An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2107239-9,Reverse Triple Negative Immune Resistant Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
Breast PTC,Postoperative Identification of Tumor Cells at the Lumpectomy Site of Patients With Early Breast Cancer,Suspended,Interventional,,Procedure,Single Group Assignment,Not Applicable,No,No
201900115B0,Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast Cancer,Completed,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
2021-A02664-37,Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor.,Recruiting,Interventional,Other,Biological,Single Group Assignment,Not Applicable,No,No
EF 160,Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
D20148,Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
CBYL719C2202,"Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
TRIO036,"Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer",Completed,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
EG017,To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
2019000486,"Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer","Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Alpha-Lipoic Acid,Alpha-Lipoic Acid in Breast Cancer Patients,Completed,Interventional,"Experimental, Experimental","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
VICC BREP 1898,Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 1,Yes,Yes
MD.22.07.674,Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 3,No,No
07-2021/EK OUSA,Impact of Novel Thoracic Wall Blocks With Dexmetomidine on Inflammatory Markers Following Breast Cancer Surgery,Not yet recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
I241,Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug",Parallel Assignment,Phase 2,No,No
853.4,"Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer",Unknown status,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
173-18-CA,Perioperative Mindfulness Proposal,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
1400,Tahini and Dermatitis in Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
NCC2167,Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
UW 18-526,The Effect of Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy,Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
H-1905-141-1035,Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
EUBREAST-2 INDAX,Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy,Withdrawn,Interventional,"Experimental, Experimental","Procedure, Radiation",Parallel Assignment,Phase 3,No,No
HRHB-CB001,"Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer",Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological",Parallel Assignment,"Phase 2, Phase 3",No,No
NSABP FB-14,Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Biological, Biological",Single Group Assignment,Phase 2,Yes,No
ADG106-T6002,"A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
1812850942,Telephone Support for Metastatic Breast Cancer Patients,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
RJBC1801,Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
UTAR- 8068/000,A Systemic Approach to Study the Traditional Chinese Medicine as an Adjuvant Treatment in Breast Cancer Patients,Recruiting,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
SH APBI RISE,Evaluating the Safety and Efficacy of a Novel Accelerated Partial Breast Irradiation Regimen for patIents With Favorable Risk breaSt cancEr,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,Yes
TOL2506A,Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 3,Yes,No
2019-A02500-57,Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol),Completed,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
JCOG1919E,A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
Prix Ruban Rose/2020/FF-03,Multidisciplinary Care Pathway With Electronic Patient Reported Outcomes (ePRO) Post-operative Follow-up of Breast Cancer Surgery Complications to Optimize Patient Quality of Life,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
SBU-SBRT-BREAST-NO-SX,Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery,"Active, not recruiting",Interventional,Experimental,Radiation,Single Group Assignment,Early Phase 1,No,Yes
E7389-M065-401,"A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer",Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
IUSCC-0680,Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,Yes
HCRN BRE20-468,"Ribociclib And Endocrine Treatment of Physicians Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
UPCC 04119,BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Other","Radiation, Drug, Procedure",Parallel Assignment,"Phase 1, Phase 2",Yes,No
2021-04,Smart Bra for Diagnosing Breast Cancer,Not yet recruiting,Interventional,"Other, Other",Device,Parallel Assignment,Not Applicable,No,No
18-000718,"Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients","Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
MOST Pain,Optimizing Psychological Treatment for Pain After Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
AQUAFIT-2018,Water-based Versus Land-based Exercise for Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
Moderate Dose Omega-3,Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer,Unknown status,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
Pro00104863,"Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast Cancer",Withdrawn,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
MA40,Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,Phase 3,No,No
HR-BLTN-003,Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
Velocity,Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Behavioral, Drug",Parallel Assignment,Phase 3,Yes,No
KN026-201,Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
GBG105,"Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer",Recruiting,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
KN026-208,Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
27600,Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Other","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
RnaDx-BRV-BC- 01,RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
ZN-c5-001,A Study of ZN-c5 in Subjects With Breast Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2020-A00398-31,Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer,Recruiting,Interventional,Other,Biological,Single Group Assignment,Not Applicable,No,No
CSIIT-C10,Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
ICON CA209-9FN,Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
31052019,Implementation of a CDSS in Oncology Patients During COVID-19,Completed,Interventional,"Active Comparator, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
iOM-110393,Self-efficacy Coaching for Women With Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
201711073,"MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer",Withdrawn,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure, Procedure, Procedure",Sequential Assignment,Phase 1,Yes,No
L21-076,Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental","Device, Combination Product",Single Group Assignment,"Phase 1, Phase 2",Yes,Yes
2020-007,Characterization of Neuromuscular Function and Fatigue After Breast Cancer Treated With Adjuvant Chemotherapy (PROTECT-04),Completed,Interventional,"Experimental, Other",Other,Parallel Assignment,Not Applicable,No,No
19-300,Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,Yes
RAD1901-308,Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
LAE205INT3101,Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 1,Yes,No
201900180,89Zr-atezolizumab PET Scan and Lobular Breast Cancer,Terminated,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
201911047,Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer,Terminated,Interventional,Experimental,"Device, Drug, Drug, Other, Other, Drug, Device, Procedure, Procedure",Single Group Assignment,Phase 1,Yes,Yes
CAAP CA,Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment,Unknown status,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
BCT 2102,Tucatinib Together With Pembrolizumab and Trastuzumab,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
OCOG-2019-RHEAL,Hypofractionated LocoRegional Radiotherapy in Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
KY20223267-1,PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SGNTUC-016,A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
GUMPTION,Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
MA-BC-II-018,"Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
SCHBCC-N041,SNF Platform Study of HR+/ HER2-advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
1401,Grape Juice and Dermatitis in Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
IBIO-301,A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
FUSCC-T-sunflower,Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower),Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
BTP-66732,"A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer",Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
CSIIT-C18,Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Not Applicable,No,No
CLOVER,Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
LOXO-PIK-21001,A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
SPI-GCF-104,"Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
HNCH-BC006,Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2019-0550,Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Other,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
NL74126.091.20,Adherence Improving Self-Management Strategy (AIMS) in Breast Cancer Patients Using Adjuvant Endocrine Treatment (AET),Unknown status,Interventional,"Experimental, Experimental, Other, Other","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
ALTERBC008,A Phase Ⅱ Study of Anlotinib Combined With Tislelizumab and AT in the Neoadjuvant Treatment of Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
IOM-050371,Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line,Completed,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,Phase 3,No,No
IRB-2021-04,Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy,Recruiting,Interventional,"Other, No Intervention",Behavioral,Factorial Assignment,Not Applicable,No,No
DPMBC301,Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SYHX2011-001,A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,Phase 1,No,No
21-225,A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,"Phase 1, Phase 2",Yes,No
KCSG-BR18-13/TR-03,Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ICPS002/20,Radiofrequency Ablation (RFA) in Breast Tumors,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
21-698,Alcohol and Breast Cancer (ABC) Trial,Recruiting,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,Not Applicable,No,No
20P.020,"Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Biological, Biological, Biological, Other, Other",Single Group Assignment,"Phase 1, Phase 2",Yes,No
RJBC2001,"Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 2,No,No
H-2009-079-1157,Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GB491-005,A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
012342QM,Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
GDWCH002(TNBC),ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HR-BLTN 015,A Multi-cohort Phase II Study of HER2-positive and Triple-negative Breast Cancer Brain Metastases.,Unknown status,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
HER2BRAIN,TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN),Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
HNCH-MBC10,A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer,Not yet recruiting,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,Phase 2,No,No
IC 2020-20,Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
2017-004909-41,Prevention of Cardiac Dysfunction During Breast Cancer Therapy,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,No,No
2022JC-55,Acupuncture for Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.,Not yet recruiting,Interventional,"Experimental, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
ICO-2020-28,Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
2021-0974,Time Restricted Eating During Chemotherapy for Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HNCH-MBC12,Study of SHR-A1811 in HER2-positive Advanced Breast Cancer With Brain Metastases,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
Twisted Pink Foundation,Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,Yes,No
HORMONOVILLE,Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
ET17-093 BreastImmune03,Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
1910208-9,Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CSPC-KAL-BC-11,Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
1503144-7,"Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)",Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
IRB00022667,Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening,Not yet recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
TOL2506A-EXT,"Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study",Enrolling by invitation,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 3,Yes,No
IKP275 / GBG91,Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients,Completed,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
BELIEVE@BC,Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast Cancer,Not yet recruiting,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,No
GCC 1926,GammaPod Dose Escalation Radiation for Early Stage Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Radiation,Sequential Assignment,Not Applicable,No,Yes
HIFU202207,To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Procedure, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
BO40747,A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
KA22053,The 24 Hour Effects of Remedial Exercises With and Without Compression Therapy on Breast Cancer-related Lymphedema,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Single Group Assignment,Not Applicable,No,No
BOOG-2017-01,"Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.","Active, not recruiting",Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
GO39869,"Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer",Completed,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
P2100-SUR-S11,"Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Radiation",Parallel Assignment,Phase 1,Yes,No
BC-IIT-FMTN-SHR6390-ET,"Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
2022JC-55-1,Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.,Not yet recruiting,Interventional,"Active Comparator, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
XJTU1AF-CRF-2020-006,Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SPY LNM 01,A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer,Completed,Interventional,Experimental,"Combination Product, Combination Product",Single Group Assignment,Phase 3,Yes,Yes
2018-062,Reducing Metabolic Syndrome Among Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
CBYL719A0US03T,"Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
QUILT-3.067,QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.,"Active, not recruiting",Interventional,Experimental,"Drug, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,"Phase 1, Phase 2",Yes,No
1808189-7,Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
17041,A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
TSL-CM-TSL1502-Ⅱ,A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations,Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
QL1701-002,"A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
FAVOR,"Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer",Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
60905722.0.0000.0072,Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
197520,Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
17249,A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
Onkologikoa,PFMT Educational Intervention for Patients With Advancer Breast Cancer,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ET17-057,Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
21-018,A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
ShandongCHI-20,Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
AL-2001,Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
kazuma,"To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
308-2017,Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
Pro00107615,TOPS for African American Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
AC682-002,A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
PRO00037175,Cemiplimab in High Risk or Locally Advanced Hormone Receptor Positive HER2 Negative or Triple-Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
55516,Effectiveness of Aerobic Exercises and Laughter Yoga Compared With Yoga in Anxiety/Depression Levels in Breast Cancer,Completed,Interventional,"Experimental, Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
MA-BC-II-007,Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
48347821.8.0000.5249,The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Not Applicable,No,No
OBU-BC-II-086,"Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy",Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
200218,Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
2017 0105,Health Benefits of HIT for Breast Cancer Patients,Withdrawn,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
MYBC,Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast Cancer,Not yet recruiting,Interventional,"Placebo Comparator, Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
D-FR-01070-003,Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MUKDEN01,"Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
R174-A11507-17-S52,Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression,Withdrawn,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
000001,Reliability and Reproducibility of Bandaging in Breast Cancer,Completed,Interventional,"Experimental, Experimental",Other,Crossover Assignment,Not Applicable,No,No
BG01-2102,Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
19-004343,"Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot",Enrolling by invitation,Interventional,Experimental,Genetic,Single Group Assignment,Not Applicable,No,Yes
Shandong CHI-11,Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
NCC2225,Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
NCC-006461,Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
OZM-103,A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SCHBCC-NO27,Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients,Unknown status,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
2020/482,"Supervised Exercise, Sleep in Patients With Non Metastatic Breast Cancer",Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
TUXEDO-1,Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CIBI375Y008,"A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
NL76658.029.21,Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Not Applicable,No,No
SCHBCC-N032,"Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
OE861801,A Phase I Study of LX-039 Tablets,Enrolling by invitation,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 1,No,No
1808189-8,Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
4-2018-0765,"Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
LB,Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
CSIIT-C34,Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
19-886,RCT of CBD for Anxiety in Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
FACILE,FACILE: FeAsibility of First-line riboCIclib in oLdEr Patients With Advanced Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
RP6530-2101,"Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients With Locally Advanced or Metastatic Breast Cancer","Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
GEICAM/2021-08,Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SYHX2011-002,A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound),Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
ZDWY.XBZL.002,Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer,Not yet recruiting,Interventional,Other,Drug,Single Group Assignment,Phase 2,No,No
BO41843,"A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
HSEARS20180509004,Acupuncture for Joint Symptoms in Patients With Breast Cancer,Terminated,Interventional,"Experimental, Sham Comparator, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
Shandong CHI-10,Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
erector-spinae,Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane Block,Completed,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
OnkoFit I,Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
103089,A Window Trial on Curcumin for Invasive Breast Cancer Primary Tumors,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
SHR6390-III-301,A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
17575,A Study of LY3484356 in Women With Breast Cancer Before Having Surgery,Completed,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,Yes,No
IMMU-132-09,Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Participants With HR+/HER2- Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2017-IIT-HER2-Aspire,Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
QL1209-301,Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 3,No,No
17395,"A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 4,Yes,No
D967RC00001,"Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2019-A01323-54,Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
UPCC 10119,ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 2,Yes,No
WO41554,"A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",Yes,No
2020-0198,Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
UC-0109/1805,My Personalized Breast Screening,Recruiting,Interventional,"Other, Experimental","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
SHR-1210-III-318,"A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.",Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
H21089,Breathing Exercise for Chronic Pain Management in Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CSPC-DMS-BC-11,Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
0379520202023,Pain Neuroscience Education and Graded Exposure to Movement in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
S63893,Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity,Withdrawn,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug",Parallel Assignment,Early Phase 1,No,No
KM10B,Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physicians Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
TriMix-Breast,Intratumoral TriMix Injections in Early Breast Cancer Patients,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,Phase 1,No,No
19-486,A Study of the Bodys Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,Phase 2,No,No
UC-GMP-2206,Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
SYSUCC-003,Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2021-005,Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer Patients,Completed,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,Not Applicable,No,No
MRG002-009,A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CBYL719G12301,Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation,Recruiting,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
TCF20-BRE-01,Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,No,No
GS-US-586-6144,Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
PMC_TTAC-0001_05,TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
EOC103A3101,"Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer","Active, not recruiting",Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
CO41012,A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SYM013,Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
SHR6390-III-302,A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
Pro2021000838,"Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care",Not yet recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Crossover Assignment,Not Applicable,No,No
CSPC-DMS-BC-K07,Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SGNLVA-002,Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
WO43919,"A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
EMBRAVE-001,Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,Yes,No
I 72218,A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity,Completed,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
FCN-437c-III201,"This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
MCC-20899,Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases,Recruiting,Interventional,"Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2021-TNBC-01,Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
FCN-437c-III202,"This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
breast-202204,Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
20150288,Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors,Withdrawn,Interventional,"Experimental, Active Comparator, Active Comparator, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",Yes,No
P170927J,Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment,Not yet recruiting,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device",Parallel Assignment,Not Applicable,No,No
HBBL-01,Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study,Unknown status,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,No,No
PCZCTP-220702-001,"Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
ERC-260,Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer,Withdrawn,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
POL6326-009,"Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer",Unknown status,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
911,"Effects of Green Coffee Extract Supplementation on Leptin, Ghrelin, Adiponectin,Anthropometric Measurements, Lipid Profile in Breast Cancer Survivors",Unknown status,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
IRB#18853,Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
EAGER-001,Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
206010,Vaccination of Triple Negative Breast Cancer Patients,Completed,Interventional,"Active Comparator, Experimental","Biological, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
UKFC-PU-2019-01-08,Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients,Not yet recruiting,Interventional,"Placebo Comparator, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Other",Parallel Assignment,"Phase 1, Phase 2",No,No
2018-001705-91,Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
KA-20007,"The Effect of Oral Cryotherapy on Anticipatory, Acute and Late Nausea and Vomiting in Breast Cancer Patients",Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
Arise-FJ-B02,Apatinib Combined With Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
SYSU-2021,Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SHR-A1811-II-202,A Phase Ib/II Study of SHR-A1811 Injection in HER2 Positive Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2019-A03112-55,Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study,"Active, not recruiting",Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
017-396,Pilot Study To Investigate Targetable Metabolic Pathways Sustaining Triple Negative Breast Cancer,Completed,Interventional,"Experimental, Experimental",Dietary Supplement,Sequential Assignment,Not Applicable,No,No
G1T28-213,Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Shengjing-LCG012,A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer,Recruiting,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
NK/7784/Study/249,Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis,Recruiting,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,Phase 3,No,No
CL0006,Intraoperative Detection of Residual Cancer in Breast Cancer,Completed,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,Yes,Yes
ZEN003694-004,A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
TED15954,Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
s2192648,Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
UC-0140/1812,"Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
MAMA_MOVE_Gaia After Treatment,Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors,Completed,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,Not Applicable,No,No
GS-US-569-6172,Study of Sacituzumab Govitecan-hziy (SG) in Japanese Participants With Advanced Solid Tumors or Triple-negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
HNCH-BC011,Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
NCC3397,Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
IC 2020-10,Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,No,No
CTMX-2009-002,Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2020-006106-23,Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva),Suspended,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HR-NeoBC-HN003,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
17320,"A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer",Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 4,Yes,No
PALBOBIN,Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
202103030005,Evaluation and Re-evaluation of Post-mastectomy Pain Syndrome by Breast Cancer EDGE Task Force Outcomes,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
2018.451,"FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET","Active, not recruiting",Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
D8530C00002,A Comparative Study of AZD9833 Versus Fulvestrant in Women With Advanced ER-Positive HER2-Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
MA-BC-II-033,The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
17-428,Olaparib In Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
NL81896.078.22,Tamoxifen Prediction Study in Patients With ER+ Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
SDX-0103,Evexomostat Plus Alpelisib and Fulvestrant in Postmenopausal Women at Risk for Hyperglycemia With Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
CO42177,"A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer",Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
MO39874,A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 3,Yes,No
202007016,Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Biological, Biological, Procedure, Procedure, Procedure",Parallel Assignment,"Phase 1, Phase 2",Yes,No
B003-101,B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
DOUBLE,Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
REaCT-5G,"A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy","Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
STUDY00019489,177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
CO40151,A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
TQB2450-Ib-07,A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC),Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
R19-149,Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
2021/609,Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast Cancer,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
BOOG-2017-02,Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer,Withdrawn,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
AK117-203,A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
HR-NeoBC-HN002,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
AND019-MN-101,A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
SKB264-Ⅲ-03,"SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer",Not yet recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 3,No,No
495573096,Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
ESPB in breast cancer surgery,Ketamine Versus Magnesium Sulphate as Adjuvants for ESPB in Breast Cancer Surgery,"Active, not recruiting",Interventional,"Placebo Comparator, Experimental, Experimental","Procedure, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
SI 475/2019,Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
JS001-026-III-TNBC,Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
CBYL719CIN01,"Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 4,No,No
SPORT-DS,Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast Cancer,"Active, not recruiting",Interventional,Experimental,Radiation,Single Group Assignment,Phase 1,No,No
WO43571,"A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)",Recruiting,Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2020-0232,Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC),Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
TQB2450-III-06,A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC),Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
CASE5119,Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Dietary Supplement, Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
AH150201,"Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c",Unknown status,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
EVER-132-001,Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior Treatments,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
99mTc-ADAPT6 in breast cancer,99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
MOST Pain Pilot,Optimizing Psychological Treatment for Pain After Breast Cancer: A Pilot Study,Completed,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
TBDBreast50,Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
I237,CFI-400945 in Patients With Advanced/Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
KarolinskaUD,"OptiBra Study, Optimal Postoperative Bra After Breastcancer Surgery",Unknown status,Interventional,"Active Comparator, Experimental",Other,Factorial Assignment,Phase 3,No,No
QUILT-3.058,A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies,Terminated,Interventional,Experimental,"Biological, Biological, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
20200225,Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI),Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
SCCC-03121; STU-2021-0657,"CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
BC-Fluzoparib,Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
NCC1969,Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
HX008-Ib/II-TNBC-01,A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
STUDY00004350,A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy,Not yet recruiting,Interventional,Experimental,"Other, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
14/2021,Efficacy of Expressive Writing on Quality of Life Among Breast Cancer Survivors in Oman: A Double Blind Randomized Controlled Trial,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HNCH-MBC07,Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
HR-BLTN-III-NeoBC,Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SYSU-2022-UCAN,Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
19-113,Exercise Treatment With Standard Therapy for Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,Phase 1,No,No
B013-301,Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 2, Phase 3",No,No
4CAST,Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
811,"Effects of Green Coffee Extract Supplementation on Adropin, Irisin, Vaspine,Systemic Inflammation and Oxidative Stress in Breast Cancer Survivors",Unknown status,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
SHR1210-III-322,A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
BC- T-DM1,Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Not Applicable,No,No
HERMIONE-7,"Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)","Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
RG1006427,Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors,Completed,Interventional,"Active Comparator, Experimental","Behavioral, Other, Behavioral, Other, Other",Parallel Assignment,Phase 2,No,No
22-x354,ATI-2231 With in Advanced Solid Tumor Malignancies Followed by ATI-2231 in Combination With Capecitabine in Patients With Hormone Receptor-positive and HER2 Negative Metastatic Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CO41863,A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
21030,Portable Scalp Cooling System for the Improvement of Chemotherapy-Induced Hair Loss in Patients With Metastatic Breast Cancer,Withdrawn,Interventional,Experimental,"Device, Other, Other",Single Group Assignment,Not Applicable,No,Yes
BAT-8001-002-CR,The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,Phase 3,No,No
MedOPP190,"Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)",Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
Combined CTH and HT in MBC,"Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study",Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
KN046-203,A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
DZ2019HE001,"DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
S62794,"Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer",Completed,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
SHR6390-SHR1020-I-101-BC,A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
IIT2022-07-YUAN-IB-TNBC,Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
MA-BC-II-047,Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
FUSCC,Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA),Not yet recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
222.20,SBRT in Early Breast Cancer in Elderly Women,Recruiting,Interventional,"Experimental, Experimental, Experimental",Radiation,Sequential Assignment,Phase 1,No,No
NCC201711008,Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer,Unknown status,Interventional,,Drug,Single Group Assignment,Phase 2,No,No
2019-0634,Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
ShandongCHI-06,Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy,Not yet recruiting,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,Phase 2,No,No
NCC2474,Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Device",Parallel Assignment,Phase 2,No,No
MK 3475-318,Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.,Completed,Interventional,"Other, Other, Other, Other, Other, Other",Drug,Single Group Assignment,Early Phase 1,No,No
Medical Research Institute,"US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation",Completed,Interventional,"Experimental, Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
MCLA-128-CL02,MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
HNCH-HER2-MBC001,Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
P170929J,PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GB491-004,GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
MORE-T trial,Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Diagnostic Test, Procedure",Parallel Assignment,Phase 2,No,No
IJB-LOB-2019,Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE),Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
MS200647_0020,Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
262840,CIPN in Early Stage Breast Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
U025,Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug, Drug, Procedure",Single Group Assignment,Phase 1,Yes,No
Soh-Med-21_10_18,One Week Adjuvant Radiotherapy for Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
SPH4336-301,Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
HCB/2019/0786,Sexual and Vaginal Health in Breast Cancer Women Receiving Aromatase Inhibitors Before and After CO2 Laser Therapy,"Active, not recruiting",Interventional,"Sham Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
2019-185-AGH,Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Phase 2,No,Yes
EC2019/0127,Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation Treatment,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,No
REaCT-OGF,Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel Chemotherapy,Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 4,No,No
NCI-2021-08921,Metformin and Nightly Fasting in Women With Early Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Drug, Other, Other, Other",Parallel Assignment,Phase 2,Yes,No
AIs with chemotherapy in MBC,Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer,Not yet recruiting,Interventional,,Drug,Single Group Assignment,Phase 2,No,No
CTRIAL-IE 22-01,Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study),Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SIBP-01-3,A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
20-068,MARGetuximab Or Trastuzumab (MARGOT),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
19-002448,Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Other, Other, Other",Single Group Assignment,Phase 1,No,No
UC Laser,Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Device",Parallel Assignment,Not Applicable,No,Yes
TEMPLATE,Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
CO42867,A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
GBG 93,"A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).",Recruiting,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
2022-0500,Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors or Chemotherapy in Luminal B/HER2-negative Breast Cancer (DAPATH),Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
IJB-LBC-NEOCHECKRAY-2018,"Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:",Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Radiation, Drug",Parallel Assignment,Phase 2,No,No
HR-MBC-HN001,A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MCC-19803,Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer,Terminated,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
20-130,Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
BG01-2001,PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,No,No
ROGABREAST,"Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.",Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
18291,A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
SYSU-2021-UCAN,Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Factorial Assignment,Phase 3,No,No
18040334,Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
Labra-001,Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy,Completed,Interventional,"Sham Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
M19-992,"A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy",Terminated,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
2021-1122,"AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer",Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
SYSKY-2022-105-01,Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
CS2-19004,Chemotherapy - Induced Peripheral Neuropathy,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
I2I1,Connecting Breast Cancer Survivors for Exercise,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2019-01-064,TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery,Unknown status,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
SHR-A1811-206,A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
FOENIX-MBC2 TAS-120-201,A Study of TAS-120 in Patients With Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
IRB18-1178,Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer,Recruiting,Interventional,"Experimental, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
ML43171,"A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physicians Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
UC-BCG-2011,Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
CSIIT-C41,Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MO43110,A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer,Recruiting,Interventional,"Other, Other, Experimental, Experimental, Other","Drug, Drug, Drug, Drug, Drug, Procedure, Radiation",Parallel Assignment,Phase 3,Yes,No
SHR-1210-III-327,A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
EOC202A2102,"HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy",Not yet recruiting,Interventional,"Active Comparator, Active Comparator","Biological, Drug",Parallel Assignment,Phase 2,No,No
IEO 675,Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
MP-05-2021-2605,Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
7339-009,Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009),"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
MC1831,"Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer",Recruiting,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,Phase 2,Yes,No
D933LC00001,A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
MA-BC-II-042,Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
2020-1190,Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Other, Device, Behavioral, Other, Other",Single Group Assignment,Not Applicable,No,No
HRS8807-I-101,"A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Device, Drug",Single Group Assignment,Phase 1,No,No
2019-00673; sp19Kurzeder,Digoxin Induced Dissolution of CTC Clusters,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
BreCLIM-2018-116-31M,BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,Phase 3,No,No
TQ-B3525-I-02,"A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer",Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
HKUCTR-2709,Use of Superparamagnetic Iron Oxide (SPIO) in Sentinel Lymph Node Detection for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
MUKDEN5,Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
Prevention of neuropathy,Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Parallel Assignment,Not Applicable,No,No
TQB3616-II-01,A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
s17-00995,MBSR During AI Therapy for Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
SHR9549-I-101,SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
3-2019-0140,Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
IRB00109957,THRIVE Breast Cancer App Study,Completed,Interventional,"No Intervention, Active Comparator, Active Comparator","Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
IRB18-00912,Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
0392-18-HMO,CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Sham Comparator",Device,Sequential Assignment,Not Applicable,No,No
UW19046,FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Diagnostic Test",Single Group Assignment,Early Phase 1,Yes,No
I 73718,Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological, Drug",Single Group Assignment,Phase 1,Yes,No
HCB/2020/0971,Evaluation of the Impact of a Multidimensional ICT Intervention on the Quality of Life of Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
FJD-LCO2-19-01,A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Combination Product",Parallel Assignment,Not Applicable,No,No
MC01/05/20; IST-325 (KPT),Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START),Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
KROG 21-07,Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients,Not yet recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
22012020,Bubble: A New VR-AI Way of Treatment for Hot Flashes in Women With Breast Cancer,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
2020-1267,Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion,"Active, not recruiting",Interventional,Experimental,"Procedure, Procedure, Other, Drug",Single Group Assignment,Not Applicable,No,Yes
HER2BAT,A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
ARIANNA (SOLTI-1502),Targeting the PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic BC,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
PROICM 2019-05 MAC,Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
BLI-1401-2-01,"Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
20221120,A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause,Not yet recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,Yes,No
CLEAR,Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,Phase 2,No,No
2.777.676,Photobiomodulation for Breast Cancer Radiodermatitis,Completed,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,"Phase 2, Phase 3",No,No
IC 2017-06,Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CO40115,A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental, Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
111-009-F,A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Phase 1,No,No
21129002,Topical Menthol Application in Chemotherapy-Related Peripheral Neuropathy in Patients With Breast Cancer,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
MCC-20915,"Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab",Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure",Sequential Assignment,Phase 2,Yes,No
PMCT-IMSLNB-MIT,Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique,Unknown status,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
V2000701,Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
University Brunswick,Physical Activity Levels and Functional Improvement in Breast Cancer Survivors,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
1605576856,Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
3475-B49,Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49),Recruiting,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2018-0287,"Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
SABO 21-01,Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
UW20037,Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study),Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
20201101,Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study),Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
ZJCH-CK19B,A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer,Unknown status,Interventional,"No Intervention, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
IPI-549-03,Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (MARIO-3),"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2017-0500,M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
APG2575XU103,"A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
BLTN-NeoBC1115,Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
22-259,A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,Yes
UW18099,Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,Yes
17384,A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
BL-B01D1-104,A Study of BL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
M21CSM,COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study,"Active, not recruiting",Interventional,Other,"Procedure, Radiation, Other",Single Group Assignment,Phase 2,No,No
4-2022-0600,Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction,Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
22239,Treatment of Frailty With Fisetin (TROFFi) in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Placebo Comparator","Procedure, Drug, Drug, Other, Other",Parallel Assignment,Phase 2,Yes,No
202107015,"Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing",Recruiting,Interventional,"Experimental, Experimental, Experimental","Device, Other",Parallel Assignment,Not Applicable,No,Yes
20171,Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer,Recruiting,Interventional,Experimental,"Other, Drug",Single Group Assignment,Not Applicable,No,No
HS-10352-101,Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
NNG17.2,Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
2019-40016-06,Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy,Unknown status,Interventional,"Active Comparator, Other",Drug,Factorial Assignment,Not Applicable,No,No
IRB-52869,Umbrella Trial Testing Integrative Subtype-Targeted Therapeutics in HR+ /HER2-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
D9266C00001,"A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
2017/78,"Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)",Not yet recruiting,Interventional,Experimental,Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
ICRG0201,"Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SHR-A1811-III-301,"A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
IRB-63041,Study Assessing QBS72S For Treating Brain Metastases of Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
U21-02-4401,Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition,Recruiting,Interventional,,Drug,Single Group Assignment,Phase 2,Yes,No
GS-US-592-6173,"Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physicians Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SCO-120-19-22,A Study in Patients With Advanced Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
GS-US-592-6238,Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Patients With Previously Untreated Metastatic Triple-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
CBYL719C2201,Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
TQB3616-III-01,TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
19/218,Increasing Access to Breast Cancer Screening Among Immigrants,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CHANGEABLE,Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
19-3032.cc,Combined Modality Exercise and Appetite in Breast Cancer Survivors,Terminated,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
SCT200IITNBC,Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,No,No
651,Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.,Recruiting,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
H3B-6545-J081-103,"Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,No,No
2019-00174 Neoadj Breast Pilot,"Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer",Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
MO40628,A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,Phase 2,Yes,No
NNG17.1,Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 1,No,No
STUDY00004618,A Patient Reminder and Self-Referral Via Online Patient Portals and Text Messaging to Improve Adherence to Breast Cancer Screening,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
19959,Effects of Computer-Assisted Cognitive Rehabilitation Programs With Breast Cancer Survivors,Unknown status,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
AIPAC-003,Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy,Recruiting,Interventional,"Experimental, Experimental, Experimental, Placebo Comparator","Biological, Drug, Other",Parallel Assignment,"Phase 2, Phase 3",Yes,No
18-1068,Clinician Communication About Sexual Health,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
SuleymanDU-SALMAN-F-001,The Effect of Mobile Application-based Information About Before and After Surgery,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
IIBSP-SIL-2017-70,Evaluation of a New Technique to Fill the Defect Generated After Conservative Surgery in Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,No
Shoulder exercise cancer,Limited Versus No-limited Shoulder Movement in Breast Cancer Surgery,Completed,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
NCI-2022-00004,Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body,Recruiting,Interventional,Experimental,"Drug, Dietary Supplement",Single Group Assignment,"Phase 1, Phase 2",Yes,No
GC-627-05,Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
LCCC 2104,Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN),Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,Phase 2,Yes,Yes
2021SQGH00743,The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
N21CPB-IRBd22-103,Communication in Breast Cancer Care,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
UPNA-CUMACA-B2022,Web-based Intervention for Long-term Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
rosuva2020,Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients,Recruiting,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,Phase 3,No,No
213831,Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
Pro00109917,Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
GCO 17-2320,Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
MA-BC-II-025,Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
CPO-NBP-2002,NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy,Not yet recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
INT/2020/VOICE,"Implementation, Effectiveness and Impact of a Value Based Intervention for Patients With Breast or Lung Cancer","Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
N assisted,A Clinical Study on Hormone Receptor Positive HER2 Positive Breast Cancer of RCB1-2 After Neoadjuvant Treatment With Trastuzumab Combined With Parezumab,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
SYSKY-2022-024-01,Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients,Recruiting,Interventional,Experimental,Procedure,Sequential Assignment,Not Applicable,No,No
PROSOM-K,Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep,Completed,Interventional,"Other, Other, Other","Other, Drug",Parallel Assignment,Not Applicable,No,No
NL62441.068.17,PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
EP0062-101,Phase 1/2 Study to Evaluate EP0062 in Patients With Relapsed Locally Advanced or Metastatic Androgen Receptor Positive (AR+)/HER2-/ER+ Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
KY2022-044-B,"CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial",Recruiting,Interventional,"Active Comparator, Other",Device,Parallel Assignment,Not Applicable,No,No
SUGBG-2021001,Sentinel Node Localization and Staging With Low Dose Superparamagnetic Iron Oxide,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
PI2018_843_0061,Feasibility of Total Mastectomy in Ambulatory Care,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2110244-11,Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Sham Comparator, Sham Comparator",Device,Parallel Assignment,Phase 4,No,No
HSM/VGH-2019-12-009CC,Web-based Oncofertility Support Tool for Reproductive-age Women With Breast Cancer,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
2021-A01550-41,Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
2449PT,Effect of Exercise Mode in Breast Cancer-Related Lymphedema,Completed,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
20220430GD,Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
StrataXRT,A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
TQB3909-Ib/II-01,A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
"S-20200021, 19-16321",An Individualised Treatment vs. a Minimal Program in Women With Late-term Shoulder Impairments After Breast Cancer.,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
Exo-LCR-1807,Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.,Withdrawn,Interventional,Experimental,"Procedure, Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
AGO/2019/003,Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer,Withdrawn,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
C4891016,A Study to Learn About the ARV-471 (PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC),"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
MCC-19220,PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient,Withdrawn,Interventional,Experimental,"Diagnostic Test, Biological, Diagnostic Test",Single Group Assignment,Early Phase 1,Yes,No
2020-A01916-33,Adapted Fencing in Breast Cancer: a Pilot Study,Recruiting,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
BR-003,Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
2021/156064(REK),Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Phase 2,Yes,No
MedOPP199,"Neoadjuvant Letrozole and Palbociclib in Patients With Stage II-IIIB Breast Cancer, HR+, HER2 -",Completed,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
RECHMPL21_0680,Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
18459,A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
PRO00030295,Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
DBCG RT SDM,Shared Decision Making With Breast Cancer Patients,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NBK 171/1/2021,Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a Window of Opportunity Study,Not yet recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
NCC1787,Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer,Unknown status,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
UCI 19-145 [HS# 1459],"Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
18496,"Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer","Active, not recruiting",Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Other",Parallel Assignment,"Phase 1, Phase 2",Yes,No
INT214/22,Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial,Not yet recruiting,Interventional,"Placebo Comparator, Experimental",Dietary Supplement,Parallel Assignment,Phase 2,No,No
201906,Psychological Interventions to Prevent Late Effects in Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
BL-M07D1-101,A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
22-250,TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HCI130492,Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
E7090-J081-102,A Study of E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,No,No
Folio No.03-2022,Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
S63330,FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
CA209-8H3,"Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
A171601,"Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Other, Other",Single Group Assignment,Phase 2,Yes,No
OP-1250-001,"A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer",Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
21-091,A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
CARDIEJERCAN,Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
RIBBS 2019/37,Risk-Based Breast Screening in Young Women,"Active, not recruiting",Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
CCR5234,Digital Delivery of Information About Genetic Testing for Breast Cancer,"Active, not recruiting",Interventional,"Experimental, No Intervention, Experimental, No Intervention","Other, Other",Sequential Assignment,Not Applicable,No,No
2574,Prospective Thinking in Hormone-Responsive Breast Cancer,Completed,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
IFG-06-2019,Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
439-21,High-intensity Exercise After Treatment,"Active, not recruiting",Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
VHIO20002,A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug",Single Group Assignment,Phase 1,No,No
H-45698,Topical Dermaprazole for Radiation Dermatitis in Breast Cancer and Head and Neck Cancer Patients (TOPAZ),Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
FDRT-BC010,Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases,"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,"Phase 1, Phase 2",No,No
D8666C00004,To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
17-0310,Narrative Visualization for Breast Cancer Survivors Physical Activity,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
OTT 17-02,Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients,Completed,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
MC1835-ACCRU-BR-1701,"TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery",Recruiting,Interventional,"Experimental, Placebo Comparator, Experimental","Biological, Biological, Other, Biological, Biological, Biological",Parallel Assignment,Phase 2,Yes,No
CCR4772,PRELUDE Study of Lymphatic Surgery to Treat Breast Cancer Related Lymphoedema,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
UC-BCG-2205,Treatment for Breast Cancer Patients With Meninges Invaded by Tumor Cells,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
21094,CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
PECP,The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
11066,Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
CBYL719A03201,Pilot Decentralized Clinical Trial in Men and Pre and Post-menopausal Women With Breast Cancer and a Specific Mutation (PIK3CA) Treated With Alpelisib in Combination With Fulvestrant,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
SDO-006-20-01,To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer,Withdrawn,Interventional,"Active Comparator, Active Comparator",Drug,Crossover Assignment,Phase 1,Yes,No
22-655,STOP-HER2: Stopping Trastuzumab in HER2+ MBC,Not yet recruiting,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Phase 2,No,No
CL0007,Investigation of Novel Surgical Imaging for Tumor Excision,Completed,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,Phase 3,Yes,Yes
MO39193,A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
HSR210410,Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer,Not yet recruiting,Interventional,"Other, Other, Other, Other","Drug, Drug, Radiation, Radiation",Parallel Assignment,"Phase 2, Phase 3",Yes,No
ALTER-BC-003,AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
NL67422.041.18,Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,Phase 1,Yes,No
AL-TNBC-01,A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
300007016,"Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations",Recruiting,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
QUILT-3.057,QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2021-0261,Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer,Completed,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,Phase 3,Yes,Yes
H3B-6545-G000-102,A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Sequential Assignment,Phase 1,Yes,No
NCI-2018-01581,"Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Drug, Procedure, Biological, Drug, Procedure, Drug, Biological, Drug, Biological",Parallel Assignment,Phase 2,Yes,No
CAR202,A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
SIB16134,Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer,Withdrawn,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
2020-11/15,"The Effect of Art Therapy on Pain, Emesis, Anxiety and Quality of Life, Breast Cancer",Completed,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
20D.876,SABR-CaRe in Early Stage Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Other, Radiation, Procedure, Other, Other, Procedure, Other",Parallel Assignment,Phase 2,No,No
41494,Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
19D.799,A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
21-110,Anti-anxiety Biotics for Breast Cancer Survivors,Completed,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
GM1-CIPN-202,"A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer",Not yet recruiting,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,"Phase 2, Phase 3",No,No
HSaleem,Kinesiology Taping Technique in Post-mastectomy Breast Cancer Related Lymphedema,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
220493,Lymphatic Function in Patients Who Have Undergone Breast Cancer Treatment,Unknown status,Interventional,Other,Drug,Single Group Assignment,Not Applicable,No,No
2020-q12,Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
1280-0022,The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
112626,Three Fraction Radiation to Induce Immuno-Oncologic Response,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
0124-18-TLV,Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor,Unknown status,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
BL2014084,"This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of Treatment",Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
RLY-2608-101,"First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Advanced Solid Tumor Patients and in Combination With Fulvestrant in Patients With Advanced Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
CLEE011A2207,"Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
21050,An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis,Recruiting,Interventional,Experimental,"Other, Procedure, Device, Biological, Biological",Single Group Assignment,Phase 4,Yes,Yes
55054,Inspiratory Muscle Training in Obese Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
PILOT 171548,RISE - Reduce Sitting Time Among Breast Cancer Survivors,"Active, not recruiting",Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
Pro00109777,Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
22-225,ETHAN - ET for Male BC,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
ShandongCHI-04,The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy,Unknown status,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
1710018694,Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients,Recruiting,Interventional,Other,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
MC1733,A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
294-2018,Efficacy Study of Mepitel Film the Prophylaxis of Radiation-Induced Skin Reactions in Breast Cancer Patients,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
29747,T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
IFG-NIB-01,Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC,Completed,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
PRESSODOU-1809,Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
WSG-AM08,"Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC",Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
MRG002-005,A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
HLX10-013-TNBCneo,to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC),Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Sequential Assignment,Phase 3,No,No
INT 192/19,Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Dietary Supplement, Drug, Drug",Parallel Assignment,Phase 2,No,No
IRB-53650,"Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer",Terminated,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
VICC BRE 17107,Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer,Terminated,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
2017-004938-28,Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal Cure,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
Pro00103625,Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2017/01,Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients,Unknown status,Interventional,"Active Comparator, Placebo Comparator",Other,Parallel Assignment,Phase 3,No,No
G0F9119N,CoMoon for Supporting Breast Cancer Patients on Adjuvant Endocrine Therapy,Completed,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,No
NCI-2018-01519,Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Radiation",Parallel Assignment,Phase 2,Yes,No
OP_1413,Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
2020-001,"Phase 2 Study to Evaluate PVX-410 + Pembrolizumab + Chemotherapy for Metastatic, PD-L1+ Triple-Negative Breast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
NCI-2022-07265,"Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer, A ComboMATCH Treatment Trial",Recruiting,Interventional,"Experimental, Active Comparator, Experimental","Drug, Procedure, Procedure, Procedure, Drug, Procedure",Parallel Assignment,Phase 2,Yes,No
G1T28-208,"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)","Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ZZBGCART-016,EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Early Phase 1,No,No
21-038,Fulvestrant + Neratinib In Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
STUDY00004257,"Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Early Phase 1,Yes,No
09.2019.865,Responsiveness of Outcome Scales in Breast Cancer Related Lymphedema,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
I-3010822,"Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer",Not yet recruiting,Interventional,"Experimental, Experimental","Procedure, Procedure, Drug, Procedure, Biological, Procedure, Biological, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
UMCC 2021.056,An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors,Completed,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
BOOG 2019-01,"TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
AZV2022,The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
RF-2016-02362383,Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
HYPART,HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
UTD-1-BM-II,"The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
2018/14-01,A New Mindfulness Intervention Called Mindfulness Based Swinging Technique (MBST) for Women With Breast Cancer,Completed,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,Not Applicable,No,No
UC-0140/1814,"Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients",Recruiting,Interventional,Other,"Drug, Other",Single Group Assignment,Not Applicable,No,No
NBG-19-01; SWEBCG 19-01,"NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
bakircaymzeren07,Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
2021SCR,Cone Beam Breast CT for Breast Cancer Screening,"Active, not recruiting",Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,Yes
Lymphedema Rehabilitation,New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA),Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
IRB-30000320,"Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors",Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
VMA-253-18,Fish Oil and EPO in Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,Not Applicable,No,No
9764,"Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Drug, Other, Drug, Other, Other, Drug, Drug",Single Group Assignment,Phase 4,Yes,No
EA1211,"Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial",Not yet recruiting,Interventional,Experimental,"Drug, Procedure, Other, Procedure, Procedure",Single Group Assignment,Phase 2,No,No
11B1920N_BCS-PAIN,The Effect of Pain Neuroscience Education and Behavioural Graded Activity on Chronic Pain in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
ShandongCHI-13,Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer,Unknown status,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
3-2020-0448,Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
Pro2020001306,Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Other, Other, Radiation, Procedure, Radiation, Other",Single Group Assignment,Not Applicable,No,Yes
17502,A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
2861/20,Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Other",Factorial Assignment,Phase 2,Yes,No
GY202201,Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia,Recruiting,Interventional,"Experimental, Sham Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
WO40181,"A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy",Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
BMTN,Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
20190304-01H,"Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain",Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
30388,"Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors","Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
STUDY00146320,Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens,Recruiting,Interventional,"Experimental, Other",Drug,Parallel Assignment,Phase 2,Yes,No
SM-88-001,Study of SM-88 in Advanced Cancers,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
2022-A00437-36,Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
2.073.549,Pilates and Dance to Breast Cancer Patients Undergoing Treatment,Completed,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Factorial Assignment,Not Applicable,No,No
2-114-18,Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?,Unknown status,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
NCI-2020-02319,Testing the Addition of Copanlisib to Eribulin for the Treatment of Advanced-Stage Triple Negative Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Drug, Drug, Procedure",Sequential Assignment,"Phase 1, Phase 2",Yes,No
P170407J,Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer,Completed,Interventional,Other,Drug,Single Group Assignment,Phase 2,No,No
QF-SC10914-203,A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
D926PC00001,"A Study of Dato-DXd Versus Investigators Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
IRB00376235,The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HCRN BRE18-360,Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physicians Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases,Recruiting,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
19-1974.cc,Appetite and Exercise in Breast Cancer Survivors,Completed,Interventional,"Other, Other","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
H19-02480,BREast Cancer And Sexuality Treatment,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HS-10342-201,A Study of HS-10342 in Chinese Patients With HR+/HER2- Advanced and/or Metastatic Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
IRB202000746,"A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)","Active, not recruiting",Interventional,"Experimental, Experimental, Other","Drug, Combination Product, Combination Product",Parallel Assignment,"Phase 1, Phase 2",Yes,No
2020-01-mp-BUS,Multi-parametric Breast Ultrasound Imaging as a Potential Biomarker for Breast Cancer,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
CBCSG041,Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction,Not yet recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
PILHLE-001,"Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
WEBAPPAC,Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
21-579,Low-field MRI for Breast Cancer Screening,Not yet recruiting,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,Not Applicable,No,Yes
A011801,"T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial",Recruiting,Interventional,"Active Comparator, Experimental","Biological, Drug, Drug, Other, Other",Parallel Assignment,Phase 3,Yes,No
Maple Tree Exercise,Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients,Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
ERC/2019/10/05,Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria,Recruiting,Interventional,"Experimental, Experimental","Procedure, Other",Parallel Assignment,Not Applicable,No,No
22145,Effects a Honey Based Syrup on Blood Parameters in Patients With Breast Cancer,Completed,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,No,No
ICS Maugeri - CE 2202,Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer,Completed,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
TCHP,Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
19-001881,Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors,Recruiting,Interventional,Experimental,"Drug, Other",Single Group Assignment,Phase 2,Yes,No
STU-2020-1043,Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
041-2018,Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer,Completed,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,"Phase 2, Phase 3",No,No
RESCREEN,Optimized Rehabilitation Following Primary Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
NCI-2019-00048,"A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
IRB-57111,Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients,"Active, not recruiting",Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2022-0959,Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Single Group Assignment,"Phase 2, Phase 3",No,No
I 60517,Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice,Completed,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
OSU-21185,Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors,Recruiting,Interventional,Experimental,"Behavioral, Other, Other",Single Group Assignment,Not Applicable,No,No
A221803,Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy,Recruiting,Interventional,"Active Comparator, Experimental","Other, Device, Other, Other",Parallel Assignment,Phase 3,No,Yes
IndonesiaU2022,The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
STUDY00003100,Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts,Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,Yes,No
FM-17-B01,Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,Phase 3,No,No
STUDY00007842,Music as a Perioperative Therapy in Breast Cancer Patients,Withdrawn,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
STUDY00001007,Peer Support For Young Adult Women With High Breast Cancer Risk,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
20-133,A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer,"Active, not recruiting",Interventional,Experimental,Procedure,Single Group Assignment,Early Phase 1,No,No
H19094,Effects of a Traditional Chinese Exercise Program on Symptom Cluster in Breast Cancer Patients,Completed,Interventional,"Other, Experimental","Other, Behavioral",Parallel Assignment,Not Applicable,No,No
16-185671,Integrative Approaches to Cancer Survivorship: Project 3,Completed,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
M18BEL,Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 2,No,No
"UPCC# 15122, IRB # 852205",CAR T Cells in Mesothelin-Expressing Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Device",Sequential Assignment,Phase 1,Yes,Yes
HCC 20-243,Apollo Device for Metastatic Breast Cancer (MBC),Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
Alaa_Negm_MSc_2023,"Effect of Kinesiotaping Augmented By Resistive Exercise on Fatigue, Physical Strength, Quality of Life in Breast Cancer Survivors",Not yet recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
SunYatsenU2H-LQ3,"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC",Recruiting,Interventional,"Experimental, Active Comparator, Experimental, No Intervention","Drug, Drug",Parallel Assignment,Phase 2,No,No
BYEC20211201,Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
18-140,Sexual Health and Rehabilitation After Ovarian Suppression Treatment,Completed,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
2022-0378,Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care,Recruiting,Interventional,"Other, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
20-221,Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
IRB-58571,Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast Cancer,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
BPI-1178-2019-001,A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
E-HHC-2016-0245,Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer,Suspended,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
21656,"A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
UC-0140/1901,Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
ACCRU-BR-1801,T-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer,Withdrawn,Interventional,"Active Comparator, Experimental","Drug, Biological",Parallel Assignment,Phase 2,Yes,No
HE072-CSP-002,Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance,Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 1,No,No
17-00890,Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC),"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2020-01,Exercise Therapy During Radiotherapy,Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
TransRosaLEE-IPC 2021-075,"Trans-RosaLEE Study: a Biomarker-directed, Translational Study",Not yet recruiting,Interventional,Experimental,"Genetic, Genetic, Genetic, Genetic",Single Group Assignment,Not Applicable,No,No
2000024495,Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer,"Active, not recruiting",Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
UMCC 2021.109,Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Sequential Assignment,Phase 4,Yes,No
TROIKA,"A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients",Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
HMCC-BR22-001,Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
I 1680021,Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Biological, Procedure, Procedure, Procedure, Biological, Other",Single Group Assignment,Phase 2,Yes,No
NCC1692,Anlotinib in Metastatic HER2 Negative Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
0201263,Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer,Unknown status,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
19/002,"Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
NCI-2019-06461,"Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Biological, Biological",Parallel Assignment,"Phase 1, Phase 2",Yes,No
HNCH-BC001,The TP Regimen in the Treatment of Early Triple Negative Breast Cancer,Completed,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
S-169,Complementary and Alternative Medicine on Mental Health in Breast Cancer Patients,Unknown status,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,Phase 1,No,No
HCI103657,Merestinib on Bone Metastases in Subjects With Breast Cancer,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
HS627-III,Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel,Unknown status,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
17782,A Study of Abemaciclib in Indian Women With Advanced Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 4,Yes,No
LQ004,Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
2021-A03166-35,Functional Evaluation After Breast Reconstruction With a Minimally Invasive Latissimus Dorsi Flap Following Radical Surgery for Breast Cancer.,Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
AAAS9859,Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI),Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
249571,Mini-AFTERc Intervention for Fear of Cancer Recurrence,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2022/050,Telerehabilitation in Survival Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
BR01/01/22,Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
UMCC 2020.122,"Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
CA048-001,A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread,Completed,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Drug",Single Group Assignment,Phase 1,Yes,No
NCI-2022-10810,"Testing the Addition of an Anti-cancer Drug, ASTX727 (Cedazuridine, Decitabine), to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer",Recruiting,Interventional,Experimental,"Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological",Single Group Assignment,Phase 1,Yes,No
RG1004302,Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Biological",Single Group Assignment,Phase 1,Yes,No
Pro00100093,A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,Phase 2,Yes,No
0201-21,Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
CORE,Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity,Terminated,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
ENZENO-C-101,ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
19206,Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.,Recruiting,Interventional,Experimental,"Drug, Other",Single Group Assignment,Phase 2,Yes,No
S00748-NIM,Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial,Not yet recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
STUDY00002373,Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure, Other",Parallel Assignment,Phase 2,No,Yes
ATENTO19,Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO),Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
SCHBCC-N048,Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
3-2020-0343,Primary Surgical Prevention of Breast Cancer-related Lymphedema,Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
KSF2-1707,Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Procedure, Biological, Procedure",Single Group Assignment,Not Applicable,No,No
UW 19-045,Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy,Unknown status,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
22-074,A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Other",Sequential Assignment,Phase 2,Yes,No
lithium and breast cancer,Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients,Completed,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,Phase 3,No,No
18549,Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema,"Active, not recruiting",Interventional,Experimental,"Other, Behavioral, Behavioral, Other, Other",Single Group Assignment,Not Applicable,No,No
EGC002,Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
Multimodal Project,Multimodal Project,Not yet recruiting,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
201710109,Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Biological, Device, Procedure",Parallel Assignment,Phase 1,Yes,No
2016-003518-28,Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer,Unknown status,Interventional,"Experimental, Active Comparator","Other, Drug, Drug",Parallel Assignment,Phase 3,No,No
BR01/02/19,Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
XJLL-KY20212136,RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2017-073,The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Other, Drug",Single Group Assignment,Phase 2,Yes,No
CMUH107-REC3-102,Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer Patients,Completed,Interventional,"Active Comparator, Placebo Comparator",Other,Crossover Assignment,Not Applicable,No,No
HBO001,Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Procedure, Drug, Dietary Supplement",Parallel Assignment,Phase 2,Yes,No
RG1718047,"Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer",Withdrawn,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 2,Yes,No
2020-006,Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients,Completed,Interventional,"Other, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
TX05-03,"Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer",Completed,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2016/65,Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer,"Active, not recruiting",Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
22-490,VS-6766+Abema+Fulv in Met HR+/HER- BC,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
19P.117,Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences,"Active, not recruiting",Interventional,Experimental,"Drug, Procedure, Other, Other",Single Group Assignment,Phase 1,No,No
HCRN BRE19-433,"A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,Phase 2,Yes,No
S2020-09,Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
J17118,Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
EQ132-201,A Study of Lerociclib in Participants With Advanced Breast Cancer,Recruiting,Interventional,Other,Drug,Single Group Assignment,Phase 2,Yes,No
UW21062,Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals,Completed,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
ACT16106,"Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer",Terminated,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2018/8361/I,MUltimodal Targeted Axillary Surgery,Recruiting,Interventional,Other,"Diagnostic Test, Diagnostic Test, Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
427 BC SDM,Enhancing Shared Decision-Making in Breast Cancer,Completed,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
20210901-jiangchunling,A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases,Recruiting,Interventional,"Experimental, Active Comparator",Combination Product,Parallel Assignment,Phase 2,No,No
2023-3181,Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
01,Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer,Recruiting,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
CHUV-DO-0009-CyberImmunoBreast,CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC),Recruiting,Interventional,"Experimental, Experimental","Radiation, Drug",Parallel Assignment,Phase 2,No,No
PEMBRACA,Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA),Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
170115,T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery,"Active, not recruiting",Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
ANG1005-CLN-07,ANG1005 in Leptomeningeal Disease From Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
IJB-EBC-Decrescendo-2020,De-escalation Adjuvant Chemo in HER2+/ER-/Node-neg Early BC Patients Who Achieved pCR After Neoadjuvant Chemo & Dual HER2 Blockade,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 2,Yes,No
FASCINATE-N,Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
Manual Therapy BCS,Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors,Terminated,Interventional,"Experimental, Sham Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
KUH5101090,"The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients",Withdrawn,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
17471,Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Other, Other, Other, Drug",Single Group Assignment,Phase 2,Yes,No
BAIBU-FTR-ED-001,Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema,Completed,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
STUDY00018239,Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer,Completed,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 1,Yes,No
NCO-21001,Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
16-015,Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Early Phase 1,Yes,No
2170-29-02/1-2,The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks,Not yet recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Device, Device, Drug, Procedure",Parallel Assignment,Not Applicable,No,No
GBG 97,Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
DOT-1871-KIE-0120-I,Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
IIT-2017-MM-BRST-Her2noRT,Omission of Radiation in Patients With Her-2 Positive Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,Yes
KaratayUHaticeTEZ,The Effect of Training Given by Mobile Application to Women Undergoing Breast Surgery,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
YBCSG-21-01,Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
UniUrb_21/10.07.2019,Movement and Health Beyond Care (MoviS),Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
Shengjing-LJY02,DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
2016-6346,Comparison of Healthy Diets on Breast Cancer Markers,Completed,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
N19TON,Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
Soh-Med-23-02-16,Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients,Not yet recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 1,No,No
SIMR_onc19_IIS_DAndre_Ashwaga,Ashwagandha for Cognitive Dysfunction,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Crossover Assignment,Phase 2,Yes,No
PROICM 2018-02 SKY,Feasibility Study: Yoga Educational Project,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
GRASPA-TNBC-2018-02,Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2),Terminated,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
NCI-2016-01293,Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,Phase 1,Yes,No
BOOG 2021-01 SEQUEL-Breast,SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast),Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
2020-1138,A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer Patients,Completed,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
432-17,Facilitating Oncology Patient-Clinician Communication Via E-health Innovations,Completed,Interventional,Other,Behavioral,Single Group Assignment,Not Applicable,No,No
20170770,"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
YX2021-070(F1),Effect of Intravenous S-ketamine on Opioid Consumption,Recruiting,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
LCI-BRE-MTN-NIR-001,LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
1B-16-11,Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
7119-001,A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001),"Active, not recruiting",Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,Phase 2,Yes,No
PRO2,Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer During Chemotherapy in Combination With HER2-targeted Therapy or Antibody-drug Conjugate Therapy.,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
KTI-21-01,Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC),Not yet recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,Yes,Yes
CDX-ONC-101,"A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer",Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,Phase 1,Yes,No
ICL-2022-1,Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog),Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
1070741-1,Subclinical Lymphedema Treatment Study,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
MO42319,A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC),"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Other",Parallel Assignment,Phase 3,Yes,No
2021-1031,"A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
MCC-19337,HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Drug, Procedure",Parallel Assignment,Early Phase 1,Yes,No
18175,"A Study of Imlunestrant, Investigators Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
4090,Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.,Completed,Interventional,"Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,Yes
2021332GD,Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy,Not yet recruiting,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
18238,Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
21152,Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Other, Other, Other",Parallel Assignment,Phase 1,Yes,No
BLTN-Ig,Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metastatic Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
I 62218,Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Procedure, Procedure, Drug, Biological, Drug, Biological",Single Group Assignment,Early Phase 1,Yes,No
Pro00080769,Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA),Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
E2019316,A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer,Unknown status,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Phase 4,No,No
22-364,Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Phase 2,No,No
ISK-N103,"Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer",Withdrawn,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
NCI-2019-02752,Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
STao-003,Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer,Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
OSU-17122,Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivors,Recruiting,Interventional,Experimental,"Other, Other, Other, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
SKB264-Ⅱ-07,SKB264 +/- KL-A167 in Recurrent or Metastatic Triple-negative Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
LonghuaH,Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women,Unknown status,Interventional,"Active Comparator, Sham Comparator",Other,Parallel Assignment,Not Applicable,No,No
OTT 18-01,Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL),"Active, not recruiting",Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
PTC-breastNAT,PTC Guiding Neoadjuvant Treatment in Breast Cancer,Not yet recruiting,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,Phase 2,No,No
ZL-1302-002,A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
MCC-21-18633,Entertainment Media to Deliver Educational Messages About Mammography in Saudi Arabia,Completed,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Fudan-P1-201701,PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product, Combination Product, Combination Product",Parallel Assignment,Phase 1,No,No
2018-0473,Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Procedure",Parallel Assignment,Not Applicable,No,No
2019-0638,Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Other, Other, Other, Other, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
NCC1786,Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
ZG-2021-002,ZetaFuse™ Bone Graft in the Repair of Bone Defects From Metastatic Breast Cancer in the Spinal Vertebral Body,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
NU 19B07,"SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Biological, Genetic",Single Group Assignment,Phase 1,Yes,No
LUT-RD-02-01,LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
MEDOPP445,Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
OSU-18174,A QoL Intervention for Young African American Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
ICR-CTSU/2017/10065,PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer,Recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
VICC BRE 18108,A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Dietary Supplement, Drug",Single Group Assignment,Early Phase 1,Yes,No
RIGAIN,RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
Survey_App,Anonymous Survey of Breast Cancer Patients Concerning Their Use of Medical Apps,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
DR210090_SILENCE,Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea,Not yet recruiting,Interventional,"Experimental, Sham Comparator","Device, Drug, Device",Parallel Assignment,Not Applicable,No,No
OSU-21035,Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
19-031,ADVANCE (A Pilot Trial),"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
20-166,Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
INCMNSZ REF 1239,Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients,Unknown status,Interventional,Experimental,"Drug, Drug, Drug, Procedure, Drug",Single Group Assignment,Phase 2,No,No
OSU-20101,A Quality of Life Intervention (Y-AMBIENT) for Young African American With Stage I-III Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
UW18063,Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
N201912134,A Patient-centered Continuous and Interdisciplinary Shared Decision Making Approach for Breast Cancer Rehabilitation,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
IRST174.21,"Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy",Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
OSU-18201,Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,Yes
H-1912-010-086,To Assess the Efficacy of the LYMPHA in the Prevention of Lymphedema Following Axillary Dissection for Breast Cancer,Unknown status,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
DAN-22220205,A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
UPCC 21118,"HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
MA-BC-II-002,Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
I 2612022,Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Procedure, Procedure, Procedure, Biological, Drug, Other",Single Group Assignment,Phase 2,Yes,No
M21CAR,DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy,Not yet recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
IFOM-CPT008/2022/PO007,Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
RG1122380,STEMVAC in Patients With Early Stage Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Biological, Biological",Single Group Assignment,Phase 2,Yes,No
4070,A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients,Terminated,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,Yes
RG1003977,Acute Exercise Intervention in Reducing Breast Cancer Risk in Healthy Participants,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
20190812,Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy,Completed,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
BabesBolyaiOncovox,A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
CADPT01A12101C,Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Biological, Biological",Single Group Assignment,Phase 1,Yes,No
V2011801,P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .,Withdrawn,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
R.18.02.33,Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,Phase 3,No,No
MCC-19-14621,Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx,Completed,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
I-19-04120,Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer,Recruiting,Interventional,Experimental,"Biological, Biological",Single Group Assignment,Phase 2,Yes,No
042001,"INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study",Recruiting,Interventional,Experimental,"Biological, Other, Other, Biological",Single Group Assignment,Phase 2,Yes,No
767/29-09-2017,Vaginal Laser Therapy in Breast Cancer Survivors,Unknown status,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,Not Applicable,No,No
WSG-AM12,NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Other, Other","Drug, Drug",Crossover Assignment,Phase 2,No,No
STUDY00002985,Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
CSIIT-C37,Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
i 67518,Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors,Terminated,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other",Parallel Assignment,Not Applicable,No,No
HCI153239,"Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC",Suspended,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Phase 2,No,No
268-2017,Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control,Completed,Interventional,"Other, Other",Device,Parallel Assignment,Not Applicable,No,No
16-304,Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma,"Active, not recruiting",Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,Not Applicable,No,Yes
2019-A02374-53,"Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer",Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2022-191,Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
NCI-2017-02320,"Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer",Withdrawn,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,Phase 2,Yes,No
GIM25-CAPT,Atezolizumab Plus CArboplatin Plus Nab-paclitaxel,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,No,No
ELA-0121,Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
APPI2-PT-2020-AIMSS,Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors,Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
EDP1503-101,"A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors",Completed,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 1,Yes,No
187519,"Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
OnerCengiz,The Effect of Mindfulness Program on Spiritual Well-BeingBreast Cancer Patients,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
PH-CP026,PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy,Completed,Interventional,"Placebo Comparator, Experimental","Drug, Drug, Procedure",Parallel Assignment,Phase 2,No,No
B1432020000025,"Pain, Nutrition and Glycemic Response in Chronic Low Back Pain and Breast Cancer Survivors",Completed,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Crossover Assignment,Not Applicable,No,No
IFG-05-2019,Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
CTP-BRST-01,Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
A221801,"Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial",Not yet recruiting,Interventional,"Experimental, Sham Comparator","Device, Device, Other, Other",Parallel Assignment,Phase 3,No,Yes
2016-0538,Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
2018/455,Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy,Unknown status,Interventional,"Experimental, Placebo Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
MC2031,"Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer",Withdrawn,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,Early Phase 1,Yes,No
9988,Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors,Completed,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Device, Other, Other",Parallel Assignment,Not Applicable,No,No
TN.32.1.17.SATF,Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes.,Completed,Interventional,"Experimental, Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,No
KN026-US-I-001,KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
MC1931,Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
CBTMMUH,Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients,Completed,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
20180259-01H,Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial,Recruiting,Interventional,"Active Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
PHRI.SCHOLAR-2,Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2017-0502,M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
OSU-18317,Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Other, Other",Parallel Assignment,Phase 1,Yes,No
e-OTCAT20,Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.,Enrolling by invitation,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
23-050,A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
19447,Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors,Withdrawn,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
20G.093,"Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial",Completed,Interventional,Experimental,"Other, Device, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
ANI251_BCS-PI,PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
NCI-2019-05187,"Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Procedure, Other, Other, Radiation",Single Group Assignment,Phase 1,Yes,No
OUMK59829,Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,Phase 2,No,No
STUDY00000057,"WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
239531,Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Combination Product",Parallel Assignment,Phase 2,Yes,No
Castle06(BC),Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,No,No
STUDY02000934_1,A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
IFG-01-2022,"Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
PI-0171-2020,Pain Treatment in a Breast Cancer Population. PaiNEd Study.,Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
STU-2019-0529,Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM),Terminated,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,Phase 4,Yes,No
NBC Sur001,Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for cN+ Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
RG1718049,Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy,Terminated,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ESPvsPECS/AOP,Comparison of Erector Spinae Plane Block With PECS II Block in Patients Undergoing Breast Cancer Surgery,Withdrawn,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
MP-12-2021-2565,Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS),Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,No
S1703,S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
OSU-19152,EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Device, Other",Crossover Assignment,Not Applicable,No,Yes
2018-11-128,Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Not Applicable,No,No
OSU-20340,Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,Early Phase 1,Yes,No
PAXMAN,Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients,Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,Yes
MC210303,Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer,Not yet recruiting,Interventional,Experimental,"Other, Procedure, Procedure, Device",Single Group Assignment,Not Applicable,No,Yes
NL80749.058.22 DIRECT 2,"Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer",Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Phase 3,No,No
2020-01097,Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
NCI-2022-04956,"Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Procedure, Procedure, Drug, Biological",Sequential Assignment,Phase 1,Yes,No
IRB-2022-329,Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
N20ESP,Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Other",Parallel Assignment,Not Applicable,No,No
UZBRU_VHH1_3,Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
17753,T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
Exactis-03,Combination of Olaparib and Navitoclax in Women With HGSC and TNBC,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
35945/10/22,Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients,Enrolling by invitation,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",Yes,No
2019-5382,Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
IRB00105944,"Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Radiation, Drug",Single Group Assignment,Phase 2,Yes,No
IRB202201483,Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
MC18C3,Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,Phase 2,Yes,No
2022-376,Digital Cognitive Behavioral Therapy for Insomnia for Chronic Insomnia in Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
20-002712,Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer,Recruiting,Interventional,Experimental,"Other, Other, Biological",Single Group Assignment,Phase 1,Yes,No
Gabapentin RCT,Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy,Unknown status,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,"Phase 2, Phase 3",Yes,No
167514,Incidence and Severity of Diarrhea in Patients With Stage II-IIIC HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib,Completed,Interventional,Experimental,"Drug, Biological, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
FS-CY1502-Ph1-01,Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
G1T48-01,"G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer",Completed,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
PH-CP032,PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
2018-0062,Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
URomLS-2019a,The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in Comparison,Completed,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
ODO-TE-B201,"Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC",Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
MAMMoutreach,Opt-in vs. Opt-out for Breast Cancer Screening,Not yet recruiting,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
20-222,Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
20-001275,"Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Procedure, Biological",Parallel Assignment,Phase 2,Yes,No
OSU-22083,Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Other, Procedure, Other",Single Group Assignment,Not Applicable,No,No
CF22200A,Effects of an Exercise Intervention on Taxane-induced Peripheral Neuropathy in Breast Cancer Survivors,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2018-0550,Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
3543,Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery.,Recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Other",Parallel Assignment,Not Applicable,No,No
EstroTEP COMPARE,Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES,Unknown status,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
2020-0715,Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Biological, Biological",Single Group Assignment,Phase 2,Yes,No
NCI-2019-06088,Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Procedure, Drug, Radiation",Parallel Assignment,Phase 2,Yes,No
MA-BC-II-037,Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
LCZ696ABM001.001,Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM),Not yet recruiting,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 4,No,No
2018-0127,Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer,Unknown status,Interventional,"Experimental, No Intervention","Drug, Procedure, Procedure",Parallel Assignment,Early Phase 1,Yes,No
S2007,Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,Yes,No
19-004024,RBX7455 Before Surgery for the Treatment of Operable Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
115300-20-52703,Early Rehabilitation for Breast Cancer - A Randomized Control Trial,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
MC1635,Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery,"Active, not recruiting",Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,Phase 2,Yes,No
IIT2019-21-Basho-TOPAZ,TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases,Withdrawn,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
81603703,Effects of Infrared Laser Moxibustion on Cancer-related Fatigue in Breast Cancer Patients,Completed,Interventional,"Experimental, Sham Comparator, No Intervention","Device, Device",Parallel Assignment,Not Applicable,No,No
BTCRC BRE15-024,Ribociclib and Bicalutamide in AR+ TNBC,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
2021-375,Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
3474028/2019,Effects of the Anchor System in the Postural Stability,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
2020-0245,"Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial",Withdrawn,Interventional,Experimental,"Drug, Biological, Radiation",Single Group Assignment,Phase 1,Yes,No
18-000427,"Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted","Active, not recruiting",Interventional,Experimental,"Biological, Biological, Biological",Single Group Assignment,Phase 1,Yes,No
CASE11119,Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ZLYNXM202014,Identification and Preservation of Arm Lymphatics,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
19.07,ImmunoBreast - A Phase Ib Study,Recruiting,Interventional,Experimental,Other,Single Group Assignment,"Phase 1, Phase 2",No,No
REaCT-Low Risk HER-2,A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer,Completed,Interventional,"Active Comparator, Placebo Comparator",Drug,Parallel Assignment,Phase 3,No,No
PRO00035701,"Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer",Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
REaCT-CHRONO,Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Phase 4,No,No
Acu-CIPN,Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Drug",Parallel Assignment,Not Applicable,No,No
202104085,Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma,Recruiting,Interventional,"Experimental, Experimental",Radiation,Parallel Assignment,Not Applicable,No,Yes
ZL-MG-BC-001,A Study to Evaluate the Pharmacokinetics of Margetuximab in Chinese Patients With HER2+ MBC,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
P170104J,"A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer",Unknown status,Interventional,Other,Drug,Single Group Assignment,Phase 2,No,No
Pro00104214,Well-Being After Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
CLEE011AIT01,"Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus Fulvestrant","Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 3,No,No
MedOPP150,"First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ODO-TE-B202,Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Study00146761,Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers,Recruiting,Interventional,"Experimental, Other",Drug,Parallel Assignment,Early Phase 1,Yes,No
17-546,Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
DRACARYS,Dragonboat Activity for Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
RIPH2_BREYSSE_ETAPH,"Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer",Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
I 60217,Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
21-001819,"Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Biological, Other, Drug, Biological, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
ARC-2 (AB928CSP0002),A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
RJ-101-RCT-001,Study to Investigate the Effect of AB-101 in Breast Cancer Survivors,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Early Phase 1,Yes,No
SCHBCC-N046,FUSCC Refractory TNBC Platform Study (FUTURE2.0),Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2021-1151-002,OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
Aqua POLO-IPC 2019-028,Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
OSU-20408,An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Other, Other",Parallel Assignment,Not Applicable,No,No
21D.625,Intermittent Fasting for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before Surgery,Suspended,Interventional,Experimental,"Other, Other",Single Group Assignment,Not Applicable,No,No
TNBC-NEO,Nab-paclitaxel Based Regimens VS Paclitaxel Based Regimens in Neoadjuvant Treatment for TNBC,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
13/21,Continuous Pectoral Nerve Block in Breast Cancer Surgery,Completed,Interventional,"Active Comparator, Sham Comparator","Procedure, Other",Parallel Assignment,Not Applicable,No,No
NCI-2017-01960,Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer,Completed,Interventional,Experimental,"Drug, Other",Sequential Assignment,Phase 1,Yes,No
USB_22 Trial,Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CSIIT-C25,Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,No,No
SAKK 95/17,Activity Program During Aromatase Inhibitor Therapy,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2018-A01019-46,Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer,Completed,Interventional,"Active Comparator, Sham Comparator","Drug, Other",Parallel Assignment,Not Applicable,No,No
Fisioterapia en Linfedema,Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
2019-0752,Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
STUDY00003705,Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
CL 2775,Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients,Recruiting,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,Phase 4,No,No
STUDY00003782,RAGE Inhibition to Decrease Therapy Cardiotoxicity in Women With Early Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
UEM Quirón,Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer,Unknown status,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
MUST-02-001,Safety and Performance of the Multi-Modal UltraSound Tomography (MUST) Device in Breast Cancer Screening,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
IB2022-04,Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer.,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
D5336C00001,To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
CE 193/17,"Oxidative Stress, Anxiety and Depression in Breast Cancer Patients: Impact of Music Therapy",Completed,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
IRAS 314460,CLI and FAR for Intraoperative Margin Assessment,Not yet recruiting,Interventional,Other,Procedure,Single Group Assignment,Phase 2,No,No
UPCC12118,Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab,"Active, not recruiting",Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 1,Yes,No
LCCC 1716,PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo,Terminated,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,Yes
YL202-INT-101-01,A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
227/KEPK/IX/2022,The Effectiveness of Lymphatic Bypass Supermicrosurgery,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
OFA,Opioid Free Anesthesia in Breast Cancer Surgery,Completed,Interventional,"Experimental, Sham Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
STUDY00021243,Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
HNCH-2022KY59,UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
Prevention of radiodermatitis,Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy,Not yet recruiting,Interventional,"Placebo Comparator, Experimental",Device,Parallel Assignment,Not Applicable,No,No
D3614C00001,Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
AH150202-1,"Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 2,No,No
D8530C00007,AZD9833 China PK Study,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,No,No
21-194,"A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer",Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
MedOPP100,A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SYSU003-2020,Nail Changes Associated With Chemotherapy and Prevention of Nail Pigmentation by Ice Water Immersion,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
MS201922_0010,Study of M4344 in Combination With Niraparib,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
HR-BLTN-III-MBC-C,A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
MC1892,Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy,Withdrawn,Interventional,Experimental,"Device, Other",Single Group Assignment,Phase 2,Yes,Yes
ZWI-ZW25-202,A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
MC1734,"Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Procedure",Parallel Assignment,Phase 2,Yes,No
UW20058,Intraoperative Evaluation of Axillary Lymphatics,Recruiting,Interventional,Experimental,"Device, Drug",Single Group Assignment,Not Applicable,No,Yes
DokuzEUBanuNihan,Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema,Completed,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
202207200MIPB,"A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC",Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2019COIMBRA001,Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer,Unknown status,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,Phase 2,No,No
C4391002,A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CPH-2022-10-MHS-2,Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
HCRN BRE17-141,Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
YOUNGBC-11,First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
C4891018,A Study to Learn About the Study Medicine (Called ARV-471) in People With ER+/HER2- Advanced BC in China,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
P-2020-246,Stick Together - Pilot Intervention Study,Enrolling by invitation,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
YOUNGBC-18,Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
SHR-1210-APTN-IIT-TNBC,A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
FMUUH-BC-2201,PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,No,No
20-153,Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
OBU-BC-II-024,Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
328717,Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy,Unknown status,Interventional,"Placebo Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2066383,Metacognitive Strategy Training in Cancer-related Cognitive Impairment,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2021-5644,App for Adverse Events to Oral Chemotherapy - Pilot Study,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
MC1935,Assessing the Rate of Complications in X-Ray Therapy Versus Proton Beam Radiation Therapy After Breast Conserving Surgery or Mastectomy in Treating Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,Phase 2,No,No
19F.265,A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
201901698B0,Music Therapy in Patients With Breast Cancer- a Randomized Controlled Trial,Unknown status,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2,A Feasibility Study of the Bone@BC App Version 3.0,Not yet recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
MedOPP253,Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
S-20180117,Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting,Completed,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure, Procedure, Biological, Procedure",Parallel Assignment,Phase 2,No,No
BZ01/17,Effect of Quilting Sutures on Post-operative Drainage After Mastectomy and/or Axillary Lymph Node Dissection,Terminated,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
RC48-C006,A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Crossover Assignment,"Phase 2, Phase 3",No,No
KGYY-001,Plasmodium Immunotherapy for Breast and Liver Cancers,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
1808852902,"Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets",Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
UHaiArtBC,The Role of Emotional Processing in Improving the Quality of Life of Breast Cancer Patients,Completed,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
16381,Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial,Completed,Interventional,"Active Comparator, Active Comparator, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
NL67059.068.18,Microsurgical Treatment of Breast Cancer-related Lymphedema by Lymphaticovenous Anastomosis,Recruiting,Interventional,"No Intervention, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
WHUH-BC-001,Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
ALRN-6924-1-05,A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
IRB00223131,Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Behavioral",Sequential Assignment,Phase 2,No,No
202111198,Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM),Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Shengjing-LCG003,Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy,Not yet recruiting,Interventional,"Other, Other","Drug, Drug",Parallel Assignment,Phase 4,No,No
AHQU-2022002,Personalized Electroacupuncture Treatment for Chemotherapy-induced Nausea and Vomiting in Breast Cancer (PET),Recruiting,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
IC 2019-04,MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery,Completed,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
STU00201961B,A Research Study for Latina Women With Breast Cancer,"Active, not recruiting",Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2-107-05-079,Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery,Completed,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,Not Applicable,No,No
2018/781,Pre-operative Hypnosis to Prevent Side Effects After Surgery,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2012-090-1182,Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer,Enrolling by invitation,Interventional,"Experimental, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
IRB00054587,Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases,Recruiting,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,Early Phase 1,Yes,No
VSN-18-199,The Effects of Light Therapy to Treat Cancer-related Side Effects,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, No Intervention","Device, Device",Parallel Assignment,Not Applicable,No,No
2022YF035-01,Dalpiciclib Plus Letrozole and Capecitabine,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
22-544,TRUDI: TDXD+Durva in HER2+/Low IBC,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
021-013772,Marker Technique Comparison in Targeted Axillary Dissection,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
GCO 15-1783,Systematic Light Exposure for Fatigue in Breast Cancer Patients,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
1191/2018,"Exercise, Cancer and Cognition: The ECCO-Study",Recruiting,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
NCI-2017-01119,Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological, Other, Other, Biological",Parallel Assignment,Phase 3,Yes,No
UAB 1794,"Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD","Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
METIS,ACH-TH vs EC-TH as Neoadjuvant Therapy for HER2-positive EBC,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
IUSCC-0616 (1709077419),Investigating the Preventative Ability of Massage Therapy on Paclitaxel Induced Peripheral Neuropathy,Terminated,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
APA-PG1,Adapted Physical Activity (APA) in a Breast Cancer Population.,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
26778919.3.0000.0072,Acupuncture for Peripheral Neuropathy Induced by Paclitaxel in Early Stage Breast Cancer,Unknown status,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
HSM/VGH-2017-01-011AC,Effects of Naturalistic Decision-Making Model-based Oncofertility Care Education,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
H2207-207-1346,Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor,Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
CRM-BRE-002,The Malaysian Soy and Mammographic Density Study,Unknown status,Interventional,"Experimental, Active Comparator, No Intervention","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
BC-TATOO-2020,Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant Chemotherapy,Recruiting,Interventional,Other,Drug,Single Group Assignment,Not Applicable,No,No
ICO-N-2018-03,Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
20190511,Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node Biopsy,Completed,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Phase 3,No,No
RG1121659,Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Drug, Other",Single Group Assignment,Phase 4,Yes,No
17-AKD-186,Erector Spinae Block in Segmental Mastectomy.,Unknown status,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
Immuno2020-01,A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
BGB-A317-ZW25-101,Anti-HER2 Bispecific Antibody ZW25 Activity in Combination With Chemotherapy With/Without Tislelizumab,"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Drug, Biological, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
STUDY00011444,Nurse AMIE: Addressing Metastatic Individuals Everyday,Completed,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
TQB3616-Ⅲ-02,"To Evaluate the Efficacy and Safety of TQB3616 in Combination With Flulvesant Versus Placebo in Combination With Flulvesant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer",Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
ATOX-2018,Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
SHAW001,Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients,Not yet recruiting,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
71306642-5/24,Serratus Plane Plus Pectoral I Block Versus Serratus Plane Block for Perioperative Analgesia in Breast Cancer Surgery,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2021-0077,Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
SYSA1501-CSP-005,"DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
1028595,Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention,Completed,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
QoLMa,Quality of Life Improvement During Chemotherapy,Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
CTPR-0015,An Efficacy Study of the Xoft® Axxent® eBx® IORT System® Lite,Withdrawn,Interventional,Other,Radiation,Single Group Assignment,Not Applicable,No,Yes
FZPL-Ib-105,A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
TDM of TAM,Therapeutic Dose Monitoring (TDM) of Tamoxifen,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
STUDY20110029,Screening Contrast-Enhanced Mammography as an Alternative to MRI,"Active, not recruiting",Interventional,Experimental,"Device, Drug",Single Group Assignment,Phase 4,Yes,Yes
ECP 250 - 15/16,Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer,Unknown status,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Early Phase 1,No,No
CTR20220630,Mindfulness Yoga and Sexual Functioning,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
REC 22/WA/0164,Acceptance and Usability of an App Promoting Healthy Behaviours Amongst Young Women at Increased Risk of Breast Cancer,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2019DEPO-TRIGGER001,DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Procedure, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
OSU-16288,Nipple Aspirate Fluid in Detecting Breast Cancer,Recruiting,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
20.478.486,Is Breast Massage Necessary to Find Sentinel Lymph Node?,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
J16146,Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
2022-A02337-36,4D CT Scan With Respiratory Gating Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy.,Not yet recruiting,Interventional,"No Intervention, Experimental",Other,Crossover Assignment,Not Applicable,No,No
STUDY00001721,Evaluation of Hydroxychloroquine to Prevent CIPN,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
H19017,Somatic Acupressure for Symptom Cluster Management in Breast Cancer Patients,Completed,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
1100903,Effect of Acupuncture vs Chinese Medicine vs Combined Therapy on Aromatase Inhibitor-related Arthralgia Among Women With Early-Stage Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Device, Drug",Parallel Assignment,Not Applicable,No,No
LAAVA2,Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients,Unknown status,Interventional,"Active Comparator, Placebo Comparator","Device, Device",Crossover Assignment,Not Applicable,No,No
BXu-1839,The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
NABP201801,A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC,Suspended,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
RG1121642,Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma or Hormone Receptor Positive Her2 Negative Metastatic Refractory Breast Cancer,Recruiting,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,Phase 1,Yes,No
C-plus-Pairs,"A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
URomLS_4,Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
46.20 PAR ComEt CBM,Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
012418QM,Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC,"Active, not recruiting",Interventional,"Other, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2020466,PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2021-0031,"An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer",Recruiting,Interventional,Experimental,"Procedure, Procedure, Other, Other",Single Group Assignment,Not Applicable,No,Yes
SYM011,AKY15-HK-301_NEPA Study,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
16-0040-02,Pink Warrior 2: Teleconference-based Gaming Support,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2022-008,Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C),Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,No,No
X4P-001-201,"A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC",Enrolling by invitation,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
2017-0479,Comprehensive Lifestyle Change To Prevent Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
SYSU-2022-01,Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure),Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Not Applicable,No,No
SAKK 21/18,Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC,Terminated,Interventional,"Experimental, Active Comparator","Drug, Other, Other",Parallel Assignment,Phase 3,No,No
736-19,The Patterns of Activity and Cognition During Treatment (PACT) Study,"Active, not recruiting",Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
198411013011,The Effect of Walking Exercise Based on TOUS on Peripheral Neuropathy and Arthralgia-Myalgia in Women With Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
AP1907-50101,Perioperative Analgesic Modalities for Breast Cancer Surgeries,Completed,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,Not Applicable,No,No
2021-19,The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
RLY-5836-101,First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
BRI-ROL-001,Combination Study of SV-BR-1-GM With Retifanlimab,Recruiting,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
RP-PG-1214-20016,What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,Not Applicable,No,No
220287,The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies,Not yet recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
PI17/01687,Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
BCP-25,Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study),Recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Phase 3,No,No
20210312/2,Neoadjuvant Chemotherapy in Breast Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Device, Drug",Parallel Assignment,Not Applicable,No,No
2018-1518,"Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic Pain",Completed,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
UCI 18-79 [HS# 2020-5660],Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
ePOST,Efficacy of Point Of Service Testing in MBC,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
URCC16070,Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Other, Drug, Drug, Other, Drug, Other",Parallel Assignment,Phase 3,Yes,No
Shengjing-LJY06,Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy,Recruiting,Interventional,"Experimental, Experimental, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
Pro00105104,Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477),Terminated,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
202210064DIPD,"LLLT for BCRL: a Randomized, Placebo-controlled Study",Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
PERT.21.001,"A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)",Not yet recruiting,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,Phase 3,No,No
HCI140278,[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
MedOPP068,PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA),Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
KCT003,A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treating Breast Cancer Related Lymphedema,Recruiting,Interventional,"Experimental, Active Comparator",Device,Crossover Assignment,Not Applicable,No,Yes
SILMET_0107665,SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET),Recruiting,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
S-20180134,Prevention of Breast Cancer-related Lymphedma With Tacrolimus,"Active, not recruiting",Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
241379,Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2021/270,Effect of Nurse-led Supportive Care on Quality of Life,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
202109031MIPD,"Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC",Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
00048814,Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
JD-LK-2022-136-01,"Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)",Not yet recruiting,Interventional,Experimental,"Drug, Radiation, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
2017/12-SBO-GHMG,Autohypnosis and Cancerology,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
LYT-100-2020-01,LYT-100 in Healthy Volunteers and BCRL,Completed,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Other, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
2017-0328,Development of Exercise Promotion Program Using a Mobile Community,Completed,Interventional,"Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,No
2179 CE,Music Listening in Radiotherapy Treatment,Completed,Interventional,"Experimental, Experimental, Other","Other, Radiation",Parallel Assignment,Not Applicable,No,No
Pro00117242,Moving Forward Together 4,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
US-003,Magseed Enabled Long-Term Localization of Axillary Lymph Nodes,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
7119-002,Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002),"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
21-169,Scalp Cooling in MBC,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Device, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,Yes
2018-002,Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
12345,The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
GLSI-21-01,Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects,Recruiting,Interventional,"Placebo Comparator, Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 3,Yes,No
A221702,Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Procedure, Procedure, Other, Other",Parallel Assignment,Phase 3,No,No
22-006606,3D Ultrasound for the Imaging of Axillary Lymph Nodes in Patients With Breast Cancer,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Early Phase 1,No,Yes
CAPRICE,Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study,Terminated,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CT/2019/CANFLAX,Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?,Unknown status,Interventional,"Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
20-754,Axillary Lymph Node Tattoo Marking Study,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
URomLS-2019,The Sequelae of Mastectomy and Quadrantectomy Respect to the Reaching Movement in Breast Cancer Survivors,Completed,Interventional,"Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
mavis20023,Application-Enabled Shared Decision-Making,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2021-01-075,PALbociclib Endocrine Therapy Followed by Talazo vs. Talazoz-Atezo Study,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
HiFi-APBI,High Five (HiFi) Accelerated Partial Breast Irradiation Study,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
Self-compassion FCR,Fear-focused Self-Compassion Therapy for Young Breast Cancer Patients Fear of Cancer Recurrence,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
20-010751,3D Ultrasound Breast Imaging,Recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,Yes
IJB-BC-TDM1BM-2016,Kadcyla In pAtients With bRAin Metastasis,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
1B-15-6,Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors,Withdrawn,Interventional,"Experimental, Experimental, Active Comparator","Other, Behavioral, Behavioral, Other, Device, Other, Other",Parallel Assignment,Not Applicable,No,Yes
P018,"A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel",Withdrawn,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
CBYL719H12301,Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
QUILT 2021-1,The QUILT Study: Quilting Sutures in Patients Undergoing Breast Cancer Surgery,Not yet recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
MC18C1,Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,Phase 1,Yes,No
WSG-AM11,"Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC",Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
2018-0528,An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast Reconstruction,Recruiting,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
1024489,Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2),Recruiting,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
OBI-822-011,Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC,Recruiting,Interventional,"Experimental, Active Comparator","Biological, Device, Other",Parallel Assignment,Phase 3,Yes,Yes
MSCW2019,Mindfulness and Self-compassion Focussed Walking,Recruiting,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2020-12-044-012,Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves,Recruiting,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,No
IJB-PRINTEMPS-2022,Multidisciplinary Approach to Fatigue,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
HNCH-BC009,"Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
c5ZTCN100,A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS,Completed,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 1,Yes,No
CRO-2019-26,Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
YM111146EF,Effects of Kombucha Intervention on Emotional Distress and Sleep Quality in Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Other",Other,Parallel Assignment,Not Applicable,No,No
AP2205-5015,Erector Spinae Plane Block Versus General Anesthesia in Breast Cancer Surgeries,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,Not Applicable,No,No
182113,Improving Cognition After Cancer,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
LCCC1921,Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
EC /2018/0996,Pre- or Postoperative Accelerated Radiotherapy,Completed,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,Not Applicable,No,No
ICO_UCC_202001,SMS Messaging as a Tool to Improve Cancer Screening Programs,Unknown status,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
19-008929,Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer Patients,"Active, not recruiting",Interventional,Experimental,"Device, Other",Single Group Assignment,Not Applicable,No,Yes
19-578,Sacituzumab Govitecan In TNBC,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Ref. 070/2018,Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
2021-04031,Supporting Women With Breast Cancer to Practice DIBH at Home Before Radiation Therapy,Not yet recruiting,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
PSCI 21-045,Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
AC-TMSQ-2018,Effect of Therapeutic Massage on Sleep Quality and Stress Levels in Women With Breast Cancer,Completed,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
STU-2019-0769,PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
R-2021-3203-005,Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.,Recruiting,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,Not Applicable,No,No
CD07_TNBC,Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
F16J16000620002,Innovation in Mammography: Tomosynthesis Pathways,Unknown status,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
NUR20-0124CRYO,The Use of Cryotherapy to Prevent Paclitaxel-induced Peripheral Neuropathy and Nail Changes in Women With Breast Cancer,Terminated,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
32551/09/2018,Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy,Completed,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
2017-1535,OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease,"Active, not recruiting",Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
12341234,Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
Mepitel RCT,Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients,"Active, not recruiting",Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Phase 3,No,No
ShandongCHI-07,Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
D8532C00005,"A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833",Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
ELIPSE (SOLTI-1905),"Elacestrant in Preoperative Setting, a Window of Opportunity Study",Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
VI-ISRP-026,A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes,Suspended,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
5652-18-SMC,Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients,Completed,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
FEMAL,Comparison of the Efficacy and Tolerability of Femal Versus Placebo,Completed,Interventional,"Experimental, Placebo Comparator",Other,Single Group Assignment,Not Applicable,No,No
20-30638,Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,Phase 1,Yes,No
R.20.11.1099,Ultrasonographic Axillary Localization,Unknown status,Interventional,Experimental,"Diagnostic Test, Procedure, Diagnostic Test, Procedure",Single Group Assignment,Not Applicable,No,No
IRB00074154,Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Dietary Supplement, Other",Parallel Assignment,Phase 2,Yes,No
JWCI OBCS WITH IORT,Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.,Recruiting,Interventional,Other,"Radiation, Procedure",Single Group Assignment,Not Applicable,No,Yes
AAAT8915,Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia,Recruiting,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,Not Applicable,No,Yes
20-513,Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Early Phase 1,No,No
IRB00313835,Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic,Recruiting,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
HE-202012,Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 4,No,No
NCC201804007,Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
PREVENT,"Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery",Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
QL-KPTB-150,Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer,Completed,Interventional,"Active Comparator, Experimental","Drug, Drug",Crossover Assignment,Phase 1,No,No
REaCT-Hot Flashes Pilot,Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study,Completed,Interventional,Other,Other,Single Group Assignment,Phase 4,No,No
COMPLEMENT,Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients,Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
DHLI-BC/OC-BE-001,Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients,Recruiting,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,Phase 1,No,No
GS18/107321,ePainQ - Feasibility Study,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2019-003825-56,"Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer",Unknown status,Interventional,Other,"Drug, Drug",Single Group Assignment,Phase 4,No,No
80252,Breast Reconstruction and Neoadjuvant Radiotherapy,Not yet recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
Exo-LCR,Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (Exo-LCR),Recruiting,Interventional,Experimental,"Procedure, Procedure, Biological",Single Group Assignment,Not Applicable,No,No
MCC-19117,Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Biological, Biological",Parallel Assignment,Phase 2,Yes,No
EA1181,CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy,Recruiting,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Drug, Drug, Biological, Radiation, Biological, Biological",Parallel Assignment,Phase 2,No,No
PAL-ZJCC-02,Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
GCO 18-1832,Leflunomide in Previously Treated Metastatic Triple Negative Cancers,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
T06/024/21,Exercise and Tumor Blood Flow in Lymphoma And Breast Cancer Patients (EXETUMOR 3),Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
ES,Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
Study00145121,Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms,Terminated,Interventional,"Experimental, Other",Drug,Parallel Assignment,Early Phase 1,Yes,No
STU 042018-083,Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod,"Active, not recruiting",Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
AcuBreast 2020,Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
A012103,Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab,Not yet recruiting,Interventional,"Active Comparator, Experimental","Biological, Other, Procedure, Procedure, Other, Other",Parallel Assignment,Phase 3,No,No
HREBA.CC-22-0128,Impact of Metabolic Health Patterns And Breast Cancer Over Time in Women,Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
A191901,Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy,Suspended,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Other, Other, Other",Parallel Assignment,Phase 3,No,No
VICCBRE2257,Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy,Not yet recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Procedure, Biological",Parallel Assignment,Phase 2,Yes,No
HCI69515,Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment,Recruiting,Interventional,Experimental,"Drug, Drug, Diagnostic Test",Single Group Assignment,Phase 2,Yes,No
TX05-03E,Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03,Completed,Interventional,"Experimental, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,Phase 3,Yes,No
2019/639,Effect of Nurse-led Supportive Care on Caregiver Burden and Well-being,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
PBCST,Precision Breast Conserving Surgery With Guidance.,Completed,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
NEODOC- 2021668610-221,Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes,Unknown status,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
9785-CL-0018,A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer,Completed,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
IRB202202679,Exercise to ReGain Stamina and Energy (The EXERGISE Study),Not yet recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Arise-FJ-B102,Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
453190,Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52,Unknown status,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,Phase 4,No,No
RenJiH-2018-038,"CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial",Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
202110124,Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
18-003544,Comparison of Three Methods for Early Detection of Breast Cancer,Completed,Interventional,Other,"Diagnostic Test, Drug",Single Group Assignment,Early Phase 1,Yes,No
MCC-21262,A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV),Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
CKRC2021-CCV,Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups,Enrolling by invitation,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
BEXMET,The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
PICC One Day 01 (ET15-123),Iterative PICC Placement Versus Long Term Device,Withdrawn,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Phase 3,No,No
IRB00049061,Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Procedure, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
SOLTI-1710,Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Early Phase 1,No,No
IJB-SYNERGY-012017,Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
IRB00046759,Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Other, Other, Device",Parallel Assignment,Not Applicable,No,Yes
18947,Sentinel Lymph Node Mapping With Near Infrared Fluorescent Markers,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
2021-A03027-34,Shared Decision Making on Care Pathways and CAMs: A Pilot Study,Not yet recruiting,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
IRB-44367,Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy,Recruiting,Interventional,Experimental,"Device, Other",Single Group Assignment,Not Applicable,No,Yes
NEPA-17-05,A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
SHR6390-III-303,"Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 Negative",Enrolling by invitation,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2022-761,Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 4,No,No
JCL2020,A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast,Recruiting,Interventional,Other,"Drug, Radiation",Single Group Assignment,"Phase 1, Phase 2",No,No
19-302,"Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer","Active, not recruiting",Interventional,Experimental,"Other, Device, Diagnostic Test",Single Group Assignment,Not Applicable,No,Yes
BFH-BC,ESM Versus OM ：A Randomized Controlled Trial,Unknown status,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
RT 1901,Hypofractionated Versus Conventional Fractionation Radiotherapy,Unknown status,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
MC1732,Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery,"Active, not recruiting",Interventional,Experimental,Radiation,Single Group Assignment,Phase 2,No,Yes
ET19-084 - CICA-RT,Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,Phase 3,No,No
21623,Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer,Withdrawn,Interventional,"Experimental, Experimental","Other, Procedure, Procedure, Other",Parallel Assignment,Not Applicable,No,No
CASE10116,Breast Reconstruction Following Breast Cancer in Very High Risk Patients,Withdrawn,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other",Parallel Assignment,Not Applicable,No,No
2021/271,Effect of Laughter Therapy on Perceived Stress and Quality of Life,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
CASE5Y21,A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose,Recruiting,Interventional,"Active Comparator, Active Comparator","Device, Other, Other",Parallel Assignment,Not Applicable,No,Yes
University in Zielona Gora,Inertial Rehabilitation in Women After Mastectomy,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
T148/2020,Exercise and Tumor Blood Flow in Breast Cancer Patients,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
ISI dV SP - NSM-01,Robotic vs. Open NSM for Early Stage Breast Cancer,Not yet recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
ATOPE18,Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
ChungnamNU.J1,VR-based Intervention for Cognitive Restoration,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
EC/2017/1261,Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
EORTC-2129-BCG,TREAT ctDNA Elacestrant,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
NCI-2021-11793,Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Procedure, Procedure, Procedure, Procedure",Single Group Assignment,Phase 1,Yes,No
2019-4433,Angiomammography and Neoadjuvant Chemotherapy,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
THERMOEDEME,Spa Therapy for Upper Limb Lymphoedema,Unknown status,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
C3621001,Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC,Terminated,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,Phase 1,Yes,No
LSB-12345,Intraoperative Use of ClearEdge Device in Breast Conserving Surgery,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,Yes
108511,Breathwork App for Cancer Survivors,Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
202101421A0,Pilot Study of Single-port Robot-assisted Nipple-sparing Mastectomy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
960-CSP-USA_DenseBreasts_USS1,A Evaluation of 3D Functional MIRA System in Women With Mammographically Dense Breasts,Terminated,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
211521,nCCR for Chemotherapy Related Cognitive Impairment Randomized Study,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
BC-P30(FZQ),Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy,Recruiting,Interventional,"Experimental, Other","Device, Drug",Parallel Assignment,Not Applicable,No,No
2017-0672,"LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas",Recruiting,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Drug, Drug, Biological, Biological, Other, Other",Parallel Assignment,Phase 2,Yes,No
22-508,Implantable Microdevice for TNBC - Pilot Study,Not yet recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 1,Yes,Yes
Pectoral nerve block in breast,Pectoral Nerve Block During Mastectomy,Not yet recruiting,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
NU 18B05,Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast,Recruiting,Interventional,Experimental,"Drug, Procedure, Other",Single Group Assignment,Phase 2,Yes,No
20476,Immune Effects in Patients Treated With Whole Breast Irradiation,Unknown status,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
ICRCTSU/2019/10068,PreOperative Endocrine Therapy for Individualised Care With Abemaciclib,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
EU001,Magseed Pro(R)/ Sentimag(R) Gen3,Not yet recruiting,Interventional,"Other, Other",Device,Parallel Assignment,Not Applicable,No,No
2018-63,Does Chemotherapy Train the Mutation of the Pig-A Gene? (PIGA),Unknown status,Interventional,Other,Biological,Single Group Assignment,Not Applicable,No,No
18-168,"Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue","Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
2021-A01407-34,Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Not Applicable,No,No
soh-Med-21-02-05,Modified Pectoral Nerve Block Versus Serratus Plane Block,Not yet recruiting,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
CIMPAX BREAST,Continuous Serrates Plane Block in Axillary Dissection,Unknown status,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
18D.003,"Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence",Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other, Behavioral, Other",Parallel Assignment,Phase 2,No,No
20-002505,Mayo Designed Soft Tissue Ultrasound-Detectable Marker,Completed,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
XianganHXiamenU,NIR Fluorescent Molecular Probe for the Identification of Breast Tissue,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
201900572,The SONImage Study,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
MEDOPP459,Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
MedOPP485,A PoC Study to Evaluate Treatments Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 2,No,No
09.2019.866,Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
020-008,Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
LQiao,HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC,Recruiting,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,No,No
2021157,Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2020-KY-051,Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction,Completed,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
BC-09374,LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
Shengjing-LCG011,"Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2021-02902,PACED-digitized Support During Adjuvant Endocrine Therapy,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
GCO 19-0477,"Vaccination With Flt3L, Radiation, and Poly-ICLC",Recruiting,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
202100318,Testosterone & Tamoxifen Trial,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
19-458,A Study of the Use of Text Message Reminders to Take Palbociclib,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
S1904,Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE),Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
Seno_Ex_MAC 003,Comparison of Conventional With Sonography Assisted Breast Surgery After Neoadjuvant Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CL(3204),Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
211-2018,MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC,Unknown status,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
AAAO1760,CBPR - BRCA Genetic Testing Among Orthodox Jews,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
J17120,"Cancer, Obesity/Overweight and Insomnia Study",Completed,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
1712078374,"Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome",Completed,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,Yes
D17168,The Prone to Supine Breast MRI Trial,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
2020-KY-007,The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
DELFINO trial,Density Lowering Effect of OFS Add on to TMX(DELFINO Trial),Recruiting,Interventional,"No Intervention, No Intervention, Active Comparator",Drug,Parallel Assignment,Phase 3,No,No
PRISMA,Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application,Not yet recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
3125001,Safety and Pharmacokinetics of ODM-209,"Active, not recruiting",Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
ShandongCHI-16,"Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis",Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
ERAS-ABR,ERAS in Autologous Breast Reconstruction: A Pilot RCT,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
ProFertil,Use of GnRHa During Chemotherapy for Fertility Protection,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
MEDOPP240,Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
TQB3616-I-0001,A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
18-00309,Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
2023-9333,The MARVIN Chatbots to Provide Information for Different Health Conditions,Not yet recruiting,Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
STUDY00020501,"Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study",Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Behavioral",Parallel Assignment,Not Applicable,No,No
[2016]124,Serratus Plane Block in Preventing Postoperative Pain of Mastectomy,Completed,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
IIT2018-04-MCARTHUR-NEOHP,Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
MCP Study,Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong,Recruiting,Interventional,"Other, Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test",Factorial Assignment,Not Applicable,No,No
STUDY00000194,"Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases",Withdrawn,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,Phase 1,Yes,No
SIB2232,SMART-ER: Symptom Monitoring With Patient-reported Outcomes,Recruiting,Interventional,"Other, Other","Other, Other",Single Group Assignment,Not Applicable,No,No
KC19EEDT0031,Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
22-008,Onvansertib + Paclitaxel In TNBC,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
1807188-16,FUSCC Refractory TNBC Umbrella (FUTURE),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
OSU-20429,Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Drug",Parallel Assignment,"Phase 2, Phase 3",Yes,No
2020/295,"The PreQ-20 TRIAL, a Prospective Cohort Study of Patients Undergoing Prepectoral Breast Reconstruction",Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
SunYatsenU2H-LQ4,"A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
Phaon1,Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Procedure, Procedure",Parallel Assignment,Phase 2,No,No
SUGBG-2021002,Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach,Recruiting,Interventional,"Other, Other","Drug, Combination Product",Parallel Assignment,Not Applicable,No,No
S2018-2450-0001,Distress Reduction by Activity Tracking and Activity Enhancement by Mobile Support Group in Oncology,Completed,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
IIT-0016,Exercise and Compression for Lymphedema,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
N.sativavsRID BreastCancerpt.,Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
00130272,PhysioTouch for Treatment of Radiation Fibrosis,Withdrawn,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
URCC-18007,Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Parallel Assignment,Phase 3,Yes,No
jcl2020-2 breast cancer,3D Printed Bolus in Post-mastectomy Radiotherapy,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
OP-1250-003,Phase 1b Combo w/ Ribociclib and Alpelisib,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
38285020.8.0000.0072,"Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer",Completed,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
TMP-0315-2018,Prevention of Paclitaxel-induced Neuropathic Pain in Patients With Planned Paclitaxel Chemotherapy (PrevTel),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
21-3117.cc,Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC,Withdrawn,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,Phase 2,Yes,No
IRB00103558,Resistance Training to Improve Fatigue and Physical Function in Postmenopausal Breast Cancer Survivors,Completed,Interventional,"Experimental, Active Comparator","Other, Behavioral",Parallel Assignment,Not Applicable,No,No
ICOnnectat-BC,"Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors",Unknown status,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
20-028,Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA),Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
STU-2022-0091,Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
2021-0048-B,Erector Spinae Block vs. Placebo Block Study,Not yet recruiting,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
Breastblock,Regional Anesthesia for Breast Surgery,Unknown status,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
OMS-I141 (KEYNOTE-890),Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC,Recruiting,Interventional,"Experimental, Experimental","Biological, Biological, Device, Drug",Parallel Assignment,Phase 2,Yes,Yes
BHP0111,Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza),Completed,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
18-001926,Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors,Recruiting,Interventional,"Experimental, Experimental","Dietary Supplement, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
REDHEMOPACH,Hemopatch Versus Axillary Drainage After Axillary Lymphadenectomy,Completed,Interventional,"Other, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,No
PMC_TTAC-0001_06 / KEYNOTE-C14,Olinvacimab With Pembrolizumab in Patients With mTNBC,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
INSPIRE-001,Intercostobrachial Nerve Sparing to Reduce Post-Surgical Pain,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
STUDY00149312,Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
IIT2021-10-Giuliano-OmitRT,Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response,Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
VICCBRE2256,Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Other, Other",Parallel Assignment,Phase 2,Yes,No
EAZ171,Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Other, Other",Parallel Assignment,Phase 2,Yes,No
2017/62,Effects of Slow-Stroke Back Massage on CRF,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
17-001864,SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer,Completed,Interventional,Experimental,"Device, Procedure",Single Group Assignment,Early Phase 1,No,Yes
SCHBCC-N031,An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
20429001,Central Obesity and Cancer Prevention for Chinese American Women,Unknown status,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2000020335,"Lifestyle, Exercise, and Nutrition Study Early After Diagnosis","Active, not recruiting",Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
KN026-CHN-001,Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
Pro00103527,mHealth Behavioral Cancer Pain Intervention for Medically Undeserved Patients,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
CBCRP 23AB-1400,Reducing Breast Cancer Risk in Korean American Women,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
MC02/04/19,"A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
EJERDIETLINF,Reduction of Lymphedema Secondary to Breast Cancer,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
22-5074,Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE),Not yet recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
STUDY00018789,StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Drug, Drug",Parallel Assignment,Not Applicable,No,Yes
SCHBCC-SOAPET,Sentinel Node Biopsy Vs Observation After Axillary PET,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
ATADEK-2022/08/20,The Effect of Manual Lymph Drainage in the Treatment of Breast Edema,Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
OBU-BC-Ⅱ-077,"Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
RG1005296,"Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer",Recruiting,Interventional,Experimental,"Biological, Drug, Biological, Biological",Single Group Assignment,Phase 2,Yes,No
RD19/123502,Plant Sterol INtervention for Cancer Prevention (PINC),Recruiting,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Crossover Assignment,Not Applicable,No,No
091-19,Study on Physical Activitys Relationship With Cancer and Cognition,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
PR139/21,Axillary Reverse Mapping in Breast Cancer,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2021.341,Project Breast47: Effect of an Educational Intervention,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
17-361,BEFORE Decision Aid Implementation Study,Unknown status,Interventional,"Other, Experimental, Other","Behavioral, Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
Overcome project,"Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases",Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
DS8201-A-A103,DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
OBU-BJ-BB-BC-II-007,Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
NU 21B01,"Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study",Recruiting,Interventional,Experimental,"Procedure, Device",Single Group Assignment,Phase 2,No,Yes
COOL-CLIN-2022-01,Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
2020-1243,Music and Surgery Associated With Relationship and Satisfaction,Unknown status,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
OSU-19085,Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer,Withdrawn,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,Phase 1,Yes,No
SYSUCC-012,GM1 Prophylaxis for WBRT Related Cognitive Dysfunction,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
UUBreast01,Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ,Recruiting,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,Phase 3,Yes,No
IMPACTT,Impact of a Patient Decision Aid Intervention,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
CBBCT2018CIH,The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast Cancer,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
30-225 ex 17/18,Laser vs Hyaluronic Acid for GSM in Breast Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
ITSligo SG,Using an Adjustable Compression Garment for Secondary Upper Limb Lymphoedema,Unknown status,Interventional,"Experimental, Active Comparator","Other, Procedure, Device",Parallel Assignment,Not Applicable,No,No
STUDY00003067,Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
PROICM 2019-02 PRA,Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic  Patient Reported Outcome ) on Breast-related Quality of Life,Recruiting,Interventional,"Experimental, Other","Other, Drug",Parallel Assignment,Phase 2,No,No
850366,"The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients",Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
2018/13,Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal Cancer,Completed,Interventional,"Experimental, Other, Experimental, Other","Drug, Procedure",Parallel Assignment,"Phase 1, Phase 2",No,No
A095053,Breast Screening - Risk Adaptive Imaging for Density,Recruiting,Interventional,"No Intervention, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
202302077,Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial),Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2.510.081,PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITY,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
GX-I7-CA-006,Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899),"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
R17137,Thermal Suit With Forced-air Warming in Breast Cancer Surgery,Completed,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
2021-395,Efficacy of Cilostazol in Prevention of Peripheral Neuropathy,Completed,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
IC 2018-09,Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR),Recruiting,Interventional,"Other, Other, Other, Other, Other, Other","Behavioral, Behavioral, Other, Other",Sequential Assignment,Not Applicable,No,No
NeoCAT,A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
AAAR9515,The CONTRoL Trial: Cryotherapy vs. cOmpression Neuropathy TRiaL,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Sequential Assignment,Not Applicable,No,Yes
RG1007463,"Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer",Terminated,Interventional,Experimental,"Drug, Drug, Drug, Biological, Biological",Single Group Assignment,"Phase 1, Phase 2",Yes,No
PA191001001,Pectoral Nerve Block II and Erector Spine Plane Block in Breast Cancer Surgery,Completed,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other",Parallel Assignment,Not Applicable,No,No
18070604,A Study of Serum Folate Levels in Patients Treated With Olaparib,"Active, not recruiting",Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,"Phase 2, Phase 3",Yes,No
2021198-1,Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
PROTOCOL-M7-037,Micrima MARIA Data Collection for Machine Learning Study,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
201801105,RANKL Inhibition and Breast Tissue Biomarkers,Completed,Interventional,Experimental,"Procedure, Drug, Procedure, Drug, Drug",Single Group Assignment,Early Phase 1,Yes,No
202004120MINB,The Effect of Intraoperative Dexmedetomidine on Postoperative Morphine Requirements After Breast Cancer Surgery,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
STUDY00001356,IIT2020-20-SHIRAZIP-WALK: Nature Walks,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
IC 2020-04,ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
Remimazolam_recovery,Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
RECHMPL21_0525,Tridimensional Geometric Modeling of the Breast,"Active, not recruiting",Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
2022037,Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
Q122-2001,Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
S64410,UZ/KU Leuven Program for Post-mortem Tissue Donation to Enhance Research,Recruiting,Interventional,Other,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
MC1689,"Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer",Suspended,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Drug, Other, Biological, Biological, Biological, Procedure, Biological, Drug, Other, Biological",Single Group Assignment,Phase 1,Yes,No
2017-0301,Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers,Withdrawn,Interventional,"Experimental, Active Comparator","Radiation, Other",Parallel Assignment,Phase 2,No,No
S59396,Cancer Related Cognitive Impairment After Chemotherapy: Evaluation of Potential Therapeutic Interventions,Unknown status,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
1105/18,The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patients Dream Study,Completed,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
SP11631,Trial to Compare the Efficacy and Safety of F-627 and GRAN®,Completed,Interventional,"Experimental, Active Comparator",Biological,Parallel Assignment,Phase 3,No,No
EKNZ 2015-026,Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus,Withdrawn,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
H-37314,Translating Research Into Practice,"Active, not recruiting",Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
852666,Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts,Enrolling by invitation,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
Three birds with one stone,Three Birds With One Stone,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
XZP-3287-1001,A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
I 56617,"Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers",Terminated,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
TAK-676-1003,A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers,Recruiting,Interventional,Experimental,"Drug, Drug, Radiation",Sequential Assignment,Phase 1,Yes,No
STUDY00022229,ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
CR108557,"A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults",Completed,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,Phase 1,No,No
UPCC 25920,Pilot Study of an NTproBNP Guided Strategy of Cardioprotection,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,"Phase 1, Phase 2",No,No
MEDOPP243,"DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease",Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
4901,An Enhanced Artificial Intelligence Breast MRI Interpretation System,Unknown status,Interventional,,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
22-269,Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial),Recruiting,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,Not Applicable,No,Yes
Yvonne Wengstrom,Sensorimotor Training Using Whole Body Vibration Exercise to Reduce Chemotherapy-induced Peripheral Neuropathy,Recruiting,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
4-2019-0795,Improvement of Patient Experience and Healthcare Providers Productivity Using Virtual Reality in the Field of Radiation Therapy,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
20180569-01H,Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study,Recruiting,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
REaCT-Hold BMA,Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer,Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
2020-0761,Evaluation of Mailers Promoting Mammogram Screening,Completed,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
202005217,Implementing BREASTChoice Into Practice,"Active, not recruiting",Interventional,"Experimental, Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
SBI-CIP 20-002,Fluorescence Imaging of Carcinoma During Breast Conserving Surgery,Recruiting,Interventional,"Placebo Comparator, Experimental","Drug, Device, Drug",Sequential Assignment,Phase 3,Yes,No
DS8201-A-U106,DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
A2018-002,Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations,Unknown status,Interventional,Other,Drug,Single Group Assignment,Phase 4,No,No
STUDY00016221,Nurse AMIE for Echo Show: Randomized Control Trial,Completed,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
PR275/20,Impact of Systematic Shaving on Margins,Recruiting,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
X-PACT 101,"X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma",Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 1,Yes,Yes
SHF-WBI,Super Hypofractionated Irradiation For Whole Breast Treatment,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
19-07020531,Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study,Recruiting,Interventional,Other,Radiation,Single Group Assignment,Phase 2,No,Yes
DS8201-A-U105,Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
NAUTILUS study,No Axillary sUrgical Treatment In Clinically Lymph Node Negative Patients After UltraSonography,"Active, not recruiting",Interventional,"Experimental, Other","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
BrUOG 387,TAS-116 Plus Palbociclib in Breast and Rb-null Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
Instituto Nacional do Câncer,Effectiveness of Compressive Bandage Use in Seroma Prevention,Not yet recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,Yes
HP-LY-CL-2063,Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE),"Active, not recruiting",Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
2008222-12,Accuracy of VABB Elite 10G Versus BARD 14G CNB,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Phase 3,No,No
2019-0837-002,Capsular Contracture After PMRT Using Prepectoral Versus Subpectoral Implant-based Breast Reconstruction: PREPER Trial,Not yet recruiting,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
BCP24,To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
IRB00083573,Cardiac Outcomes With Near-Complete Estrogen Deprivation,Recruiting,Interventional,Experimental,"Drug, Diagnostic Test, Diagnostic Test, Other, Behavioral",Single Group Assignment,Early Phase 1,Yes,No
CCR5199,ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,No,No
HVST-HEMO-20,The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage,Recruiting,Interventional,"Experimental, Other","Device, Other",Parallel Assignment,Phase 4,No,No
STUDY00019979,Women In Steady Exercise Research - Window of Opportunity for Exercise and Tumor Biology,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
109489,Time Restricted Eating on Cancer Risk,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
IIT2019-14-SHIRAZIP-SWEAT,Streaming Web-based Exercise At Home: A Pilot Study,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Early Phase 1,No,No
SGNTUC-019,Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
EORTC-1984-BCG,Chemo-free BRCA-targeted Neoadjuvant Strategy,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
H-43277,Wrist Cooling for Hot Flashes Clinical Trial,Recruiting,Interventional,"Experimental, Experimental","Device, Device, Other",Crossover Assignment,Not Applicable,No,Yes
Oncolact2020,Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
OE20/2020,Effectiveness of Cohesive Bandage on Axillary Web Syndrome After,Unknown status,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
GNC-035-101（V1.1）,"A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors",Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
2022-0880,Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation,Recruiting,Interventional,"Experimental, Experimental","Radiation, Other",Single Group Assignment,Phase 3,No,No
ACT16432,Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
AAAT8817,IMPACT Trial: Intervention to iMProve AdherenCe Equitably,Recruiting,Interventional,"Experimental, Other","Behavioral, Other",Single Group Assignment,Not Applicable,No,No
19-07020533,Prospective Randomized Study of Accelerated Radiation Therapy (PRART),Recruiting,Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,Phase 3,No,Yes
PSIBBR,Prepectoral and Subpectoral Implant-based Breast Reconstruction,Unknown status,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
THRIVORSBH-01,Physical Activity Platform to Improve Bone Health in Cancer Survivors,Completed,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
20190516,Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib,Completed,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,No,No
RECHMPL20_0614,Assessment of Cryotherapys Analgesic Impact in Anti-aromatase-induced Arthralgia,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
RD19/121361,Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy,Unknown status,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
BRAVEHeartV1,Breast Radiotherapy Audio Visual Enhancement for Sparing the Heart,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
R/19.08.578,Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.,Unknown status,Interventional,Experimental,Procedure,Single Group Assignment,Phase 1,No,No
DHP107_Bioimaging,A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor,Completed,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
18-5029,Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
201902048MINC,Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,Phase 3,No,No
050811,Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
0594,The Genomic Medicine at VA Study,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
APHP201173,BENEFIT OF MECHANICAL ISCHEMIC PRECONDITIONING ON TOLERANCE OF ADIPOSE TISSUE TO ISCHEMIA REPERFUSION OF TYPE DIEP (DEEP INFERIOR EPIGASTRIC PERFORATOR) FREE FLAPS.,Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
2019-001,Evolution of the Physical Condition in Treated Cancer Patients,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
2022P000354,Evaluating the Impact of an Equity Focused Dashboard and Clinical Support,Recruiting,Interventional,"Experimental, Experimental, No Intervention, No Intervention","Other, Other",Crossover Assignment,Not Applicable,No,No
UMCC 2019.125,Altering Lipids for Tolerance of Aromatase Inhibitor Therapy,"Active, not recruiting",Interventional,Experimental,Dietary Supplement,Single Group Assignment,Phase 2,Yes,No
00001137,Improving Genetic Counseling for BRCA+ Mothers,Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
C3661001,A Study of PF-06873600 in People With Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 2,Yes,No
4-2020-0430,The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction,Completed,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
N16PRB,Preoperative Breast Irradiation,Terminated,Interventional,Other,Radiation,Single Group Assignment,Not Applicable,No,No
CASE10119,"Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography",Recruiting,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,Not Applicable,No,No
21-012300,Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain,Recruiting,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,Not Applicable,No,No
KY-Q-2021-182,Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,Not Applicable,No,No
METC20-099,External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery,Recruiting,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
D8534C00001,Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6),Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
NUV-422-03,Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
OSU-18094,Evaluation of Perforator Phase Contrast Angiography in Developing Surgery Plans for Patients With Breast Cancer Undergoing Breast Reconstruction With Free-Flap Methods After Mastectomy,Withdrawn,Interventional,Experimental,"Procedure, Procedure, Other",Single Group Assignment,Not Applicable,No,Yes
10840098-604.01.01-E.184,"Effectiveness of PNF Training for Improving for Muscle Strength, Function, and Pain After Axillary Lymph Node Dissection",Completed,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
Breast Cancer Chemotherapy,Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses,Recruiting,Interventional,Experimental,"Procedure, Procedure, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Drug",Single Group Assignment,Not Applicable,No,No
STUDY02001039,"21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial",Not yet recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
CSCS,Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,Not Applicable,No,No
2020/6422,"Effects of Bromelain and Boswellia Serrata Casperome With Centella Asiatica and Vitamins on Edema, Paresthesia and Postoperative Pain After Quadrantectomy With or Without Sentinel Lymph Node Biopsy.",Unknown status,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,Phase 4,No,No
2022-0150,A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care,Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,Phase 2,No,No
2007-0003,Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
GEN-602-CT-101,Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
CASE2119,A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy,Withdrawn,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
STUDY00000228,RCT Comparing ESPB Solutions in Breast Surgery,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
PRESIONA20,Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
IPAC,Optimizing the Management of Patients With Oral Therapy,Unknown status,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
CTMS# 18-0135,Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy,Suspended,Interventional,Experimental,"Other, Other",Single Group Assignment,Not Applicable,No,No
STX-478-101,First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumor,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
18-486,Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,Phase 2,No,Yes
2019-02661,Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions,Recruiting,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
110181,Probiotics and Breast Health,Completed,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
IRB-55153,"Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts",Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
20953,"Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer",Withdrawn,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
MC1932,TrAstuzumab Cardiomyopathy Therapeutic Intervention With Carvedilol,Recruiting,Interventional,"Experimental, Experimental, Active Comparator",Drug,Parallel Assignment,Phase 2,Yes,No
EXPLLN21-01,A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG,Not yet recruiting,Interventional,Experimental,Diagnostic Test,Parallel Assignment,Not Applicable,No,No
22-457,Losartan in Prevention of Radiation-Induced Heart Failure,Not yet recruiting,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,Early Phase 1,Yes,No
GW10029,Assessing the Sensitivity of SureTouch™ in Women Undergoing Diagnostic and Screening Mammography,Terminated,Interventional,"Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,No
GCC1950,First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,Yes,No
Erector block after mastectomy,Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy.,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
2021-0025,Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge,Recruiting,Interventional,Experimental,"Procedure, Procedure, Drug, Other",Single Group Assignment,Not Applicable,No,Yes
HCI148669,Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Early Phase 1,No,Yes
21/59848,Lymphaticovenous Anastomosis as Treatment for Lymphedema,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
221-005,Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 1,No,No
P.T.REC/012/002615,Aquatic Versus Land Based Exercise on Lymphedema Post Mastectomy,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
INT31/19,Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases,Unknown status,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
B00394,Automated Low Dose Risk Assessment Mammography (ALDRAM),Completed,Interventional,Other,Radiation,Single Group Assignment,Not Applicable,No,No
CKMW-1801,Compass Course: Efficacy Study,Completed,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,Not Applicable,No,No
EGC101,A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers,Completed,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
69HCL20_1018,Remediation for Mild Cognitive Deficits After Cancer,Recruiting,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
300.08-2018-Samsungmedison-S,Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms,Unknown status,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Procedure",Crossover Assignment,Not Applicable,No,No
ICO-A-2020-10,Electrotherapy in the Management of Myofascial Syndrome,Recruiting,Interventional,"Other, Other","Device, Device",Crossover Assignment,Not Applicable,No,No
INT157/17,Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
13155,ciNPT in Autologous Abdominal Tissue Breast Reconstruction,Not yet recruiting,Interventional,"Experimental, Active Comparator","Procedure, Device, Other",Parallel Assignment,Not Applicable,No,Yes
IRB20-0528,Low-dose Imaging Technique (LITE),Unknown status,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
BO40933,"A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.",Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
NL67696.068.18,Functional MRI Study Reconstructed Breasts,Unknown status,Interventional,"Active Comparator, Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
UW17032,Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention,Terminated,Interventional,Experimental,Device,Single Group Assignment,Phase 2,No,Yes
MedOPP321,"ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL",Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2017-8737,Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction,Unknown status,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
AP2204-50104,Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery,Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
IRB-53132,LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
5160378,Effect of Resveratrol on Serum IGF2 Among African American Women,Suspended,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
R.21.11.1523,Comparison of Different Volumes Spread of Erector Spinae Block in Post Mastectomy Pain Syndrome Management,Recruiting,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,Phase 2,No,No
CYP003,A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
315581,Randomised Trial Comparing Biological Matrices With Synthetic Meshes,Not yet recruiting,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
CTB in Breast surgery,Ultrasound Guided Costotransverse Block for Breast Cancer Surgery,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
RIS42756,Remote Time-restricted EAting DeliverY,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
YH32367-101,Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
2021.127,Music Intervention for Preoperative Anxiety and Acute Pain Among Mastectomy Patients,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
ShantouCH,Lidocaine Mucilage-ICG as an Optical Agent for Tumor Delineation During Breast-conserving Surgery,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Not Applicable,No,No
HYACOM,"Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies",Recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,Not Applicable,No,No
36264PR116/2/23,Vitamin C on Acute and Chronic Post Mastectomy Pain,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Not Applicable,No,No
00101494,Technology-Based Cancer Screening Intervention,Enrolling by invitation,Interventional,"Other, Other, Other",Behavioral,Sequential Assignment,Not Applicable,No,No
ETK00-2020-0103,Effects of Clinical Pilates and Yoga Training in Lymphedema,Completed,Interventional,"Experimental, Experimental, Other","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
DIVA-001,"Randomized, Controlled Trial With Hybrid Fractional Laser",Completed,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,Not Applicable,No,Yes
PRO00030436,The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Single Group Assignment,Not Applicable,No,No
JS2021-6-1,Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
20180335,An Investigator Initiated Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® eBx System,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
DRBX201901/PRO,A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection,Completed,Interventional,"Experimental, Active Comparator",Drug,Crossover Assignment,Not Applicable,No,No
21-04,Performance Assessment of the Fluorescence Technique Alone in the Search for the Sentinel Node in Breast Surgery,Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
A221505,Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Radiation, Other, Other, Other, Radiation",Parallel Assignment,Phase 3,No,No
UC-0107/1803,Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast,Recruiting,Interventional,"Active Comparator, Experimental","Radiation, Other",Parallel Assignment,Not Applicable,No,No
SHS-An-1-2022,Nociception Level Monitor (NOL) During Guided Analgesic Delivery in Breast Surgeries,Enrolling by invitation,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
R01CA249419,The Engaging Primary Care in Cancer Survivorship (EPICS) Study,Enrolling by invitation,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
STU 072016-058,Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity,Enrolling by invitation,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Early Phase 1,Yes,No
DS1103-074,A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Biofeedback_based_music,Effects of Biofeedback-based Music Program Using a Smart Device Application on Perioperative Sleep Quality.,Not yet recruiting,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,Not Applicable,No,No
IRB-21-28,Can Chronic Post-surgical Pain be Reduced by Preserving Intercostobrachial Nerve During Axillary Lymph Node Dissection? : A Randomized Controlled Trial,Enrolling by invitation,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
BREAST-Pyrotinib,Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
L19-065,Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
TQB211-III-01,A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
AP2110-30111,Erector Spinae Plane Block Versus Serratus Anterior Block on Post Mastectomy Pain Syndrome,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Procedure, Procedure",Sequential Assignment,Not Applicable,No,No
IRB202101449,UFPTI 2105-BR05: Improving Breast Radiotherapy Setup and Delivery Using Mixed-Reality Visualization,Recruiting,Interventional,"Sham Comparator, Experimental",Device,Parallel Assignment,Not Applicable,No,No
IIT2021-01-Shiao-CSF1Ri,Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation,Not yet recruiting,Interventional,Experimental,"Drug, Radiation, Drug",Single Group Assignment,Phase 2,Yes,No
WHITE TEA,White Tea for Prevention of Chemotherapy Induced Mucositis,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2017/15,Study of the Impact of DPD Activity on the Efficacy of Capecitabine,Recruiting,Interventional,Experimental,"Other, Drug",Single Group Assignment,Not Applicable,No,No
A222101,Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II),Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other, Other, Drug",Parallel Assignment,Phase 2,No,No
AP2014-50103,Dexmedetomidine in Erector Spinae Block in Postoperative Analgesia,Completed,Interventional,"Experimental, Experimental, No Intervention","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
21-318,Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
BXU572940,Doxil/Caelyx BE Study,Not yet recruiting,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,Phase 1,Yes,No
62/19-06-18,Guided Imagery & Music in Cancer,Unknown status,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
ZUH-MICB-UMPR,The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.,Completed,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,Phase 4,No,No
RG1007834,Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy,"Active, not recruiting",Interventional,Experimental,"Drug, Procedure, Procedure, Drug, Procedure, Procedure, Other",Single Group Assignment,Phase 2,Yes,No
KCT001,"Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study",Completed,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
HE641269,Efficacy of Parecoxib Combined With Paracetamol in Mastectomy,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
AIUR trial,The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy,Not yet recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
S-20200094,Lymphedema Screening,Unknown status,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
ATADEK 2021-14/18,Aromatherapy Methods in Reducing Anxiety Before Breast Biopsy,Recruiting,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
19-665,CONFIRM: Magnetic Resonance Guided Radiation Therapy,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Radiation,Parallel Assignment,Not Applicable,No,Yes
RECHMPL18_0244,Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
TBio-4101-001,A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,Phase 1,Yes,No
UCCS19102,Memory and Attention Adaptation Training-Geriatrics (MAAT-G),Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
UCCS20127,Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II,Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
RCB: 2022-A01349-34,Algology in Oncology Osteopathic Support (ALGOS),Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
211820931,Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
CTC-SMMiL-E-1901,Feasibility of a New Technology for Isolating Circulating Tumour Cells,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
LCI-BRE-VITD-001,A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation,Recruiting,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
CLEE011A2412B,Roll-over Study to Allow Continued Access to Ribociclib,Recruiting,Interventional,Other,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 4,Yes,No
OX2022-203-01,Study To Assess Safety And Efficacy Of AsiDNA In Combination With Olaparib In Participants With Recurrent Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2018-0561,"ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
IRB00180383,e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
ID-RCB: 2018-A03356-49,Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
2011684,Radiofrequency Chip for Localization of Non-Palpable Breast Lesions,Completed,Interventional,"Other, Experimental, Active Comparator","Device, Device, Device",Parallel Assignment,Not Applicable,No,Yes
2021/058,Novel Skin Care Product for the Management of Acute Radiodermatitis,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
CDK-002-101,"A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors",Completed,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",Yes,No
SAPB for MRM 2.0,Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point,Recruiting,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
TJ107001STM202,Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,No,No
2015C0090,Tango for Neuropathy Among Breast Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Study-21-00112,Mammography and Breast Arterial Calcification: An Information-Sharing Trial,Recruiting,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2020-013-00US3,A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
NeuroMod-PCCI,Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment,Recruiting,Interventional,"Experimental, Sham Comparator","Device, Device, Behavioral",Parallel Assignment,Not Applicable,No,No
D8530C00004,"A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833",Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,No,No
19-5250.0,Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy,Suspended,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
STU 2019-1099,Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity,Suspended,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Early Phase 1,Yes,Yes
2020.253 NL72539.029.20,Supervised Exercise to Promote Infiltration of NK-cells Into the Tumor,Completed,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
A5481173,Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies,Recruiting,Interventional,"Other, Experimental, Other, Other","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
RCT Pristina 2/TR,Self-compression Mammography in Clinical Practice,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
2021-0568-001,A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia,Recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Phase 3,No,No
STUDY00143316,Sexual Health Empowerment for Womens Health,"Active, not recruiting",Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
19-238,Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 4,Yes,No
FDRT-BC007,Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
2004-219-1119,Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy,Completed,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
DS1062-A-J101,First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Other",Sequential Assignment,Phase 1,Yes,No
CMUH110-REC1-122,Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® Gel,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
IIT-ePRO,A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys,Recruiting,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Phase 3,No,No
22-091,Culturally Aware AET Non-Initiation Intervention,Not yet recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
UTK-IRB-22-07195,Womens Interventions for Sexual Health: WISH,Recruiting,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,Not Applicable,No,Yes
PROICM 2018-07 BPR,Memory Perception Assessment in Central/Non-central Nervous System Cancers,Recruiting,Interventional,"Other, Other, Other, Other",Other,Factorial Assignment,Not Applicable,No,No
5271,SEroma Reduction pOst MAstectomy SEROMA Study,Unknown status,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
ZG01012019,Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction,Unknown status,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
PO18091,Per-operative Exploration of the Peri-pancreatic Lymphatic Pathways During Pancreatic Surgical Resection,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
22-197,The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Procedure, Other",Parallel Assignment,Phase 2,No,No
20-5111,The Person-centered Evolution of Radiotherapy Services in Ontario Study,"Active, not recruiting",Interventional,"Experimental, Other",Other,Parallel Assignment,Not Applicable,No,No
PROICM 2020-06 BIO,Pain Monitoring After Breast Biopsy: Benefit of E-health,Recruiting,Interventional,"Experimental, Experimental, No Intervention","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
IRB-46373,Phase 2 Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Radiation",Parallel Assignment,Not Applicable,No,No
2019_NOV_CP_001,Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
DEGENCA,"Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the Massive Parallel Sequencing on Circulating Tumor DNA",Unknown status,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
IRB-2022- 1451,Axillary Versus Primary Breast Approach for Second-stage Breast Reconstruction,Not yet recruiting,Interventional,"Placebo Comparator, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
ASO.RianGen.22.02,Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery,Enrolling by invitation,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
19-00222,Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
C4431001,A Study of PF-07260437 in Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Diagnostic Test",Sequential Assignment,Phase 1,Yes,No
M336,Comparison of Erector Spinae Plane Block With Serratus Anterior Plane Block for Breast Surgery,Completed,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
KIA 2018/155,The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery,Completed,Interventional,"No Intervention, Experimental",Procedure,Crossover Assignment,Not Applicable,No,No
B-1206-158-005,Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts,Withdrawn,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,Not Applicable,No,No
190311,Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction,Recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
20-021,Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other, Other",Parallel Assignment,Phase 3,No,No
202200395A3,"Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia",Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
PECS in Breast Cancer Surgery,PECS Block With Bupivacaine Vs Bupivacaine and Dexmedetomidine in Modified Radical Mastectomy,Unknown status,Interventional,"Placebo Comparator, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
HREBA.CC-19-0354,Protein Needs Study,Recruiting,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
Analgesia in breast surgey,Combined PECS II and Transversus Plane Blocks Versus Erector Spinae Block in Modified Radical Mastectomy,Unknown status,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
159-2019,Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization,Recruiting,Interventional,"No Intervention, Experimental",Device,Sequential Assignment,Not Applicable,No,No
LCCC1920,Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
MCC-19650,Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1,Terminated,Interventional,"Active Comparator, Active Comparator, Experimental, Experimental",Biological,Single Group Assignment,Phase 2,Yes,No
2018-05-0009,Living Well After Breast Surgery,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
DCIS Cryo,Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ,Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
STU00214745,Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
ENTheR,Exploratory Study on Therapy for Breath Hold in Radiotherapy,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
Michal Nissim 2,"Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients",Recruiting,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
IUSCC-0533,Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias,Withdrawn,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
Version 1.1.6,Magnetic Occult Lesion Localization and Imaging (MOLLI),Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
GALENO 1,Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies,Unknown status,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
MMSTD1Pecs2,Establishing Technique for PECS2 Catheter Insertion,Completed,Interventional,"Other, Other","Procedure, Procedure, Other",Parallel Assignment,Not Applicable,No,No
875329,Training Data Collection & AI Development,"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
ST-067-001,"Phase 1a and Phase 2 Study for PK, PD, Safety and Preliminary Efficacy of ST-067",Recruiting,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,"Phase 1, Phase 2",Yes,No
H-40045,Scalable Communication Modalities for Returning Genetic Research Results,Recruiting,Interventional,"No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
SYSKY-2023-122-02,Clinical Value of Breast High-Resolution MR Ductography in Patients With Pathological Nipple Discharge,Recruiting,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
KOU KAEK 2018/487,Comparison of Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Surgery,Completed,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,Not Applicable,No,No
TREM-1,Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis,Recruiting,Interventional,"Other, Other, No Intervention, No Intervention, No Intervention",Biological,Parallel Assignment,Not Applicable,No,No
RC31/17/0335,Quality of Life in Patients With Standard External Compared to Custom-made Breast Prosthesis.,Unknown status,Interventional,"Other, Other","Device, Device",Crossover Assignment,Not Applicable,No,No
201912245RINB,Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia,Not yet recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
CUT_DN_02,Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
PKUPH10B001,Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physicians Choice,Unknown status,Interventional,"Active Comparator, Experimental",Combination Product,Parallel Assignment,Early Phase 1,No,No
19.58/ONCO19.08,PBMT for the Management of CIA ( HAIRLASER ),Recruiting,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
CCS1477-01,Study to Evaluate CCS1477 in Advanced Tumours,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CO-338-098,A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR),Terminated,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
UBP-A103-HER2,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers",Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Biological, Biological",Sequential Assignment,Phase 1,No,No
UMCC 2021.071,Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
Pro00040035,Home-Based Physical Activity Intervention for Taxane-Induced CIPN,Recruiting,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
18-6047,The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease,Recruiting,Interventional,"Experimental, Experimental",Radiation,Single Group Assignment,Not Applicable,No,No
PI2018068,Peer Support Program in Cancer Patients Elkar Laguntza,Recruiting,Interventional,"Experimental, Experimental",Behavioral,Crossover Assignment,Not Applicable,No,No
Metimedi-202,OMT-111 for Terminal Stage Solid Tumors,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CBCSG-040,Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA),Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
NUV-422-02,Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
UBT 2022-01,A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
2020-A01534-35,A Proximity-incentive Strategy for Cervical Cancer Screening,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
181367,Physical Activity Intervention for Young Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
PRO00041443,Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction,Recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
METCZ20190024,The Risk of Postoperative Wound Complications Following the Use of Negative Pressure Wound Therapy in Patients Undergoing Mastectomy,Completed,Interventional,"No Intervention, Experimental",Device,Single Group Assignment,Not Applicable,No,No
22-01024342,Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation,Not yet recruiting,Interventional,"Active Comparator, Active Comparator",Radiation,Parallel Assignment,Phase 3,No,Yes
SY-5609-101,"A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
MCC-20487,Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2022/73,The Effect of the Motivational Interviewing Technique on Breast and Cervical Cancer Screenings,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
TBMZ-Radio-boron gel,Preventive Effect of Boron-based Gel on Radiation Dermatitis,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
BT5528-100,Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
REaCT-TEMPO,Evaluating an Endocrine Therapy Dose-frequency Escalation Strategy and Its Effects on Tolerability and Compliance,Not yet recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 4,No,No
SYSKY-2022-117-01,Endoscopic Breast Conserving Surgery With Intra-operative Navigation System,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
PROT-P2-024,M5 vs. M6 Comparison Study With a Sub Study Into the Dielectric Constant of Aspirated Cyst Fluid,Completed,Interventional,"Other, Other",Device,Parallel Assignment,Not Applicable,No,No
2022-0454,Vapocoolant Analgesia for Breast Lymphoscintigraphy,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
Pro00101109,Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS),Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
22-071,A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction,Recruiting,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,Phase 3,No,No
ZL-2306-006,A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
OTT-15-02,"Tumor Bed Dose Delivery Using A Breast Specific Radiosurgery Device, The Gammapod: (A Clinical Feasibility Study)",Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
K 2020-9716,[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors,Recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,Phase 2,No,No
NCC20180327,Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Not Applicable,No,No
3121_MATFIH22,"First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Immediate Breast Reconstruction After Mastectomy for Cancer",Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
Modi-1-001,"Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Device",Parallel Assignment,"Phase 1, Phase 2",Yes,Yes
20-437,Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
16-01,Contrast-Enhanced Cone Beam Breast CT for Diagnostic Breast Imaging,Terminated,Interventional,Experimental,"Radiation, Drug",Single Group Assignment,"Phase 2, Phase 3",No,Yes
IEO 1002/,Evaluation of the Effectiveness of Prepectoral Breast Reconstruction,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
3271,PBI for Breast In Situ Carcinoma of Intermediate Low Risk as Local Adjuvant Treatment,Recruiting,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,Not Applicable,No,No
21-559,Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
LCCC2139,Comparison of CE-DBT and MRI in Patients With Known Breast Lesions,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
NK-101,FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
1903399639,High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT),Not yet recruiting,Interventional,Experimental,"Diagnostic Test, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,Yes
MCC-19-15167,Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video,Recruiting,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
CASE5117,Drain-Less Abdominally Based Breast Reconstruction Using Lysine-Derived Urethane Adhesive,Withdrawn,Interventional,"Active Comparator, Experimental, Active Comparator","Device, Device, Other",Parallel Assignment,Not Applicable,No,Yes
CASE10117,Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Medipol Hospital 18,ESPB and RIB for Pain Management Following Mastectomy Surgery,Completed,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
18-431,Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,Phase 2,Yes,No
SPI-POZ-203,A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 2,Yes,No
STUDY21070030,CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study,Recruiting,Interventional,Experimental,"Device, Drug",Single Group Assignment,Phase 4,Yes,Yes
E2018124,Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients,Unknown status,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,Not Applicable,No,No
2140-002,A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002),"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
21-288,A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
RadOnc,Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
INX-315-01,"Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
JSKN003-101,First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
228012,Impact of Topical Tranexamic Acid in Breast Reconstruction,Recruiting,Interventional,Experimental,"Drug, Other",Single Group Assignment,Phase 4,Yes,No
20-275,Testing a New Imaging Agent to Identify Cancer,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 1,Yes,No
IGAR-TO-007,IGAR-Breast TeleOp Trial,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
Laser LabCorp #001,Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics,Suspended,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
2020-04936,Mammography Screening With Artificial Intelligence (MASAI),"Active, not recruiting",Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
IRB-50877,Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution,Not yet recruiting,Interventional,Experimental,"Drug, Device",Single Group Assignment,Early Phase 1,Yes,Yes
PER-19-04,Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.,Recruiting,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,Not Applicable,No,Yes
KL166-I-01-CTP,A Study of A166 in Patients With Advanced Solid Malignant Tumors,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,No,No
PROTOCOL-P2-054,The ABC Study: Assessment of Breast Density Classification,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
254-18,Reconstructions With Back Donor Site Flaps and Validation of Quality of Life Scales,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
B076201420067,Zhongnan Hospital of Wuhan University,Unknown status,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,Not Applicable,No,No
MIP-2019-001,BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory),Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
21051,Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults,Completed,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
DE-17-17,Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection,Completed,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
201701045,Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach,Completed,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,Phase 1,No,No
E20210210,Breast Mesh Used in Two-staged Breast Reconstruction,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
EMC-0124-18,Evaluation of the SmartBx System for Breast Biopsy,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
LYL797-101,A Study to Investigate LYL797 in Adults With Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
2834,TIVA Admnistration and Autologous Fat Transfer in Breast Reconstruction,Completed,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Not Applicable,No,No
IC 2021 07,Opioid Free Versus Opioid Based Anaesthesia for Secondary Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
GEN1B-01,Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications,Suspended,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,Not Applicable,No,Yes
IIT2018-25-MITA-NEOBREADS,NEOBREADS: Neoadjuvant Breast Diet Study,Terminated,Interventional,Experimental,"Other, Drug",Single Group Assignment,Phase 1,No,No
2020-00493,Red Bull Energy Drink Intake After Autologous Microsurgical Breast Reconstruction,Recruiting,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
20210817-01H,TAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction,Not yet recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CIRB Ref. No: 2019/2090,Accessible Cancer Care to Enable Support for Survivors Programme,Unknown status,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
20295,Dermacell ADM Without Basement Membrane,Unknown status,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
TO-TAS0728-101,A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities,Terminated,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
124.03-2017-GES-0005,Patient-Assisted Compression in 3D - Impact on Image Quality and Workflow,Completed,Interventional,Other,"Device, Device",Single Group Assignment,Not Applicable,No,Yes
IIT2018-21-AMERSI-BREADS,BREADS: Breast Adjuvant Diet Study,Recruiting,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,Phase 2,No,No
3-2021-0468,Pectoralis Nerve Block and Quality of Recovery in Mastectomy Patients,Recruiting,Interventional,"Experimental, Placebo Comparator","Procedure, Other",Parallel Assignment,Not Applicable,No,No
IB 2019-01,Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
2022-010,F-Tryptophan PET/CT in Human Cancers,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
Reader-02 Study,Optoacoustic Images Versus Imagio® Ultrasound,Completed,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,Not Applicable,No,Yes
20-03,"A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy",Completed,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
YWBC-002,Prevention and Treatment of Pyrrolitinib-associated Diarrhea,Recruiting,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
2019-1176,Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Other, Other",Parallel Assignment,Not Applicable,No,No
2018-4107,Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy,Completed,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Not Applicable,No,No
2021-0290,Effect of Neurotization on QoL and Sensory Restoration,Not yet recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Phase 2,No,No
0180910/16,The Combination of PECS II Block and Parasternal Block for Radical Mastectomy,Completed,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,Not Applicable,No,No
INTRUSION,INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
R.22.09.1830,Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery,Recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,"Phase 2, Phase 3",No,No
SCOUT2021,Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc ),Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
PROICM 2019-07 PRE,Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
2022-A01940-43,Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL,Not yet recruiting,Interventional,"Placebo Comparator, Experimental","Drug, Other",Parallel Assignment,Phase 2,No,No
Reader-01,"Imagio Feasibility Multi-Reader, Multi-Case Study",Completed,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,Not Applicable,No,Yes
STUDY00025461,Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms,Not yet recruiting,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
19D.203,Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast Findings,Completed,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
BCD-178-1,"A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers","Active, not recruiting",Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 1,No,No
SHR6390-I-114,Study of SHR6390 in Renal Insufficiency and Healthy Subjects,Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
2204MDJ,Testing Video Information About Mammography Screening,Unknown status,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
mastectomy regional anesthesia,Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection,Completed,Interventional,Experimental,Other,Single Group Assignment,Phase 3,No,No
PECS 2019,The Analgesic Efficacy of the Pectoral Nerves Block Versus Local Anesthetic Infiltration After Mastectomy,Unknown status,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Phase 4,No,No
R-2017/UEM11,Acute Effect of Chromatic Environment During Chemotherapy,Unknown status,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other",Crossover Assignment,Not Applicable,No,No
IBIO-302,Food Effect Study of D-0502 Tablet in Healthy Volunteers,Completed,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,Phase 1,Yes,No
LAE203CN2101,PhI to Solid Tumors and PhII to Locally Advanced or mTNBC,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator, Placebo Comparator","Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
SN132D CSP final version 6.0,A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
2022-1151,Implementation of Population Breast Cancer Genetic Services in Federally Qualified Health Centers (FQHC),Not yet recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
NINTAU,ConquerFear-Group: A Psychological Intervention for Fear of Cancer Recurrence,Completed,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
21-002713,3D Ultrasound Microvessel Imaging for Breast Masses,Recruiting,Interventional,Experimental,"Other, Procedure",Single Group Assignment,Early Phase 1,No,Yes
LIVFOU-930411,Pectoral Nerves Block vs Wound Infiltration for Partial Mastectomy - a Prospective Randomized Trial.,Completed,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure, Procedure, Drug, Device",Parallel Assignment,Not Applicable,No,No
21-BI-1607-01,BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
20-378,Researching the Effect of Exercise on Cancer,Recruiting,Interventional,"Experimental, Experimental",Other,Sequential Assignment,Not Applicable,No,No
2019-A0872-55,Study on Skin Toxicities Induced by Cancer Treatments,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
CAAA504A12101,Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Early Phase 1,Yes,No
D6900C00001,First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
HNCH-BC004,A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,No,No
20200491,Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
PRO2021-1428,Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer,Not yet recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
ZN-A-1041-101,Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,No,No
HCC 21-265,"Dignity, Legacy, Advocacy, and Support for Advanced Cancer: Reimagined End of Life Care in the Black Community",Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
HNCH-BC007,GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel,Withdrawn,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,No,No
2020-0498,Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome,Withdrawn,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other, Other",Parallel Assignment,Not Applicable,No,Yes
NBE-002-01,NBE-002 in Patients With Advanced Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
1B-22-2,"In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors",Recruiting,Interventional,"Experimental, Experimental","Biological, Drug, Radiation, Biological",Sequential Assignment,Phase 1,Yes,No
PROT002 - Test Plan 01 Rev A,Blue Note Therapeutics Product BNT 103 Usability and User Engagement,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
Gen 2 - 01,Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
PROT001,Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment,Terminated,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
MW05-2020-CP301,Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF,Completed,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",No,No
BYON5667.002,Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
UZBRU_VHH2_1,Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
19-007547,"Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
Pro00092817,VR Ultrasound Guided Breast Localization,Completed,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
Pro00112215,The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures,Enrolling by invitation,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
5R44CA203608,LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge),Recruiting,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Not Applicable,No,Yes
M16-573,A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
ACROPOLI (SOLTI-1904),Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
NL52329.075.15,Intra-individual Comparison of Conventional and Digital PET/CT Scanners,Completed,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
AAAT2490,AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other, Other, Other",Factorial Assignment,Not Applicable,No,No
CMP-001-009,A Trial to Find Out if Vidutolimod Together With Cemiplimab is Safe and if it Works in Adult Participants With Advanced Cancer or Metastatic Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
SS-SP01-201904,Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
5890-001,Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001),"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Biological, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
H19-03343,Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
BPI-2358-106 phase 3,Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,Phase 3,Yes,No
EK 1623/2020,Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection,Recruiting,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
TRX518-004,A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
20200110,Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients,Recruiting,Interventional,"Sham Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
ASPB vs ESBP for mastectomy,Comparison Between Serratus Anterior Plane Block and Erector Spinae Plane Block for Mastectomy,Completed,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
2018-01,Quantitative Evaluation of the Breasts Morphological Variations During Radiotherapy: MorphoBreast3D,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
TYKM1602101,A Study of TY-302 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
BrUOG 351,BrUOG 351: PRE-OPERATIVE APBI USING NIBB,Withdrawn,Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,Not Applicable,No,No
KL264-01,"Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
Medipol Hospital 26,Different Volumes of Erector Spinae Plane Block for Breast Surgery,Recruiting,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Not Applicable,No,No
NeoVAB,Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB),Unknown status,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
16-136,Ipilimumab and Nivolumab in Leptomeningeal Metastases,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
SGN228-001,A Study of SGN-CD228A in Advanced Solid Tumors,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
1612017795,Web-based Family History Tool,Completed,Interventional,"No Intervention, Experimental, Experimental",Other,Single Group Assignment,Not Applicable,No,No
7902-005,Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005),"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Drug",Parallel Assignment,Phase 2,Yes,No
UUBreast02,PREMs on PROMs in Breast Disease (PREMs_PROMs),Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Phase 3,No,No
2021-0842,Single Step Lesion Annotation and Localization of Suspicious Breast Lesions,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Early Phase 1,No,Yes
GN19HS442,Augmented Reality (AR): The Future of Patient Information Leaflets,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Crossover Assignment,Not Applicable,No,No
MCC-21622,Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,Phase 1,Yes,No
SIBP-03-01,A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
IRB00047335,Speeding Recovery From Pain and Opioid Use,Withdrawn,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Early Phase 1,Yes,No
217510,Microbiome and Association With Implant Infections,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,Yes,No
RIN20230039,Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure,Not yet recruiting,Interventional,"Experimental, Experimental",Behavioral,Sequential Assignment,Not Applicable,No,No
UI/EC/20/0275,The Effect of Octreotide on Wound Drainage After Mastectomy,Completed,Interventional,"Active Comparator, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 4,No,No
AB-201-01,A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
IOM-040369,Patient Preference for Pegfilgrastim (Neulasta®) Application Forms,Completed,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
233,Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and Vomiting,Unknown status,Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
TQB3616-I-02,Clinical Trial for Effect of TQB3616 Capsule on Pharmacokinetics in Healthy Adult Subjects,Completed,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,Phase 1,No,No
MAR-BAS-18-005,The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,No,No
107709,Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women,Terminated,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,Yes
20-1456,Improving Cancer Screening and Follow-up in Community Health Centers,Not yet recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
UTN: U1111-1278-1680,CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
19-104,The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea (CINV) and Vomiting,Recruiting,Interventional,"Active Comparator, Active Comparator, Placebo Comparator",Other,Parallel Assignment,Not Applicable,No,No
MASCT-I-1003,A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor,Unknown status,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 1,No,No
REC/RCR&AHS/22/0511,Effects Of Lymphatic Drainage on Axillary Web Syndrome,Recruiting,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
18-264,Enhancing Cancer Prevention and Control Pathways-Native Health Initiative,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,Not Applicable,No,No
KY20202093-F-1,Clinical Study of 68Ga Labeled HER2 Affibody Analogues,Not yet recruiting,Interventional,,Drug,Single Group Assignment,Early Phase 1,No,No
2021-0262,Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study),Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
262180,Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,Yes,No
H18-02014,CARA Treatment Pilot Study for Breast Positioning,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
IRB19-2074,Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
TG1819ONC,A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,"Biological, Biological, Biological, Biological, Biological, Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",No,No
STUDY00018917,The PAI Trial for Breast and Colon Cancer Survivors,Withdrawn,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,Not Applicable,No,No
STUDY00002789,CONTIGO - Informing Latinas About HBOC Risk,Enrolling by invitation,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
S66520,Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors,Recruiting,Interventional,"Active Comparator, Active Comparator, Sham Comparator",Device,Parallel Assignment,Not Applicable,No,No
P.T.REC/012/002677,Effectiveness of Low Level Laser Therapy on Insulin Resistance and Inflammatory Biomarkers,Recruiting,Interventional,"Active Comparator, Sham Comparator","Device, Other",Crossover Assignment,Not Applicable,No,No
ISPY-P1.01,ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
NCI-2017-01921,Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Other, Other",Parallel Assignment,Phase 1,Yes,No
"2016-051-000001, 1835",Investigating Public Enthusiasm for Mammography Screening in Denmark,Completed,Interventional,"Other, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
CF21163B,Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
D-FR-01072-002,"Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)",Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
Breast-Nektaria,The Impact of Pecs Blocks on Postmastectomy Pain Syndrome,Completed,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
1413727,An Intimacy Intervention for Couples Completing Breast or Prostate Cancer,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
20200426,Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,Phase 1,Yes,No
VALO-001,START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer,Recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,No,No
IMU R204/2017,Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
LCCC1915,3-D Super Resolution Ultrasound Microvascular Imaging,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Device",Single Group Assignment,Phase 2,Yes,Yes
RiphahIU Shafaq,Effects of Active Release Technique (ART) on Pectoralis Minor Tightness in Post Mastectomy Women.,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
CRX100-001,Study of CRX100 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Biological,Sequential Assignment,Phase 1,Yes,No
HREBA.CC-20-0077,Time-restricted Eating in Survivors Trial,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
TST-9-H,Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in Patients With Solid Tumors,Withdrawn,Interventional,"Experimental, Active Comparator","Biological, Drug",Parallel Assignment,Phase 1,No,No
OCOG-2022-RAPID2,A Randomized Trial of Five Fraction Partial Breast Irradiation,Not yet recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Phase 3,No,No
20181004,Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
18-571,EHR-embedded OCDT in Breast or GI Cancer,Completed,Interventional,"Other, Other","Other, Other",Sequential Assignment,Not Applicable,No,No
R19-159,Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
2018B0521,Southeast Asian Womens Health Project,Recruiting,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
287482,ARTISS a Single-centre Randomised Control Study,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Other",Parallel Assignment,Phase 4,No,No
HR-BLTN-DDI-07,Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects,Completed,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,No,No
201612723,NR in Chemo-induced Peripheral Neuropathy,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
AWS,Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome,Recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
2022-0328,"Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics",Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
20/007-E_TFM,Study of the Effectiveness of Supervised vs. Non-Supervised Therapeutic Exercise in Cancer Patients,Unknown status,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
Internal Code 012-23,"STUDY OF THE EFFECTIVENESS AND SAFETY OF SUPERVISED THERAPEUTIC EXERCISE IN CANCER PATIENTS WITH AND WITHOUT SIMULTANEOUS CHEMOTHERAPY, RADIOTHERAPY OR HORMONAL TREATMENT.",Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
0352-2189,"A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis",Not yet recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
HCI128055,[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
180097,Olaparib in People With Malignant Mesothelioma,Completed,Interventional,Experimental,"Drug, Device",Single Group Assignment,Phase 2,Yes,Yes
190134,Vaccine Response With NT-I7,Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Biological, Biological, Biological",Sequential Assignment,Phase 1,Yes,No
TH1902-CTR-0001,TH1902 in Patients With Advanced Solid Tumors,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
18112,64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy,Recruiting,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,Early Phase 1,Yes,No
KY20172047-1,Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Phase 1,No,No
mRNA-2752-P101,Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 1,Yes,No
1380800-R,Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments,Recruiting,Interventional,"Active Comparator, Experimental, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
7621,Opening the Conversation Study,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
TomBakerCC,Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
SVIFT Nodal Trial,Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation,Recruiting,Interventional,"Active Comparator, Other",Radiation,Factorial Assignment,Not Applicable,No,No
CASE1Z21,Patient Recall of Cancer Screening and Diagnosis,Recruiting,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
IRB00075787,Mastectomy Flap Temperature Study,Recruiting,Interventional,Experimental,"Other, Other",Single Group Assignment,Not Applicable,No,No
HB-AT-001,Radiation Therapy (HB-001) by Alpha-particle Sources for Recurrent Malignant Solid Tumors in Japan,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
ART4215C001,A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
Duke-NUS,Marital Satisfaction and Sexual Health of Female Cancer Patients in Singapore,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
SKNA pilot,Measurement of the Skin Sympathetic Nerve Activity,Completed,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,Not Applicable,No,No
IIT2018-05-ASHER-IMPROV2,LOL: Its All Improv After Cancer!™,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
OU-SCC Virtual Reality,Virtual Reality Software to Reduce Stress in Cancer Patients,Not yet recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
2020-A03205-34,"Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)",Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
OPERA2,Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA),Completed,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
201907039,RANKL Inhibition and Mammographic Breast Density,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Procedure, Procedure",Parallel Assignment,Phase 2,Yes,No
TaiHao BR-USCAD VT 20-249,Evaluation of TaiHao Breast Ultrasound Diagnosis Software,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Crossover Assignment,Not Applicable,No,Yes
UMCC 2021.004,Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors,Completed,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
UPMREB 2021-140-01,Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis,Recruiting,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Phase 2,No,No
KS01,Serratus Plane Block vs Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Unilateral Breast Surgery,Completed,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,Phase 4,No,No
MS-268-2019,Effectiveness of Ultrasound Guided Erector Spinae Plane Block Against Ultrasound Guided Serratus Anterior Block in Modified Radical Mastectomy,Completed,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
BoCCE,Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE),Unknown status,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
875329B,Real-Life Pilot Feasibility Study (LC_RLP_PUC1),Recruiting,Interventional,"Experimental, Experimental","Device, Device",Single Group Assignment,Not Applicable,No,No
MS-536-2021,Dexmedetomidine Versus Dexamethasone as Adjuncts in Erector Spinae Plane Block in Modified Radical Mastectomy,Completed,Interventional,"Experimental, Experimental, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
Gyn F-Chem,Effects of Music or Hypnotherapy on Cancer Patients During Chemotherapy,Terminated,Interventional,"Experimental, Experimental, Placebo Comparator",Other,Parallel Assignment,Not Applicable,No,No
PROICM 2019-06 COH,Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
D3614C00004,A Study to Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
1449,Pre-pectoral Versus Sub-pectoral Implant Placement in Immediate Breast Reconstruction,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CHD22_0002,Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
CLINP-001001,Motiva Flora Tissue Expander PMCF,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
17-VIN-0855,A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition,Unknown status,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,Phase 1,Yes,No
2019-0557,Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients,Completed,Interventional,Experimental,Diagnostic Test,Sequential Assignment,Early Phase 1,Yes,Yes
D0817C00098,Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib,Enrolling by invitation,Interventional,Experimental,Drug,Sequential Assignment,Phase 3,Yes,No
2017-377,The Effect of Double Injection Erector Spinae Plane Block on Postoperative Pain Following Breast Surgery,Completed,Interventional,"Active Comparator, Sham Comparator","Other, Device",Crossover Assignment,Not Applicable,No,No
IZKSZ3_188408 / 1,The DIALOGUE Study: Swiss-Korean Billateral Collaboration,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2018-94,Comparison of Erector Spinae Plane Block With Thoracic Paravertebral Block for Breast Surgery,Completed,Interventional,"Active Comparator, Active Comparator, Other","Device, Other, Other",Crossover Assignment,Not Applicable,No,No
ORIN1001-C1,Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
UMCC 2020.041,Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
H-42207 GAIL-N,C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N),Recruiting,Interventional,"Experimental, Experimental",Genetic,Single Group Assignment,Phase 1,Yes,No
Esogu Anesthesia,Comparison of Erector Spina Plane Block and Thoracic Epidural Block,Completed,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
TED16925,Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Telerehab CH Feasibility,Telerehabilitation Cognitive Impairments Following Chemotherapy Feasibility Study,Recruiting,Interventional,"Experimental, Sham Comparator","Device, Other",Parallel Assignment,Not Applicable,No,No
RPC006,A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.,"Active, not recruiting",Interventional,"Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator","Dietary Supplement, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
BEX15859,"Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women",Completed,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 1,No,No
waitingroom,Anxiety on the First Day of Chemotherapy,Unknown status,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
CP-10-001,In Vivo Smart Biopsy Device Protocol In Radiology,Unknown status,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
REB16-1463,Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors,Unknown status,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,"Phase 2, Phase 3",No,No
UF-STO-ETG-003,Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
UMCC 2020.157,Lighting Intervention for Cancer-related Fatigue,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
OnkoFit II,Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy,Recruiting,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
R7075-ONC-2009,REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CART-TnMUC1-01,A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers,"Active, not recruiting",Interventional,"Experimental, Experimental","Biological, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
PT06-01,A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
2019/2944,Cryotherapy in Breast B3 Lesions,Recruiting,Interventional,,Procedure,Single Group Assignment,Not Applicable,No,No
SPI-POZ-501,A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
LCB-1801-001,A Study of NI-1801 in Patients With Mesothelin Expressing Solid Cancers,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
PECS vs SAP,Comparing the Quality of Analgesia With Pectoral Nerve Block and Serratus Plane Block in Modified Radical Mastectomy,Completed,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
2020-000495-37,"Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer",Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Early Phase 1,No,No
2018-0175,Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo,Unknown status,Interventional,"Experimental, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,Phase 2,Yes,No
012018CONTROL,Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
R19258,The LYSA (Linking You to Support and Advice) Trial,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
2020/03FEV/065,Mechanically-Assisted and Non-Invasive Ventilation for Breathing-related Tumor Motion Mitigation.,Unknown status,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Other","Device, Other",Parallel Assignment,Not Applicable,No,No
2012-001-108,Ramosetron on Late PONV (Postoperative Nausea and Vomiting),Completed,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,Phase 4,No,No
HREC/74777/Alfred-2021,Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
7905,Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
ARX788-1711,"A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)","Active, not recruiting",Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
69HCL18_0492,Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture),Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
BB-1701-101,A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors,Recruiting,Interventional,"Other, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,Phase 1,Yes,No
D9720C00001,Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
XuanWuH-NK,Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
FPX-01-01,A Phase 1/2 Study of [225Ac]-FPI-1434 Injection,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
RAPA-201-STP-01,RAPA-201 Therapy of Solid Tumors,Recruiting,Interventional,Experimental,"Biological, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
HC-404-FCP-2011,A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
assuitu faculty of medicine,Outcomes of Breast Conservative Surgery for Post Chemotherapy Tumour Size After Response to Neoadjuvant Chemotherapy,Recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
STUDY00015358,Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
ONCX-NAV-G201,A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Parallel Assignment,Phase 2,Yes,No
CRUKD/22/002,HMBD-001 in Advanced HER3 Positive Solid Tumours,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
042201,Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
DCC-2036-01-004,A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
NM1F-T1-01,"A First-in-human, Phase I, Open-label, Multicenter Study of NM1F Administered as Monotherapy and in Combination With Pembrolizumab to Patients With Advanced Solid Tumors.",Not yet recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
213409,A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
ICO-2020-06,Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
OMO-103-01,"Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours","Active, not recruiting",Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
849679,RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR),Recruiting,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
UC-0101/1709,Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
ZN-A-1041-101-US,A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
UW21084,Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
TAEK-VAC-HerBy-001,TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,Phase 1,Yes,No
C4161001,PF-07104091 as a Single Agent and in Combination Therapy,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
MORAb-202-G000-201,"A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types",Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
18-27025,SCOPE-Chinese Women Study,Completed,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
19-652,"Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers","Active, not recruiting",Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
BESTa,"Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs",Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
SOLTI-1804,HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a),Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
M19-037,"A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
2020-00256; ch18Weber4,Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC,Recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
OSU-21313,A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer,Recruiting,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,Not Applicable,No,No
AN0025S0103,AN0025 and Pembrolizumab Combination in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
Medipol Hospital 9,Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery,Completed,Interventional,"Active Comparator, Active Comparator, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
69HCL18_0369,Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients,Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
200023,Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
CHANCES-IPC 2021-008,A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
17-694,Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia,Terminated,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
SLS17-201/MK3475-770,Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
AP2207-30110,Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries,Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Drug",Parallel Assignment,Not Applicable,No,No
2015-KAEK-64-22-09,High Intensity vs Low Intensity Resistive Exercise In Patient With Upper Extremity Lymphedema,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
FZPL-Ⅲ-301-OC,A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2022-0329,Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.,Recruiting,Interventional,"Other, Other","Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
CLODIS,Local Compression Seroma DIminution Objective (CLODIS),Unknown status,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,Phase 3,No,No
KE-0254/92/2018,ESP in Breast Surgery Due to Cancer,Completed,Interventional,"Placebo Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure, Procedure, Drug, Drug",Parallel Assignment,Phase 4,No,No
G423 Multi TP,Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.,Completed,Interventional,,Other,Single Group Assignment,Not Applicable,No,No
2019-001982-34,Measuring Oncological Value of Exercise and Statin,Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Drug, Other",Parallel Assignment,Phase 3,No,No
201803061RIND,Ventilation Efficacy of Size 3 or Size 4 I-gel in Female Patient Weighing 50 to 60 Kilograms,Unknown status,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
192004,"KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer",Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,Phase 1,Yes,No
22339,Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors,Not yet recruiting,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Other",Parallel Assignment,Early Phase 1,Yes,No
TAS2940-101,A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Bio2738,Shoulder Rehabilitation Using a Mobile App Following Breast Reconstruction,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
20252,Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
STM-IRB-22B-001,Development and Testing of a TTDSS for Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention","Device, Device",Parallel Assignment,Not Applicable,No,No
21-5539,Rehabilitation for People With Advanced Cancer,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2018-1361,Physical Activity Promotion for Breast and Endometrial Cancer Survivors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Sequential Assignment,Not Applicable,No,No
MC1713,A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ,Recruiting,Interventional,Experimental,"Biological, Biological, Procedure",Single Group Assignment,Phase 1,Yes,No
HREBA.CC-18-0028,The ONE-MIND Study: Evaluating the Efficacy of Online Mindfulness-Based Cancer Recovery During Chemotherapy Treatment,Recruiting,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
E-SN@P PROJECT-IPC 2017-029,Assessment of Outpatient Digital Follow-up of Patients Over 70 Years of Age Undergoing Chemotherapy Treatment,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
PASCA,A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
H-49731,Improving Comprehensive Care of Cancer Patients,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
BrUOG 390,BrUOG 390: Neoadjuvant Treatment With Talazoparib,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
EC/2018/0315,Hormone Replacement Trial Against ALzheimers Disease,Recruiting,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other, Other, Other",Procedure,Parallel Assignment,Not Applicable,No,No
CIMS-2019-01,4FMFES-PET Imaging of Endometrial and Ovarian Cancers,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
XL102-101,Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Dnr 2019-04151,Exercise as Medicine for People With Cancer Sweden,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2021-001624-17,Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy,Recruiting,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
GCO 21-0012,Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials,Recruiting,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2018-0004,Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
823981A,Oncology Episode Payment Model in Hawaii,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
NIT-110 (KEYNOTE PNA60),NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
BT-001.01,A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",No,No
Pro00106186,Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study),Recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
Laser treatment,Laser Treatment of Genito-urinary Syndrome in Women,Not yet recruiting,Interventional,"Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator","Procedure, Device, Device",Parallel Assignment,Not Applicable,No,No
PROICM 2017-05 BAL,Analysis of Circulating Tumor Markers in Blood,Recruiting,Interventional,"Other, Other",Biological,Parallel Assignment,Not Applicable,No,No
Breast Biopsy,The Effect of Education Given at Different Times Before a Breast Biopsy,Completed,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
GOP,Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide,Unknown status,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,Phase 2,No,No
IRB00167074,Sensory Restoration After DIEP Flap Neurotization,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
CDKY709A12101C,Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
IRB#21-001169,Postoperative Opt-In Narcotics Treatment in Breast,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Pro00102260,Hypertension Management in Cancer Patients,Suspended,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
19829,"A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
CE3220.,Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.,Not yet recruiting,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,"Phase 1, Phase 2",No,No
00011271,HeartPhone Cancer Survivors Trial 2019,Terminated,Interventional,Experimental,"Behavioral, Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
METCZ20220056,EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery,Not yet recruiting,Interventional,"Experimental, No Intervention",Device,Single Group Assignment,Not Applicable,No,No
RC31/17/0350,Use of Compression Bandages in the Prevention of Post-mastectomy Lymphoceles,Recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
19-179,Acupuncture Pilot Study for Cancer-related Cognitive Function,"Active, not recruiting",Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,Phase 2,No,No
180276,Promotora Navigator - Culturally Appropriate Patient Navigator,Completed,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
213353,Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer,Terminated,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
ebeddows,Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
IFCT-1703,Her2-positive Lung Cancer Treated With Dedicated Drug,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CS001-SA,Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
MSK8/22,The Effect of Rhomboid Intercostal Block and Serratus Anterior Plane Block on Postoperative Respiratory Functions,Not yet recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
JAB-2485-1001,JAB-2485 Activity in Adult Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
BA3021-001,CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2),Recruiting,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,"Phase 1, Phase 2",Yes,No
2020-05-001B,Regional Anesthesia in Breast Surgery,Unknown status,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
PRT2527-01,A Study of PRT2527 in Participants With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
13104,Tranexamic Acid for Alloplastic Breast Reconstruction,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
RECHMPL22_0024,Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC),Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
21-369,A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer,Recruiting,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
120134,NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT,Not yet recruiting,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,Not Applicable,No,Yes
Pro00078230,Erector Spinae Plane Block Versus Paravertebral Block,Completed,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Drug, Drug, Drug",Parallel Assignment,Not Applicable,No,No
18-000948,Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.,Completed,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,Not Applicable,No,No
20-08,Prospective Case Collection Study for New Mammography Technologies,Recruiting,Interventional,"Other, Other",Device,Single Group Assignment,Not Applicable,No,Yes
AP2001-50504,Erector Spinae Block Versus PECS Block Type II for Breast Surgeries,Completed,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,Not Applicable,No,No
FMBSURECS/30042019/Ali,Efficacy of Serratus Anterior Plane Block Mastectomy,Completed,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,Not Applicable,No,No
21-192,TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance),Completed,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
SBT6290-101,A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
CRYO for Mastectomy (DoD),Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy,Enrolling by invitation,Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
FMASUMD45/2021,Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,"Phase 2, Phase 3",No,No
PT3465,Effect of Thera Band Exercises on Adhesive Capsulitis Post Mastectomy,Completed,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
Lishui Peoples Hospital,Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
HAN2014005-CT02,"Evaluation of the Efficacy and Safety of A High Molecular Weight, Natural Hyaluronic Acid Vaginal Gel in Women With Genitourinary Syndrome of Menopause",Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
SHEBA-19-6136-RS-CTIL,Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors,Unknown status,Interventional,"Active Comparator, Active Comparator",Combination Product,Sequential Assignment,Phase 1,No,No
GS-US-417-5937,Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,Phase 1,Yes,No
2021/01159,Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI,Not yet recruiting,Interventional,Experimental,"Device, Device, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
SOGUG-2016-A-IEC(PRO)-12,Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL),Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
PPP005-Ph2/3-01,Cannabis Oil and Radiation Therapy for the Management of Pain,Terminated,Interventional,"Experimental, Placebo Comparator","Radiation, Radiation",Parallel Assignment,Phase 2,No,No
AAAS9968,Hair Care Product Use Among Women Of Color,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
METCZ2019016,Seroma Reduction and Drain Free Mastectomy,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
HSL 2016-83,Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.,Unknown status,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
IMM2902-101,"IMM2902, a HER2/SIRPα Bispecific mAb-Trap Antibody-receptor Fusion Protein, in Patients With HER2-expressing Advanced Solid Tumors",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
NOX66-005,A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Radiation",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CCR5063,Evaluation of an Educational Intervention for Women With Breast Pain,Unknown status,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,Not Applicable,No,No
BGB-3111-108,A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
2020/14MAI/273,Serum Neurofilament Light (NFL) in Surgery Under General Anaesthesia (GA) Compared to Surgery With Hypno-analgesia (Hyp),Recruiting,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
B4T2-PRC-IIT-001,A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
PROACTIVE,"Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 4,No,No
875351,Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Phase 2,No,No
CX-839-011,Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
16-010491,Preventing Lymphedema in Axillary Lymph Node Dissection,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
INT17676,A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects,Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
ESG401-101,Study of ESG401 in Adults With Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
GS-US-382-1587,Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
20221202,Primary Lesion Treatment for Bone Metastases,Not yet recruiting,Interventional,"Experimental, Experimental, No Intervention","Radiation, Procedure",Parallel Assignment,Not Applicable,No,No
KSCM-CRD-001,KeraStat(R) Cream for Radiation Dermatitis,Completed,Interventional,"Other, Experimental","Device, Other",Parallel Assignment,Not Applicable,No,Yes
201707042,Diagnostic US for Reduction of Benign Breast Biopsies Using US-guided Optical Tomography,Recruiting,Interventional,"Experimental, Experimental",Device,Sequential Assignment,Not Applicable,No,Yes
201810102MINC,Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?,Unknown status,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 4,No,No
1237087,A Mind-Body Intervention for Hot Flash Management,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
P.T.REC/012/003747,Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
GIHSYSU-26,"RC48 Plus Tislelizumab, Low-dose Capecitabine and Celecoxib for HER2-positive Metastatic Colorectal Cancer",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GO-1,SHARON: A Clinical Trial for Metastatic Cancer With an Inherited BRCA or PALB2 Mutation Using Chemotherapy and Patients Own Stem Cells,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Device",Single Group Assignment,Phase 1,Yes,Yes
BRCA-ACP.2022,Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers,Not yet recruiting,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
JK08.1.01,"A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
NC762-01,A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
PARPA-293-001,Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
INT 36/18,Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
17237,HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
MER-XMT-2056-1,A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2,Suspended,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
ZL-2306-912 ALTER-OC-02,Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors,Unknown status,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
CEP1:4/2016,BRCA Main Home Nutritional Intervention-random Study,Unknown status,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,Not Applicable,No,No
Chemobrain Study,Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies,Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
XB002-101,Study of XB002 in Subjects With Solid Tumors (JEWEL-101),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
KlusPharma,Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
AJIRB-MED-THE-18-236,Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG,Completed,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,"Phase 1, Phase 2",No,No
JTU-6H-20210227001,Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery,"Active, not recruiting",Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
69HCL22_0275,Control Cohort CTRL COH,Not yet recruiting,Interventional,Other,Biological,Single Group Assignment,Not Applicable,No,No
REPLAMOD,Histological Modifications of Postmenopausal Vaginal Mucosa After Repeated Carbon Dioxide (CO2) Laser Treatment,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
BTC-HER2,Trastuzumab in HER2-positive Biliary Tract Cancer,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
CASE2117,Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer,Withdrawn,Interventional,"Active Comparator, Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
H-38855,Ruxolitinib for Premalignant Breast Disease,Recruiting,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
4-2019-0648,Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
TG-iConquerFear,Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
TCM-padia001,Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese Medicine,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
GO43860,"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
C/35/2017,MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,No,No
2018-003115-21,Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors,Withdrawn,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
EC29,Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase,Recruiting,Interventional,"Placebo Comparator, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
2021/117,Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia,Recruiting,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
Health consortium maresme,Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain,Recruiting,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,Not Applicable,No,No
HS-10502-101,A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
STUDY00023183,Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer,Enrolling by invitation,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
DCC-2036-01-003,A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
E-19-3943,Erector Spina Plane Block Versus Deep Serratus Anterior Plane Block for Post Mastectomy Analgesia,Completed,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CASE6118,Free Flap Breast Reconstruction Using Virtual Surgical Planning and 3-D Modeling,"Active, not recruiting",Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
MCART-006,Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
PRO1184-001,PRO1184 for Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
ONC-392-001,"Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
BPI-2358-105 phase 3,Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3,Completed,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,Phase 3,Yes,No
HCC 20-064,Telehealth and Memory Study,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
E-19-773,"A Randomized Controlled Trial to Evaluate the Efficacy of Acupuncture Versus Aromatherapy as Treatments to Lessen Nausea, Vomiting and Anxiety Associated With Adriamycin and Cytoxan",Recruiting,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
STUDY00003387,Exercise and Nutrition Interventions During Chemotherapy K07,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Phase 2,No,No
MCART-002,Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Early Phase 1,No,No
SBT6050-201,A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
ARRAY-818-103,Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
MC210302,Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer,Recruiting,Interventional,Experimental,"Procedure, Procedure, Drug, Procedure",Single Group Assignment,Early Phase 1,Yes,No
QSPainRelief-patientCNS,"QSPainRelief-patientCNS : Clinical Biomarkers of Nociception, Sedation and Cognition",Not yet recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Single Group Assignment,Not Applicable,No,No
CARTIER,Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial),Recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
The Swedish DIRECT study,Direct Information to At-risk Relatives,Enrolling by invitation,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
CKAF156A2104,"Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir",Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Combination Product, Drug, Drug, Drug, Combination Product",Sequential Assignment,Phase 1,No,No
Elasto Trial,Comparison of Real-time and Shear Wave Elastography,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,Not Applicable,No,No
N201810002,Spirulina (FEM-102) Supplement to Chronic Hepatitis B Patients,Completed,Interventional,"Other, Experimental, Experimental",Dietary Supplement,Parallel Assignment,Not Applicable,No,No
MastoVit150,Possibilities of Phytomedicine in Monotherapy of Benign Breast Diseases,Completed,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 4,No,No
CASE1219,Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
RELI/19/Der-Rdt/001,Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.,Completed,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,No
GS-US-467-5643,"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
PRO00031416,Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors,Recruiting,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,Not Applicable,No,No
7635,Cannabinoids for Taxane Induced Peripheral Neuropathy,Terminated,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 2,Yes,No
VAC for HPV,Video-Assisted Counseling for HPV Vaccination,Unknown status,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ONCB-006-19F,Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
70781,Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover,Recruiting,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
1407426,Family History Study on Cancer Risk,Recruiting,Interventional,"Other, Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
PRS-343-PCS_08_18,PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
NL72939.078.20,Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?,Recruiting,Interventional,"Other, Other",Procedure,Parallel Assignment,Not Applicable,No,No
HCI105691,Fatigue Interventions in Cancer (Exercise Intervention),"Active, not recruiting",Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Phase 2,No,No
AP2007-50104,Comparison of Duloxetine Versus Pregabalin,Unknown status,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
PRO00032593,Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy,Terminated,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
H00020209,Dotarem vs Gadobutrol Contrast for Breast MRI,Recruiting,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
BG01-2002,Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
Rhomboid,Analgesic Effects of Rhomboid Block,Recruiting,Interventional,"Experimental, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
GC101 TIL-ST-01,A Phase I Study on Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) for the Treatment of Advanced Malignant Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
IM014-032,Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 1,Yes,No
CEEGOG EX-02,Tracers for Endometrial Cancer Sentinel Node Labeling,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
93 /1801/2021,Lifting Effect on Recovery After Mastectomy,Not yet recruiting,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2020-3627-1407,"SSI Rates in Patients Undergoing Mastectomy Without Reconstruction- A Multicenter, Double-blinded RCT.",Unknown status,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
OTH267,Iraqi Trial for Lung Cancer Screening,Unknown status,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
MF 22-02,Idiopathic Granulomatous Mastitis Combination Therapy,Recruiting,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
2019-0989,Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physicians Choice (TPC) in Patients With HER2-positive Solid Tumor,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
UCSD IIT 150729,Histology-Independent Study of Palbociclib in Patients With Advanced Cancer,Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
P.T.REC/012/003464,Impact of Scapular Mobilization And Strengthening Exercises on Shoulder Function Post Mastectomy,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
BPX603-201A,Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
KEEP-G 07,Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
2021-0611,"Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases",Recruiting,Interventional,"Other, Other, Other","Drug, Drug",Single Group Assignment,Phase 2,Yes,No
13022260-300-180785,Effect of Exercise in the Management of Peripheral Neuropathy,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
INCB 123667-101,Study of INCB123667 in Subjects With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
ICO-2020-19,Clinico-biological Data Collection Study of Metastatic Lung Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,Not Applicable,No,No
CRUKD/21/004- Treatment Arm 4,"DETERMINE Trial Treatment Arm 4: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations",Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 2, Phase 3",No,No
NU22-09-00539,Prostate Cancer Screening With Abbreviated MRI Protocol,Recruiting,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Procedure",Single Group Assignment,Not Applicable,No,No
2019-A03336-51,Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy,Recruiting,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
09.2020.125,Efect of Erector Spina Plane Block on Mastectomy,Completed,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
ANAE-341-19,Improving Tissue Oxygenation in Breast Reconstruction Surgery,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,"Phase 1, Phase 2",No,No
01-2/141 27,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,Completed,Interventional,"Active Comparator, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
KF2019#1,KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug,Recruiting,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug, Drug",Crossover Assignment,Phase 1,No,No
Vein-project,Training of Arms to Reduce Pain With Peripheral Venous Catheter,Recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
thoracic sympathectomy,Radiofrequency Thoracic Sympathectomy for Chronic Postmastectomy Pain; Randomized Placebo Controlled Study,Completed,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,Not Applicable,No,No
20-240,Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases,Recruiting,Interventional,"Experimental, Experimental","Radiation, Drug, Other",Parallel Assignment,Phase 2,Yes,No
Debio 1143-106,Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143,Completed,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
457,Diagnostic Value of Bronchoscopic and Thoracoscopic Frozen Section Biopsies in Patients With Pleuropulmonary Tumors,Not yet recruiting,Interventional,Other,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
D8410C00001,Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
229510,Combination Therapy in Cancers With Mutations in DNA Repair Genes,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Estim Breast,Electrical Stimulation for Improving Postoperative Breast Sensation,Not yet recruiting,Interventional,"Experimental, Placebo Comparator","Device, Procedure",Single Group Assignment,Not Applicable,No,No
YS-RVON-001,Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
RG1006143,Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization,Completed,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,Not Applicable,No,No
ZL-2306-914,Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
SNK01-102,Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers,Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
C4551001,Study of PF-07248144 in Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
ONT-380-011,Effects of Tucatinib on Cardiac Repolarization in Healthy Participants,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,Phase 1,Yes,No
KCSG-ST18-20,AZD8186 and Paclitaxel in Advanced Gastric Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",No,No
HCC 20-117,GIST and Memory and Attention Adaptation Training,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
HEM-ONCO-013,CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
STUDY00002021,Study of Sulphoraphane in Chronic Kidney Disease,Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",Yes,No
22-501,Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC),Enrolling by invitation,Interventional,"Experimental, No Intervention, Experimental, Experimental","Other, Other",Factorial Assignment,Not Applicable,No,No
OLATRA,Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ELVN-002-001,ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
FN-1501-UP1,A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
RBN-2397-19-001,"Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors",Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
STUDY00000334,Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers,Completed,Interventional,"Other, No Intervention",Device,Single Group Assignment,Not Applicable,No,Yes
OPT-IN Research Protocol,"Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring",Recruiting,Interventional,,Other,Single Group Assignment,Not Applicable,No,No
2017-A02018-45,OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients,Unknown status,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
CX-5461-04,"Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
MC16C2,Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Crossover Assignment,Early Phase 1,Yes,No
NL75863.068.21,Magtrial: Magtrace® as Tracer for Sentinel Lymph Node Detection in Early Stage Epithelial Ovarian Cancer,Not yet recruiting,Interventional,"Experimental, Experimental",Device,Parallel Assignment,Not Applicable,No,No
20-009,Pre-consultation Compassion Among Patients Referred to a Cancer Center,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
PUMCH-NM-11/041,68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
ISU104-001,"Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,Phase 1,No,No
BR/2019/487,Binaural Music Study,Completed,Interventional,"No Intervention, Other, Other",Other,Parallel Assignment,Not Applicable,No,No
ATADEK/2022.11,Genital Laser Treatment in Postmenopausal Patients,Not yet recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
60116787-020/34123,Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
CHUB-Hystocor,Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer,Withdrawn,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
BLU-222-1101,(VELA) Study of BLU-222 in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
CHUBX 2015/17,Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT,Completed,Interventional,"Other, Other",Procedure,Parallel Assignment,Not Applicable,No,No
1766419-7,Storytelling Intervention for African Americans Living With Hypertension,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
NUV-868-01,NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
436,Effects of Clinical Pilates Exercises in Patients With Rheumatoid Arthritis,Unknown status,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
200155,"Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta Trap/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2021-BRV-004,Scaffold-guided Breast Surgery,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
EJC001,Compassion Meditation for Cancer Survivor-Caregiver Dyads,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,"Phase 1, Phase 2",No,No
PHOX-CLI_001,"First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
NICSO,NICSO National Study: Physician - Nurse Monitoring Project About Oncological Adverse Events,Completed,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
BJK-Z-F18HN-202010-YZGK,Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT,Completed,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,Phase 3,No,No
A-ER-109-415,Effect of Reconditioning Exercise on Older Adults With Urinary Tract Cancer Following Curative Surgery,Recruiting,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
2-107-05-162,Investigation of the Strategy of Preventing Post-operative Opioid-induced Hyperalgesia,Unknown status,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 4,No,No
20.60-onco20.07,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
YBCSG-21-04,Granisetron Transdermal Patch for Prophylaxis of Delayed CINV,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,No,No
SamanRostambeigi,Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
20190131,Study of AMG 650 in Adult Participants With Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
IRB00038262,"The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems",Terminated,Interventional,"Other, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Device, Other, Other",Factorial Assignment,"Phase 2, Phase 3",Yes,No
IRB00095260,Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
TapeK_Gesso_ABM_PSO,Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture.,Unknown status,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
29BRC18-0005 (VinMetAtezo),Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
OPTIMUM,Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
2017-003582-10,Immunotherapy In Locally Advanced Rectal Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,Phase 2,No,No
2017_43,Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases,Recruiting,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
4397,Social Risk Factors and Discrimination in Cancer Survivorship,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
00000001,Effects of Selected Exercise Program on Microcirculation and Lymphedema in Postmastectomy Patients,Not yet recruiting,Interventional,"Experimental, Other",Combination Product,Parallel Assignment,Not Applicable,No,No
IRB-2019-118,Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery,Recruiting,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,Yes
RGC-1501-001,Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
20-03021615,FaCT Trial (Facilitated Cascade Testing Trial),Recruiting,Interventional,"Other, Other","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
210026,Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma,Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
702576,Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo,Recruiting,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,Phase 4,Yes,No
MT-5111_001,Study of MT-5111 in HER2-positive Solid Tumors,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
2020-1255,High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies,Recruiting,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
RC2022_prg.15,Evaluation of the Effects of Orange Consumption on Carbohydrate and Lipid Metabolism in Subjects With MAFLD (Metabolic Associated Fatty Liver Disease),Recruiting,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,Not Applicable,No,No
UW 19-436,A Resilience Promotion Program for Parents of Children With Cancer,Completed,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
EDGE 000339,"SHIFTPLAN: an RCT Investigating the Effect of a Shift Work Intervention on Fatigue, Sleep and Health.",Not yet recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
METCZ20210156,Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
2000031462,Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
METCZ20210103,Sentinel Lymph Node Mapping Using Magtrace and MRI in Healthy Subjects for Potential Use in Melanoma Patients,Completed,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
2017/184 HP,VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
20-002000,Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer,"Active, not recruiting",Interventional,Experimental,"Behavioral, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
18.068,PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Phase 3,No,No
2020-3547,Impact of Aerobic Exercise on Immune Response and Side Effects of Cancer Treatments,Completed,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Crossover Assignment,Not Applicable,No,No
CTM-N2D,Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour,Unknown status,Interventional,Experimental,Biological,Sequential Assignment,Phase 1,No,No
IMT-009-101,Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
B.30.2.ATA.0.01.00/1/6,Ultrasound-guided Paravertebral Block Versus Mid-point Transverse Process Pleura Block in Mastectomy Surgery,Completed,Interventional,"Experimental, Active Comparator","Drug, Device, Drug, Drug",Parallel Assignment,Phase 4,No,No
SYSKY-2022-019-02,Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC,Recruiting,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
CHGH-IRB:(864)110-10,The Effect of Nursing Education Intervention on Womens Health Literacy of Plasticizers,Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
PROT-CI2021,US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism,Not yet recruiting,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
CP-MGC018-01,MGC018 With or Without MGA012 in Advanced Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",Yes,No
RTX-224-01,RTX-224 Monotherapy in Patients With Solid Tumors,Terminated,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
2021-A01625-36,Clinical and Cyto-histological Evaluation of Fractional CO2 Laser Treatment on Genito-Urinary Syndromes of Menopause Related to Vaginal Atrophy,Recruiting,Interventional,Other,Device,Single Group Assignment,Not Applicable,No,No
SGNB7H4V-001,A Study of SGN-B7H4V in Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
P130935,"Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
2000029793,Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
794/2020/Farm/IOR,Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
SBNK-YJ-2020-016-02,Study of Recombinant Human Endostatin Combined With CV Regimen in the Treatment of Pediatric Low-grade Gliomas,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
ThirdMMUb,Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 2, Phase 3",No,No
2693-CL-0307,A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,No,No
2020NZKY-062-01,The Effects of Intraoperative Esketamine on Postoperative Pain and Mood in Patients With Inflammatory Bowel Disease,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 4,No,No
2021-13614,Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color,Recruiting,Interventional,"Experimental, Experimental, No Intervention","Device, Device",Parallel Assignment,Not Applicable,No,Yes
MER-XMT-1660-1,A Study of XMT-1660 in Participants With Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
no: P.T.REC/012/002774,"Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological Changes",Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
SBNK-YJ-2019-006-02,Study of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent Gliomas,Recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
2020/900/88,Assessment of the Efficacy of Injectable Hyaluronic Acid for Genitourinary Syndrome of Menopause,Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
DF1001-001,Study of DF1001 in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
STUDY00000224,Connecting Families to Overcome Ovarian Cancer,Recruiting,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2693-CL-0304,A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause,Completed,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ZUH-ITP-MBCS,ITP Block: Single or Multiple Injection?,Recruiting,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,Phase 4,No,No
1 TP2AH000076-01-00,Evaluation of Momentary Affect Regulation - Safer Sex Intervention,Recruiting,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
21-007867,Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers,"Active, not recruiting",Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
Masters thesis,The Effect of Art-Based Mandala on Mental Health in Bone Marrow Transplant Patients,Completed,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
CPI-006-001,CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
RG1001812,Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants,Completed,Interventional,Experimental,"Dietary Supplement, Procedure, Other",Single Group Assignment,Not Applicable,No,No
25922,Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition,Not yet recruiting,Interventional,Experimental,Other,Sequential Assignment,Not Applicable,No,No
2693-CL-0305,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2021-A01570-41,Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2693-CL-0302,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2,Completed,Interventional,"Experimental, Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
2693-CL-0301,A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause,Completed,Interventional,"Placebo Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
PUMCH-NM-RR,68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,Early Phase 1,No,No
1-1-7-05-114,Decision Support for the Renal Replacement Therapy With End-stage Renal Disease,Completed,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
ALXN2040-HV-102,Potential Drug Interaction Between ALXN2040 and Rosuvastatin,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,Yes,No
NCI-2020-01206,Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer,Recruiting,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,Phase 1,Yes,No
21083,Narrative Exposure Therapy to Reduce Symptoms of Traumatic Stress in Cancer Survivors,"Active, not recruiting",Interventional,Experimental,Other,Sequential Assignment,Not Applicable,No,No
STUDY00144314,KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice,Recruiting,Interventional,"Active Comparator, Experimental",Behavioral,Single Group Assignment,Not Applicable,No,No
19-068,OPTimizing Treatment Focused Genetic Testing IN Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
69HCL21_0409,"CAncer, NUtrition and Taste 2",Recruiting,Interventional,"Experimental, Active Comparator","Other, Other, Other, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
D8532C00003,A Study to Assess the Pharmacokinetics of Camizestrant (AZD9833) When Administered Alone and in Combination With Itraconazole,Completed,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 1,No,No
UC-0107/1603,Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 3 Bone-only Metastases,Recruiting,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,Not Applicable,No,No
AK_2021_HP,Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients,Enrolling by invitation,Interventional,Experimental,"Drug, Drug, Procedure",Single Group Assignment,Phase 2,No,No
C4391001,Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Combination Product, Combination Product, Drug, Combination Product",Sequential Assignment,"Phase 1, Phase 2",Yes,No
ICO-2020-14,"Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery",Recruiting,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Drug",Parallel Assignment,Not Applicable,No,No
20-2458.cc,Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.,Recruiting,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
844554,TumorGlow Intraoperative Molecular Imaging (IMI),Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,"Phase 1, Phase 2",Yes,No
GCT1047-01,Research Trial to Study Safety of GEN1047 (DuoBody®-CD3xB7H4) in Participants With Malignant Solid Tumors,Recruiting,Interventional,Experimental,Biological,Sequential Assignment,"Phase 1, Phase 2",Yes,No
659/2017BO1,Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Diagnostic Test",Single Group Assignment,Not Applicable,No,No
HSC-SPH-20-1117,Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
XL092-001,A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
PH-FAPGA-01/22,A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
GCT1029-01,GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors,Terminated,Interventional,Experimental,Biological,Sequential Assignment,"Phase 1, Phase 2",Yes,No
FPA150-001,FPA150 in Patients With Advanced Solid Tumors,Completed,Interventional,Experimental,"Biological, Biological",Single Group Assignment,Early Phase 1,Yes,No
HEALED_CPS3,Health and Energy Through Active Living Every Day (HEALED) After Cancer Pilot Intervention for Cancer Survivors,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
IMP7068 - 101,The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Other,Drug,Sequential Assignment,Phase 1,Yes,No
PY314-1-01,A Study of PY314 in Subjects With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
LAUMCRH.YJ1.16/Jul/2019,Effect of Dexmedetomidine on the Duration of Pain Control in ESP Block for Breast Surgery,Unknown status,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,Phase 4,Yes,No
1474/19,Trigger Point Injections for Post-Mastectomy Pain Syndrome,Recruiting,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure, Other",Parallel Assignment,Phase 2,No,No
CNZV930X2101,A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Drug",Parallel Assignment,Phase 1,Yes,No
TirolGESUND,"TirolGESUND: Baseline-controlled Comparison of the Effects of Fasting Dietary Intervention or Smoking Cessation Combined With Exercise in Healthy Female Tyrolean Volunteers Aged 30-60 on Epigenetic and Multi-omic Biomarkers of Health, Ageing, and Disease","Active, not recruiting",Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
R20-3896L,PECS Block in Partial Mastectomy for Postoperative Pain Control,Unknown status,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
69HCL19_0992,Interest of Virtual Reality to Prevent Cancer Patient Anxiety Before Chemotherapy or an Invasive Act,Recruiting,Interventional,Other,Behavioral,Single Group Assignment,Not Applicable,No,No
201805930,Comparison of Pre-op and Post-op Pectoralis Nerve Block,Completed,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
2018-0075,Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 2,Yes,No
IRB-300003680,Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Early Phase 1,Yes,No
HSC-MS-16-0467,Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies,Withdrawn,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
2021/03-12,Effects of US-guided SAPB During Breast Surgery,Completed,Interventional,"Active Comparator, No Intervention",Procedure,Crossover Assignment,Not Applicable,No,No
VAR-2021-12,Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
WVU010518,Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy,Suspended,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Not Applicable,No,No
NUSMart NM,Evaluating the Relative Effectiveness of Two Front-of-pack Nutrition Labels,Completed,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,Not Applicable,No,No
XmAb22841-01,A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,Phase 1,Yes,No
SC103,Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
ACE1702-001,ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
RP12146-2101,"Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, a PARP Inhibitor, in Patients With Locally Advanced or Metastatic Solid Tumors",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
RG1005815,"Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study",Enrolling by invitation,Interventional,"Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
MP01,Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
5688,Psychosocial Transitional Group Pragmatic Trial,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
RG1005140,"Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer",Recruiting,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 1,Yes,No
BT8009-100,Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Solid Tumor Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
HN20190929,PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,No,No
STUDY00018000,EXERCISING TOGETHER for Couples Coping With Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Other, Other",Parallel Assignment,Not Applicable,No,No
00003543,Comorbidities And Reducing inEquitieS,"Active, not recruiting",Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
OSU-19199,Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM),Recruiting,Interventional,Experimental,"Procedure, Other, Device",Single Group Assignment,Not Applicable,No,Yes
KB-0742-1001,A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
GQ1001X2101,Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
21820,"A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
NL 70691.091.19,TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention,Recruiting,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
ORM-5029-01-001,Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
NCI-2017-01232,PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery,"Active, not recruiting",Interventional,Experimental,"Drug, Other, Other, Drug",Single Group Assignment,Phase 1,Yes,No
PRT3645-01,A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
HMBD-002-V4C26-01,"A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
RG1121550,Clinical Outcomes for Offering Genetic Testing in a Tiered Approach,Completed,Interventional,Experimental,"Other, Other, Behavioral",Single Group Assignment,Not Applicable,No,No
KYL[2020091],Surgical Intervention for Refractory Granulomatous Lobular Mastitis,Recruiting,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
TJ004309STM103,A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
AP1904-50102,Magnesium and Ketamine in Postoperative Analgesia,Completed,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 4,No,No
GCT1044-01,A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors,Terminated,Interventional,Experimental,Biological,Sequential Assignment,"Phase 1, Phase 2",Yes,No
SZMC-0216-22,A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC,Not yet recruiting,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
7465-CL-202,A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202),"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
ELU-FRα-1,A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα),Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
D17062,Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity,Completed,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,Yes
SGNPDL1V-001,A Study of SGN-PDL1V in Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
SAIL-002,Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 4,No,No
101,CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 1,Yes,No
ASN004-101,Study of ASN004 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
C3881001,PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
TT420X1103,Study of TT-00420 Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Combination Product",Parallel Assignment,"Phase 1, Phase 2",Yes,No
RP2-001-18,Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,Phase 1,No,No
STUDY00020679,SMMART Adaptive Clinical Treatment (ACT) Trial,Not yet recruiting,Interventional,Experimental,"Procedure, Procedure, Biological, Drug, Biological, Biological, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other",Single Group Assignment,Phase 2,Yes,No
21-508,Video Education With Result Dependent dIsclosure,Recruiting,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
CPG-01-001,COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
TJCC-LC-20190108,Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC,Unknown status,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 4,No,No
2000026840,Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Combination Product",Single Group Assignment,Phase 2,Yes,No
INCB 106385-102,INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
GCT1046-01,GEN1046 Safety Trial in Patients With Malignant Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",Yes,No
127-CL-01,Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product",Sequential Assignment,Phase 1,No,No
KY1044-CT01,Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
UAB30,A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer,Recruiting,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
MCC-20086,Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance,Completed,Interventional,"No Intervention, Experimental, No Intervention",Behavioral,Sequential Assignment,Not Applicable,No,No
Oncoplastic breast surgeries,The Role of Lipofilling After Oncoplastic Breast Surgeries : Evaluation of Outcomes and Patient Satisfaction,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
XmAb20717-01,A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors,Completed,Interventional,Experimental,Biological,Sequential Assignment,Phase 1,Yes,No
PBC017,Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
NCI-2017-01979,"Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery",Withdrawn,Interventional,Experimental,"Drug, Biological, Other, Biological, Other",Single Group Assignment,"Phase 1, Phase 2",Yes,No
Pro20170001392,"Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability",Recruiting,Interventional,Experimental,"Other, Biological",Single Group Assignment,Phase 2,Yes,No
A005D-E01-201,[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR),Terminated,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
TAP_Sett17,Kinesio Tex Tape in Reducing Edema and Seroma After Complex Reconstructive Breast Surgery,Unknown status,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,Not Applicable,No,No
CPO-100-US-101,Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
20-117,Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Other","Radiation, Radiation, Other, Other",Parallel Assignment,Phase 2,No,Yes
19-002006,Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer,"Active, not recruiting",Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,Early Phase 1,No,No
Plasticity Longitudinal cANcer,Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET),Recruiting,Interventional,"Experimental, Experimental, Experimental",Biological,Parallel Assignment,Not Applicable,No,No
2021-025,Ask Questions (ASQ):Implementation of a Communication Intervention,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
ATRC-101-A01,A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug",Sequential Assignment,Phase 1,Yes,No
ST101-101,A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
190143,Non-Viral TCR Gene Therapy,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Biological",Single Group Assignment,Phase 2,Yes,No
CYT-0851-01,A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
MC210102,"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study",Recruiting,Interventional,Experimental,"Drug, Biological, Biological, Biological",Single Group Assignment,Phase 1,Yes,No
17573,A Study of Lasmiditan in Healthy Volunteers,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
NCI-2020-13883,"Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial",Recruiting,Interventional,Experimental,"Drug, Biological",Single Group Assignment,Phase 1,Yes,No
TT00420CN04,To Evaluate Efficacy and Safety of TT-00420 as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
ONCR-177-101,"Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,Phase 1,Yes,No
SGNSTNV-001,A Study of SGN-STNV in Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
2021-0299,Tumor Treating Fields Therapy in Combination With Chemotherapy for the Treatment of Advanced Solid Tumors Involving the Abdomen or Thorax,Recruiting,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Procedure",Parallel Assignment,Phase 1,Yes,Yes
SKL27969C001,"Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients",Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
ACE-Pan tumor-02,ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02),Withdrawn,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
HCC 20-266,Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC),Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
D9090C00003,A Study to Assess the Effect of Multiple Doses of AZD5462 on the Pharmacokinetics (PK) of Drugs in Healthy Participants,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
FT500-101,FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
17364,A Study of LY3435151 in Participants With Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
NCI-2020-06906,Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations,Recruiting,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,Phase 2,Yes,No
IDE161-001,A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
AK2018_1,18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer,Completed,Interventional,Experimental,"Drug, Other",Single Group Assignment,Phase 1,No,No
FT536-101,FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,Phase 1,Yes,No
STUDY00000719,Adaptive Symptom Self-Management Immunotherapy Study,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Sequential Assignment,Not Applicable,No,No
JZP712-201,Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
TMPS-101,Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
CancerDyads,Improving Survivorship Among Minority Cancer Dyads,Withdrawn,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
00000441,Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction,Unknown status,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
CCI-2003,Study of MEM-288 Oncolytic Virus in Solid Tumors Including Non-Small Cell Lung Cancer (NSCLC),Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
SGNB6A-001,A Study of SGN-B6A in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,Phase 1,Yes,No
MLB-PK-001,A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer,Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
XmAb23104-01,A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3),Recruiting,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,Phase 1,Yes,No
2020-0439,Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
CYH33-G102,Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
20-410,Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer,"Active, not recruiting",Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
202101,Comprehensive Outcomes for After Cancer Health,Recruiting,Interventional,"Experimental, Other","Behavioral, Device",Crossover Assignment,Not Applicable,No,No
NB-ND021 (NM21-1480)-101,A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Biological,Sequential Assignment,"Phase 1, Phase 2",Yes,No
SBT6050-101,A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
17-262-01,REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies,Terminated,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
UC-IMM-2101,Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO,Recruiting,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,Phase 3,No,No
ADCT-301-103,Study of ADCT-301 in Patients With Selected Advanced Solid Tumors,Terminated,Interventional,"Experimental, Experimental, Experimental","Drug, Biological",Sequential Assignment,Phase 1,Yes,No
170177,Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer,Terminated,Interventional,Experimental,Biological,Single Group Assignment,Phase 2,Yes,No
TPST-1120-001,TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
180032,Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer,Completed,Interventional,"Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,Phase 1,Yes,No
VICC SUPP 2112,Improving Care After Inherited Cancer Testing,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
IB2022-03,Streamlined Geriatric and Oncological Evaluation Based On IC Technology,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,Not Applicable,No,No
PR148/21,Axillary Lymph Node Dissection vs Axillary Radiotherapy in Positive Sentinel Node After Neoadjuvant Therapy,Recruiting,Interventional,"Experimental, Active Comparator","Radiation, Procedure",Parallel Assignment,Not Applicable,No,No
A9001502,Treatment Resistance Following Anti-cancer Therapies,Terminated,Interventional,Other,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
2020-117,DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer,Recruiting,Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
NCI-2020-05428,"Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer",Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
2021-0175,Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors,Withdrawn,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
CCT303-406-mST01,A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
6B-20-1,18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases,"Active, not recruiting",Interventional,Experimental,"Procedure, Drug, Procedure, Procedure",Single Group Assignment,Early Phase 1,Yes,No
NRG-BN009,Testing the Addition of Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Radiation, Radiation",Parallel Assignment,Phase 3,No,No
TCR2-21-01,A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer,Recruiting,Interventional,Experimental,"Biological, Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",Yes,No
NCI-2020-05956,Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV,Recruiting,Interventional,Experimental,"Procedure, Drug, Procedure, Procedure, Biological",Single Group Assignment,Phase 1,Yes,No
CA052-002,A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
IMX-110-001,IMX-110 in Patients With Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
IIR 17-127,Measuring and Improving the Safety of Test Result Follow-Up,"Active, not recruiting",Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
WPH 2201,A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
IRB20-0462,The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care,Recruiting,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,Not Applicable,No,No
XmAb808-01,"Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors",Recruiting,Interventional,Experimental,"Biological, Biological",Sequential Assignment,Phase 1,Yes,No
2019-1091,Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases,"Active, not recruiting",Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,"Phase 1, Phase 2",Yes,No
VAR-2022-04,Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy,Not yet recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
Phase 1 SV-101,Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
NYPC ERC# 2019-002,Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention",Radiation,Single Group Assignment,Not Applicable,No,Yes
TTX-080-001,TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
P.T.REC/012/003744,Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema,Recruiting,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
P.T.REC/012/004199,Effect of Wii-console Based Exercise on Shoulder Range of Motion for Post-mastectomy Lymphedema Patients,Recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
Doaa Atef,Virtual Reality Versus Proprioceptive Neuromuscular Facilitation on Postmastectomy Lymphedema,Completed,Interventional,"Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
0752-20-HMO,Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers,Recruiting,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
OCEL-01,A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,"Phase 1, Phase 2",No,No
ILBS-VASMPCa-103,Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects .,Completed,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
NuTide:303,NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours,Not yet recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
IC 2020-11_ALCINA4,Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4,Recruiting,Interventional,"Other, Other, Other, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
AMT-151-01,AMT-151 in Patients With Selected Advanced Solid Tumours,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
MDNA11-01,A Beta-only IL-2 ImmunoTherapY (ABILITY) Study,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
SGNTGT-001,A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
PT199X1101,Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
GB1275-1101 (KEYNOTE-A36),GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma,Terminated,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
INCAGN 2385-101,A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies,Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
IB 2017-01,A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
INCAGN 2390-101,A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
NU04,.Exercise and Follow-up After a Mastectomy,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
STUDY00001436,Enhance the Use of Genetic Counseling and Testing in Latinas,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,Not Applicable,No,No
20430,HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Procedure, Other",Parallel Assignment,Not Applicable,No,No
STUDY00015588,Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial,Recruiting,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Procedure, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Biological, Biological, Drug, Other, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
IRB00092505,Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy,Not yet recruiting,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Sequential Assignment,Not Applicable,No,No
NX-1607-101,A Study of NX-1607 in Adults With Advanced Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
GLP-CDK-1009,Evaluation of GLR2007 for Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
Teleclub_cam,Telerehabilitation in Oncology Patients,Unknown status,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,Not Applicable,No,No
HZDH20-002,Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 1,No,No
Pro00100029,Calming Alternatives Learned During MRI-Guided Breast Biopsy,Completed,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
2022-0712,Feasibility Study: IGNITE-TX (Identifying Texans at Risk for Hereditary Cancer) Intervention,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,Not Applicable,No,No
2018-0439,Genetic Education in BRCA Families,Enrolling by invitation,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
CR109080,A Study of Lazertinib (JNJ-73841937) in Healthy Participants,Completed,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
GIMI-IRB-20004,4SCAR-CD44v6 T Cell Therapy Targeting Cancer,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",No,No
2020-0079-E,Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program,Recruiting,Interventional,"Experimental, Other","Other, Behavioral",Parallel Assignment,Not Applicable,No,No
EOC317X1101,Study of EOC317 in Chinese Patients With Advanced Solid Tumors,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,No,No
IRB00056774,Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
EAQ202,Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials,Recruiting,Interventional,"Other, Other",Other,Parallel Assignment,Early Phase 1,No,No
V937-013,A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013),"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
10000045,"T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers",Recruiting,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,Phase 1,Yes,No
19-006717,Cancer Genetic Testing in Ethnic Populations,Recruiting,Interventional,Experimental,"Procedure, Other",Single Group Assignment,Not Applicable,No,No
ATLAS-101,A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies,Recruiting,Interventional,Experimental,"Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
19-151,Personalized Disease Prevention,Recruiting,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,Not Applicable,No,No
21-00715,Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain,Recruiting,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,Phase 3,Yes,No
TAC01-HER2-03,TAC T-cells for the Treatment of HER2-positive Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",Yes,No
UW17009,Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Radiation",Single Group Assignment,Early Phase 1,Yes,No
UMCC 2021.076,Methods for Increasing Genetic Testing Uptake in Michigan,Recruiting,Interventional,"Active Comparator, Experimental, Experimental","Other, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
H19-04010,Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
F/N-R19-3893L,Effect of Hemp-CBD on Patients With CIPN,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,Phase 2,Yes,No
CRUKD/21/005,TT-702 in Patients With Advanced Solid Tumours.,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",No,No
YXLL-KY-2022(057),Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients,Completed,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
ISI dV Xi-NSM,Robotic-Assisted da Vinci Xi Prophylactic Nipple-Sparing Mastectomy,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
16712,A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
HREBA.CC-20-0098,EXCEL: Exercise for Cancer to Enhance Living Well,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
IPO/PI134,Impact of Group Psychological Interventions on Extracellular Vesicles in People Who Had Cancer,Unknown status,Interventional,"Experimental, Experimental, Other","Behavioral, Behavioral, Other",Parallel Assignment,Not Applicable,No,No
IMM2520-001,"IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
OM-GRPR-02,Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
17493,A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
LOXO-IDH-20002,Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
1623168,Healthy Moms: Prenatal Counseling for Postpartum Health,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
PACT-0101,A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors,Suspended,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,Phase 1,Yes,No
PROICM 2021-05 SER,Quantifying Systemic Immunosuppression to Personalize Cancer Therapy,Withdrawn,Interventional,Experimental,Diagnostic Test,Single Group Assignment,Not Applicable,No,No
IRB-300002068,Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health,Recruiting,Interventional,"Experimental, Experimental, Experimental","Behavioral, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
0000-0001-5580-7256,Education Intervention in Patients With Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.,Unknown status,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,Not Applicable,No,No
2017-0319,Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF,Recruiting,Interventional,Experimental,"Procedure, Procedure, Radiation, Radiation, Procedure, Procedure",Single Group Assignment,Phase 1,Yes,No
ATOS-016R,Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density,Recruiting,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
Pro00104093,Assessing the Immunogenicity of pING-hHER3FL,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
VNC-236-101,Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
Metabolic Cancer 001,"Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer",Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,No,No
19-000756,Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues,Recruiting,Interventional,Experimental,"Procedure, Radiation, Radiation, Procedure, Radiation",Single Group Assignment,Early Phase 1,Yes,Yes
7339-002,"Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
2018-001744-62,Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors,Suspended,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
20-533,Pembrolizumab And Lenvatinib In Leptomeningeal Metastases,Recruiting,Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
D9950C00001,First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours,"Active, not recruiting",Interventional,"Experimental, Experimental","Drug, Biological",Sequential Assignment,Phase 1,Yes,No
19-011472,"Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study","Active, not recruiting",Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,Phase 1,No,No
7684A-005,MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
2017-0719,Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT,Recruiting,Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,Phase 1,Yes,No
CBX-12-101,Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
1801,9-ING-41 in Patients With Advanced Cancers,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
IJB-IRAES-2020,Immunological Variables Associated to ICI Toxicity in Cancer Patients,Recruiting,Interventional,,Drug,Single Group Assignment,Phase 2,No,No
IRB00229163,Behavioral Weight Loss Program for Cancer Survivors in Maryland,"Active, not recruiting",Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
ON-1002,"A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer",Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
SGN47M-001,A Safety Study of SGN-CD47M in Patients With Solid Tumors,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
P-MUC1C-ALLO1-001,P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,Phase 1,Yes,No
NTI1GSA,"Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid",Recruiting,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,Phase 1,No,No
FT538-102,FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Combination Product, Combination Product",Sequential Assignment,Phase 1,Yes,No
OHSN-REB#20170381-01H,Randomized Trial of eOncoNote,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
H-43405 VISTA,"Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors",Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
QUILT-2.025,QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.,Unknown status,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
ZZTIL-012,Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors,Recruiting,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
20201421,"With Love, Grandma (Con Cariño, Abuelita) Pilot Study",Recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
YSCH-01-0000,Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,No,No
SNB101P01,"Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,No,No
1224/2018,Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy,Recruiting,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,Not Applicable,No,No
438-IO-101,Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
831-IO-101,Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,Phase 1,Yes,No
BHP0120,A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation,Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Phase 2,No,No
CDX527-01,A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
Meet-URO 12,Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy,Completed,Interventional,"Experimental, Other","Drug, Other",Parallel Assignment,Phase 2,Yes,No
NC318-01,A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
STR-004-001,Strata PATH™ (Precision Indications for Approved Therapies),Recruiting,Interventional,"Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,Phase 2,Yes,No
Pro00103249,Symptom Management for YA Cancer Survivors,Recruiting,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,Not Applicable,No,No
21850,Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Drug, Drug",Parallel Assignment,Phase 1,Yes,Yes
180049,Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Biological, Drug",Parallel Assignment,Phase 2,Yes,No
ARC-5 (AB928CSP0005),A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies,Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
201809177,PROactive Evaluation of Function to Avoid CardioToxicity,Terminated,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,Phase 2,No,Yes
2020-2110,Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel,Completed,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
IIT2020-24-SHIRAZIP-BURN,The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
PY159-2-01,A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
C3651010,Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Palliach,Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care,Unknown status,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
TAK-500-1001,A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
PRT1419-02,A Study of PRT1419 in Patients With Advanced Solid Tumors,Completed,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,Yes,No
IIT2020-13-GRESHAM-ELLY,Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
2018-0663,Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients,Recruiting,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,Phase 1,Yes,No
C3441037,A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors,Completed,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,Phase 1,Yes,No
CE 07-14-2020,Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
ELVCAP-001-01,Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,Yes,No
143631,"Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.",Withdrawn,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
ZZITICI-004,Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,"Phase 2, Phase 3",Yes,No
QBS-72S-1001,"Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S",Completed,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
2440LM-002,DNX-2440 for Resectable Colorectal Liver Metastasis,Recruiting,Interventional,"Experimental, Experimental, Experimental",Biological,Sequential Assignment,Phase 1,Yes,No
DB-1303-O-1001,A Study of DB-1303 in Advanced/Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Single Group Assignment,"Phase 1, Phase 2",Yes,No
VISTA-101,A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
ZZICI3-015,Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
ALS-6000-101,"A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours",Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
AA1809,Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors,Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
PMV-586-101,The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
AMXT1501-102,Oral AMXT 1501 Dicaprate in Combination With IV DFMO,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
201909133,Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
FPI-1966-101,A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,"Phase 1, Phase 2",Yes,No
JAB-3312-1002,A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China,Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
707-IO-101,Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Factorial Assignment,"Phase 1, Phase 2",Yes,No
UW18101,Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction,Completed,Interventional,Experimental,Dietary Supplement,Single Group Assignment,Phase 3,No,No
JAB-3312-1001,"A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors",Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
PAL-E602-001,Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,"Phase 1, Phase 2",Yes,No
340-74,CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC),Withdrawn,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,Yes,No
PRO17070414,Self-Advocacy Serious Game in Advanced Cancer,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
MAPreminder1,UCLA Health Patient Health Maintenance Text Reminder,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
MFLeong,RCT of Acceptance and Commitment Therapy Versus Mindfulness-based Stress Reduction in Head and Neck Cancer,Not yet recruiting,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
1100,NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy,Recruiting,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
MAPinitial,UCLA Health Patient Health Maintenance Outreach Text Message,Enrolling by invitation,Interventional,"Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
MAPreminder2,UCLA Health Patient Health Maintenance With Interactive Text Reminder,Not yet recruiting,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
G190165,Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites,"Active, not recruiting",Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
JSKN003-102,To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,Phase 1,No,No
RAIN-3202,Milademetan in Advanced/Metastatic Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
56160922.7.3001.5274,Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds,Not yet recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,No,No
A222001,Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer,Recruiting,Interventional,"Experimental, Experimental, Placebo Comparator, Placebo Comparator","Drug, Drug, Other, Other",Crossover Assignment,Phase 2,Yes,No
CH1701,CH1701 for Prevention and Treatment of Radiation Burns,Unknown status,Interventional,"Placebo Comparator, Placebo Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",No,No
D0816C00020,Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients,Completed,Interventional,Experimental,Drug,Single Group Assignment,Phase 3,No,No
K01CA190659,Culturally Appropriate Nutrition Communication for Mexican American Women,"Active, not recruiting",Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,Not Applicable,No,No
TOS-358-001,A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors,Recruiting,Interventional,Experimental,Drug,Single Group Assignment,Phase 1,Yes,No
UW19-183,"The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence",Recruiting,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
SI-B003-101,"A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors",Recruiting,Interventional,Experimental,Drug,Sequential Assignment,Phase 1,No,No
PROT004,Virtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With Cancer,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,Not Applicable,No,Yes
EK 1612/2018,Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing,Completed,Interventional,"Other, Other",Procedure,Parallel Assignment,Not Applicable,No,No
202006168,Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome,Recruiting,Interventional,"No Intervention, Experimental",Other,Sequential Assignment,Not Applicable,No,No
BO41929,A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
IRB202201399 -N-R,A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials,Not yet recruiting,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,Not Applicable,No,No
FLX475-02,Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
2019-A02135-52,Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine,Recruiting,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other",Genetic,Single Group Assignment,Phase 2,No,No
18-504,Smartphone Technology to Alleviate Malignant Pain (STAMP),Completed,Interventional,Other,Behavioral,Single Group Assignment,Not Applicable,No,No
DB-1305-O-1001,First-in-human Study of DB-1305 for Advanced/Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,"Phase 1, Phase 2",Yes,No
TAS0612-101,A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer,Recruiting,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,Phase 1,Yes,No
IIT2021-07-Atkins-CARMA,Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial,"Active, not recruiting",Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
1948-CL-0101,"A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
CO-338-100,A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes,Terminated,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
STUDY00020629,Identifying and Caring for Individuals With Inherited Cancer Syndrome,Recruiting,Interventional,Other,"Procedure, Other, Other, Other",Single Group Assignment,Not Applicable,No,No
E7766-G000-101,Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101,Completed,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
NRG-GU006,BIOMARKER TRIAL of APALUTAMIDE and RADIATION for RECURRENT PROSTATE CANCER,"Active, not recruiting",Interventional,"Placebo Comparator, Experimental","Drug, Radiation, Other",Parallel Assignment,Phase 2,Yes,No
BBI-20201001,A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
ZWI-ZW49-101,A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers,Recruiting,Interventional,Experimental,Drug,Parallel Assignment,Phase 1,Yes,No
BVAC-B-P1,Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care,Completed,Interventional,Experimental,Biological,Single Group Assignment,Phase 1,No,No
IDE397-001,Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
MDK-703-102,A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors,Recruiting,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
19-011444,Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,"Phase 2, Phase 3",Yes,No
ATTCK-34-01,Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers,Terminated,Interventional,Experimental,"Biological, Drug",Single Group Assignment,Phase 1,Yes,No
BDTX-189-01,"A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.",Terminated,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
DB-1310-O-1001,A Study of DB-1310 in Advanced/Metastatic Solid Tumors,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
NRG-GU009,"Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial",Recruiting,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other, Other, Radiation, Drug",Parallel Assignment,Phase 3,Yes,No
17504,A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer,Completed,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 1,Yes,No
DGD-44-065,Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years,Recruiting,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure, Procedure, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 4,Yes,No
22-OBU-SH-CA-II-019,Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 1,No,No
20220586-01H,Reexamining Her Cardiovascular Risk - Ottawa WomeNs Longitudinal Cohort Study,Not yet recruiting,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,Not Applicable,No,No
D8532C00004,"Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers",Completed,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 1,Yes,No
CLIN-17-008,Study of the Safety and Effectiveness of Motiva Implants®,"Active, not recruiting",Interventional,"Other, Other, Other, Other",Device,Single Group Assignment,Not Applicable,No,Yes
Ad-p53-002,Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.,Unknown status,Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
TUMAGNOSTIC(CP506-001),Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI,Not yet recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",No,No
20210104,A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression,Recruiting,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,Phase 1,Yes,No
217228,First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
FT516-102,FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors,Completed,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
IMC-F106C-101,Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,"Phase 1, Phase 2",Yes,No
TK-Onko,Evaluation of a Oncology Day Care Unit Programme With Two Different Focuses,Completed,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
Pro00103812,Neoadjuvant Immunotherapy in Brain Metastases,Terminated,Interventional,"No Intervention, Experimental","Drug, Drug",Single Group Assignment,Phase 2,Yes,No
17894,Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children,Completed,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
M19-345,"Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of ABBV-151 as a Single Agent and in Combination With ABBV-181 in Participants With Locally Advanced or Metastatic Solid Tumors",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
21-00072,Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy,Completed,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 4,Yes,No
20246,"Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants",Completed,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,Phase 1,Yes,No
UW21090,The Effect of Surgeon Emotional Support on Treatment Choice for Low-risk Thyroid Cancer,Completed,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
18-222,GENetic Education Risk Assessment and TEsting Study,"Active, not recruiting",Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
4830-001,Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological",Parallel Assignment,Phase 1,Yes,No
2020-002766-14,Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,Phase 2,No,No
AG0315OG/CTC0140,RegoNivo vs Standard of Care Chemotherapy in AGOC,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
63646,Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer,Recruiting,Interventional,"Active Comparator, Experimental","Other, Behavioral",Parallel Assignment,Not Applicable,No,No
201617079.3,Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following BCS,Unknown status,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,Not Applicable,No,No
C4221015,A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
ARRAY-818-202,An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,Yes,No
03.CP.0.3,Study to Evaluate VORTX Rx (Theresa),Completed,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
0482-001,A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001),Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
GO42144,"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation",Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,Phase 1,Yes,No
Ordu55,Nutrition Education and Quality of Life in Cancer Cachexia,Not yet recruiting,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
ORDU551,"Slimming Myokines, Cancers,Nutritional and Psychology Support",Not yet recruiting,Interventional,"Other, Other, Other, Other","Other, Other, Other, Other",Crossover Assignment,Not Applicable,No,No
ONO-4059-09,Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study),Recruiting,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,Phase 2,Yes,No
19741,"Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,Phase 1,Yes,No
JTX-8064-101,"Study of JTX 8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors","Active, not recruiting",Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,"Phase 1, Phase 2",Yes,No
IBC0966-I/IIa,Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,"Phase 1, Phase 2",No,No
LCH-112020,Subzero and Scorpion Trial,Recruiting,Interventional,,Procedure,Single Group Assignment,Phase 2,No,No
"019/026/ICI, CEI/1330/18",Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients,Unknown status,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,Not Applicable,No,No
HP-00070946,Exercise Effect on Chemotherapy-Induced Neuropathic Pain,"Active, not recruiting",Interventional,"Other, Experimental, Experimental","Behavioral, Other, Behavioral",Parallel Assignment,Not Applicable,No,No
FGCL-4592-898,A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies,Recruiting,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,Phase 3,No,No
2000034075,Buprenorphine Integration Research and Community Health,Recruiting,Interventional,Experimental,Behavioral,Single Group Assignment,Not Applicable,No,No
APHP180586,Evaluating Effectiveness of a Communication Facilitator : A Randomized Trial,Unknown status,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NCI-2020-07841,Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer,Recruiting,Interventional,Experimental,"Procedure, Procedure, Drug, Biological",Single Group Assignment,Phase 1,Yes,No
S60857,FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
T30-0002,Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood,Unknown status,Interventional,Experimental,Device,Single Group Assignment,"Phase 1, Phase 2",No,Yes
CAMH2_1001,"A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer",Recruiting,Interventional,Experimental,Drug,Sequential Assignment,"Phase 1, Phase 2",Yes,No
CIRB Ref. No: 2019/2135,Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial,Unknown status,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,Phase 2,No,No
Nigeria World Cancer Walk 2022,"Step up to Health, Nigeria! Impact of 2022 World Cancer Day Walk on Health Behaviors Among Nigerians",Not yet recruiting,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
NRG-HN010,"Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) for Recurrent, Metastatic, or Unresectable HER2-Positive Salivary Gland Cancer",Recruiting,Interventional,"Active Comparator, Experimental","Drug, Other, Biological, Biological",Parallel Assignment,Phase 2,Yes,No
D081SC00001Sub,Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort),"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
D081SC00001,Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer,"Active, not recruiting",Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,Phase 3,Yes,No
H18-02052,BREAST ADM Trial for Alloplastic Breast Reconstruction,Unknown status,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Device, Device, Device, Device",Parallel Assignment,Not Applicable,No,No
REG-114-2019,Histopathologic Effect of Calcium Electroporation on Cancer in the Skin,Recruiting,Interventional,Experimental,Combination Product,Single Group Assignment,Phase 2,No,No
20-0270-E,Family History App in Personalized Medicine,"Active, not recruiting",Interventional,"Experimental, No Intervention",Other,Parallel Assignment,Not Applicable,No,No
PRO00104179,Onco-primary Care Networking to Support TEAM-based Care,Recruiting,Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,Not Applicable,No,No
SJHH_PSPM,Post SBRT Pulmonary Metastasectomy (PSPM) Trial,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
823871-iGame,Digital Intervention for the Modification of Lifestyles (iGame),Not yet recruiting,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
2018-0419,Pediatric Reporting of Adult-Onset Genomic Results,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Genetic, Genetic, Genetic",Parallel Assignment,Early Phase 1,No,No
2019-00965,The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer,Completed,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
COALESE/2021/103,Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy,Recruiting,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2017_71,PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Pagets Disease of the Vulva (EMPV).,Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
PYC001,The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments,Unknown status,Interventional,"Experimental, Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement, Dietary Supplement",Crossover Assignment,Not Applicable,No,No
22-01516,NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation,Not yet recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
2U01HG007292-05,Cancer Health Assessments Reaching Many,"Active, not recruiting",Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,Not Applicable,No,No
20201224,Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate,Not yet recruiting,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,Phase 2,No,No
CTMS# 19-0069,Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Early Phase 1,Yes,No
E2019453,Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.,Unknown status,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
21-103,A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer,"Active, not recruiting",Interventional,Experimental,Behavioral,Single Group Assignment,Early Phase 1,No,No
ABCSG C08,ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer,Recruiting,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,Not Applicable,No,No
PCA001,Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer,Recruiting,Interventional,,"Biological, Biological",Single Group Assignment,"Phase 1, Phase 2",Yes,No
CASE1121,Prepectoral vs Partial Subpectoral Two-Stage Implant-Based Breast Reconstruction,Not yet recruiting,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
Nigeria Cancer Walk,"Step up to Health, Nigeria! Impact of World Cancer Day Walk on Health Behaviors Among Nigerians",Completed,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,Not Applicable,No,No
20-565,Comparing Two Different Surgical Techniques for Breast Reconstruction,Withdrawn,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,Phase 3,No,No
Arabic BREAST-Q,Validity and Reliability of Arabic Version of Breast Questionnaire,Not yet recruiting,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
UPCC 11919,Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients,Recruiting,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,Not Applicable,No,No
segmental thoracic TEA-spinal,US-guided Thoracic Spinal Epidural Anesthesia VS GA for Abdominal and Breast Surgeries,Completed,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,Not Applicable,No,No
IRB-22-34,Comparison of Patient Satisfaction in Post-operative Breast Surgery Patients Having Physical Clinic and Tele Clinic Follow up: A Randomized Controlled Trial,Enrolling by invitation,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,Not Applicable,No,No
PSCI-19-112,Diminish Chemotherapy Related Side Effects Through Patient Education,Recruiting,Interventional,Experimental,Other,Single Group Assignment,Not Applicable,No,No
2016-0463,REVOLVE or PureGraft Technique in Processing Fat Grafts for Patients Undergoing Breast Reconstruction,Completed,Interventional,"Experimental, Experimental","Other, Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
IIT-0013,MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1),Recruiting,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
BND and RND,Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection,Unknown status,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,Not Applicable,No,No
TheNethersole,Effects of Music Intervention Combined With Progressive Muscle Relaxation in Cancer Patients,Completed,Interventional,"Experimental, No Intervention","Other, Other",Parallel Assignment,Not Applicable,No,No
N-111012422,Diet Effect on Cancer Treatment Outcome,"Active, not recruiting",Interventional,"Active Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, No Intervention, No Intervention","Dietary Supplement, Other",Parallel Assignment,Phase 1,No,No
302,"177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)",Withdrawn,Interventional,Experimental,Biological,Single Group Assignment,"Phase 1, Phase 2",Yes,No
MC01/01/19,Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE),Unknown status,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,Not Applicable,No,No
LCCC1748,Academic-Industrial Partnership for Translation of Acoustic Angiography,Completed,Interventional,"Experimental, Experimental","Device, Drug",Sequential Assignment,Phase 4,No,Yes
69HCL22_0466,Lung Cancer Screening Implementation Among Employees at Lyon Hospital,Not yet recruiting,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,Not Applicable,No,No
IMPACNEO,IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients,Recruiting,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
GCO 19-2707,To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer,Withdrawn,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,Phase 2,Yes,No
RECO_CT29A,Investigation of Urinary Biomarkers for the Detection of Prostate Cancer,Suspended,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,No
INT 292/20,Lung Cancer Prevention Screening Programme in Italy,Recruiting,Interventional,"Experimental, Experimental","Diagnostic Test, Other",Parallel Assignment,Not Applicable,No,No
STUDY21020095,Efficacy of a Self-advocacy Serious Game Intervention,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
D967MC00001,A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations,"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
UHHeidelberg,Decision Aid to Support Advanced Cancer Patients,Recruiting,Interventional,"No Intervention, Other",Other,Sequential Assignment,Not Applicable,No,No
R01CA205025,Understanding the Post-Surgical Non-Small Cell Lung Cancer Patients Symptom Experience,Recruiting,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
HCB/2021/0130,Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer,Recruiting,Interventional,Experimental,Procedure,Single Group Assignment,Not Applicable,No,No
S1614,Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors,"Active, not recruiting",Interventional,"Experimental, Experimental, Experimental","Other, Drug, Drug, Drug",Parallel Assignment,Phase 3,Yes,No
TMHPO1763,A Pilot Study on HPV and Cervical Cancer Screening in Mumbai,Unknown status,Interventional,Other,Other,Single Group Assignment,Not Applicable,No,No
APHP210359,Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II),Not yet recruiting,Interventional,Other,Procedure,Single Group Assignment,Not Applicable,No,No
M16VIB,Vinorelbine in Advanced BRAF-like Colon Cancer,Unknown status,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,Phase 2,No,No
EPOC1903,Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer,"Active, not recruiting",Interventional,Experimental,"Drug, Drug",Single Group Assignment,Phase 2,No,No
CASE2118,Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye,Suspended,Interventional,Experimental,Device,Single Group Assignment,Not Applicable,No,Yes
PARALUC,Pneumonitis After Radiotherapy for Lung Cancer,Recruiting,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,Not Applicable,No,No
CTC20200417,Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy,Completed,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,Not Applicable,No,No
CASE4119,The Impact of Functional Medicine On Wound Healing From Delayed Autologous Breast Reconstruction,Recruiting,Interventional,"Active Comparator, Experimental","Procedure, Behavioral",Parallel Assignment,Not Applicable,No,No
29BRC20.0021,Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism,Recruiting,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,Not Applicable,No,No
CRUKD/21/004 - Treatment Arm 2,"DETERMINE Trial Treatment Arm 2: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition",Not yet recruiting,Interventional,Experimental,Drug,Single Group Assignment,"Phase 2, Phase 3",No,No
20201491,Culturally Tailored Nurse Coaching Study for Cancer Symptom Management,Recruiting,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,Not Applicable,No,No
32900654326,"TPVB, PECSB, ESPB for Postmastectmy Pain",Completed,Interventional,"Placebo Comparator, Active Comparator, Active Comparator, Active Comparator","Procedure, Drug",Parallel Assignment,Not Applicable,No,No
ReDA 13176,A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.,Not yet recruiting,Interventional,"Active Comparator, Experimental","Radiation, Drug, Drug, Drug, Drug, Other, Radiation, Procedure, Other, Radiation",Parallel Assignment,Phase 3,No,No
64121317.4.1001.5330,Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial),"Active, not recruiting",Interventional,Experimental,Drug,Single Group Assignment,Phase 2,Yes,No
3-2020-0038,Intraoperative Radiation Therapy for Resectable Pancreatic Cancer,Recruiting,Interventional,Experimental,Radiation,Single Group Assignment,Not Applicable,No,No
